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This thesis is structured in 7 chapters, which are preceded by a summary, both in Portuguese and 
English, outlining the aims, results and outcomes, of this Malaria research project. The first chapter 
places our work within the Malaria scientific field giving a background and significance of its input, 
and also specifies the objectives that we proposed to accomplish. A general introduction to Malaria 
ant its current world situation is presented in chapter two, together with a literature review of the 
late insights to liver stage biology and immunity, in addition to the present  knowledge concerning 
apoptosis at host-pathogen interface. A description of the methods and materials employed to carry 
out the present work is done in chapter three. The results obtained throughout this research project 
are presented in the next three chapters from four to six. Each one is organized as follow: a short 
specific introduction to the particular subject, data observed and analyzed, and a discussion of those. 
Finally, chapter seven encloses an overall discussion and conclusion of the studies performed, 
together with an additional perspective of the recent highlights to what lies ahead within this 




The data presented in this dissertation is the result of my own work and it is stated in the text 
whenever data or reagents produced by others as part of collaborations were used. This work has 























































Cover Legend| A cell undergoing apoptosis with generation of apoptotic bodies that are engulfed by a phagocyte. 
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A malária é uma das doenças infecciosas mais importantes a nível mundial, sendo anualmente 
responsável por mais de 1 milhão de mortes. O agente causador da doença é o parasita intracelular, 
denominado Plasmodium, que possui um ciclo de vida bastante complexo. A infecção tem início com 
a inoculação de esporozoítos através da picada de um mosquito fêmea Anopheles, o vector de 
transmissão da doença. Uma vez na corrente sanguínea, o esporozoíto migra até ao fígado onde 
infecta a célula hospedeira, o hepatócito. No fígado, o parasita replica-se e desenvolve-se até atingir 
o seu próximo estado de maturação – o merozoíto. 
Dada esta complexidade, é natural que o Plasmodium provoque no hospedeiro uma variedade de 
mecanismos distintos, especialmente ao nível imunitário. Por isso, a resposta imune desenvolvida 
pelo hospedeiro, contra o parasita, é caracterizada como sendo complexa e específica em relação à 
espécie e ao estádio do mesmo. 
De forma a adquirir uma resposta imune protectora contra a malária é necessário que o indivíduo 
seja infectado consecutivamente durante a vida. Mesmo assim o resultado obtido é apenas uma 
imunidade parcial contra o parasita.  
Melhorias significativas têm sido registadas, no que diz respeito à compreensão dos mecanismos de 
protecção envolvidos na doença, assim como na identificação de novas moléculas que possam ser 
utilizadas no desenvolvimento de novas vacinas. No entanto, ainda não está disponível uma vacina 
que seja eficaz conferindo uma protecção total.  
O uso de esporozoítos irradiados em imunizações induz uma protecção total contra a doença, que é 
mediada pela activação de linfócitos T CD8+ específicos para antigénios do parasita. O início desta 
resposta é mediado por células dendríticas, embora a origem dos antigénios intervenientes seja ainda 
desconhecida. 
Os esporozoítos irradiados conseguem infectar os hepatócitos. Contudo, não são capazes de 
progredir para a fase sanguínea da doença. Este desenvolvimento incompleto da fase hepática é uma 
característica fundamental para que ocorra imunidade. Embora alguns dos mecanismos protectores 
induzidos pela infecção com esporozoítos irradiados já tenham sido identificados é, ainda, 
necessário proceder a uma caracterização detalhada dos mesmos. 
Sendo o fígado um local de extrema importância durante o ciclo de vida do parasita da malária, 
qualquer descoberta ao nível das interacções que se estabelecem entre o Plasmodium e o hepatócito, 
terá uma repercussão no melhoramento do processo de indução de uma resposta imune contra a 
doença. 
Utilizando um modelo murino, demonstrou-se que os hepatócitos infectados com esporozoítos 
irradiados entram em apoptose logo após o início da infecção. Durante esta fase as células 
Sumário|vii 
 
dendríticas são recrutadas para o fígado, local onde fagocitam os corpos apoptóticos provenientes 
dos hepatóctios que entraram em morte celular. Uma vez que estas células são capazes de apresentar 
antigénios exógenos e ainda induzir o priming e activação das células T, os resultados por nós obtidos 
sugerem que os hepatócitos infectados apoptóticos são a fonte de antigénios do parasita utilizada 
pelas células dendríticas durante a iniciação de uma resposta imune contra a malária.  
Durante o curso de uma infecção, a morte celular possui um papel fundamental no estabelecimento 
de uma resposta imune contra um agente patogénico. Os parasitas possuem a capacidade de 
modular esta resposta através da indução ou inibição da morte da célula hospedeira, de forma a 
possibilitar o seu desenvolvimento e sobrevivência. 
Previamente, foi demonstrado que durante a migração dos esporozoítos através dos hepatócitos, as 
células atravessadas secretam um factor de crescimento específico, o HGF -“hepatocyte growth 
factor”, que aumenta a susceptibilidade celular à infecção. Esta via de sinalização iniciada pelo HGF 
através do seu receptor, o MET, provoca uma série de efeitos em diversos tipos de células. Entre 
eles destaca-se a protecção contra a morte celular programada. Considerando tal facto, estudou-se 
qual o efeito desta protecção durante a infecção por Plasmodium, tendo como hipótese que a 
activação da via de sinalização do HGF/MET induziria uma protecção da apoptose nas células 
infectadas. Os resultados por nós obtidos confirmaram esta teoria. A inibição desta via de 
sinalização induziu um aumento na quantidade de morte celular observada. 
Tendo em conta que, usualmente, a activação da sinalização do HGF ocorre segundo o sinal de 
transdução do PI3K/Akt, testou-se se o bloqueio desta via produzia algum efeito na infecção. De 
facto, os resultados observados indicam que esta via de sinalização é utilizada durante a infecção 
quando o HGF/MET é activado. Estas observações demonstram que a inibição da apoptose da 
célula hospedeira durante a infecção por Plasmodium é necessária para ocorrer doença. 
Na parte final deste trabalho, procurou-se ainda identificar um gene do parasita responsável pela 
inibição da morte do hepatócito. Algumas observações preliminares levaram-nos a sugerir que a 
proteína HSP70 do parasita possa exercer uma função neste processo, daí que sugerimos que no 
futuro este envolvimento seja mais aprofundado. 
Assim, os resultados apresentados nesta tese contribuem para um maior esclarecimento e 
compreensão das interacções que se estabelecem no fígado aquando da infecção por Plasmodium, e 
para um conhecimento mais alargado da relação entre o parasita e o hepatócito.   
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Malaria is one of the most predominant infectious diseases worldwide, accounting for more than 1 
million deaths annually. The intracellular parasite Plasmodium is the causative agent of malaria which 
undergoes a complicated life cycle. Infection is initiated by inoculation of sporozoites through 
mosquito bite, which journey to the liver where they must migrate and invade hepatocytes in order 
to replicate and mature.  
Immunity to malaria is complex and is essentially both species and stage specific, thus a wide variety 
of distinct immune mechanisms are provoked by the parasite in the host.  
The generation and maintenance of protective immune responses requires repeated infections over 
the lifetime of an individual and even though only partial immunity is achieved against the disease. 
Despite the significant advances in understanding mechanisms of protection and identifying new 
targets for vaccine design, an effective protection against malaria is still not available.  
However, immunization with irradiated Plasmodium sporozoites induces antigen-specific CD8+ T 
cells immune response that confers complete protection against malaria. The initiation of this 
response is mediated by dendritic cells, but the source of parasite antigens intervening in this 
response remains unknown. Irradiated sporozoites are capable of infecting hepatocytes but do not 
progress into blood stages forms. Both this incomplete liver development and the hepatic stage itself 
are indispensable steps for the outcome of a successful malaria protection. Although some 
protective mechanisms conferred by irradiated sporozoites have been identified, a thorough 
characterization is still needed. 
The liver plays a key role in the life cycle of the malaria parasite and therefore insights into 
Plasmodium-hepatocyte interactions will have a promising effect in improving the process of 
triggering an immune response against the disease. 
Using a rodent malaria model, we show that hepatocytes infected with irradiated Plasmodium 
sporozoites undergo apoptosis shortly after infection. In addition, after infection dendritic cells are 
recruited to the liver where they phagocytose apoptotic bodies derived from infected hepatocytes. 
Given that dendritic cells are capable of cross-presenting exogenous antigens and elicit the priming 
and activation of T cells, our results suggest that the apoptotic Plasmodium infected hepatocytes 
provide a source of parasite antigens for the initiation of the protective immune response against the 
disease. 
Cell death plays a central role in the course of an infection helping establish an immune response 
against a pathogen. Furthermore, some parasites have the capacity to modulate this response by 




Previously it was shown that wounding of hepatocytes by sporozoite migration induces the secretion 
of hepatocyte growth factor (HGF) by traversed cells, which renders neighbor hepatocytes 
susceptible to infection. The signaling initiated by HGF through its receptor MET has 
multifunctional effects on various cell types. Survival signals and protection of host cells is one of 
these features of HGF/MET signaling. The role of this protection on Plasmodium infected 
hepatocytes was also a subject of study in this thesis. 
Therefore, we hypothesize that HGF/MET would induce in infected host cells protection from 
apoptosis, which in turn would lead to an increased infection. Our data confirms that HGF/MET 
signaling protects infected cells from apoptosis, since an increase in apoptosis of infected cells was 
observed when the signaling pathway was inhibited. 
Given that HGF inhibits cell death primarily through the PI3-kinase/Akt signal transduction 
pathway, we tested if the infection susceptibility increase was impaired by inhibition of this pathway. 
In fact, inhibition of PI3-kinase completely abrogates the HGF effect on malaria infection. Taken 
together, these results implicate that the permissive effect of HGF for susceptibility to malaria 
infection is, at least in part, mediated by its anti-apoptotic signal. To our knowledge, these results 
demonstrate for the first time that active host’s cell apoptosis inhibition during infection by 
Plasmodium is required for a successful infection. 
Finally, an attempt at identifying a Plasmodium candidate gene responsible for the apoptosis inhibition 
of the host cell was carried out. Preliminary results evidence a promising role for Plasmodium heat 
shock protein 70 which broad function should be studied in the future. 
In summary, data presented in this thesis contributes to a wider understanding of the events that 
occur in the liver during a malaria infection and expand our knowledge within the interactions 
established between the malaria parasite and its host. 
 






Ab  antibody 
APC  antigen presenting cell 
CS  circumsporozoite protein 
CTL  cytotoxic T Lymphocyte 
DAPI   4'6-diamidino-2-phenylindole 
DC  dendritic cell 
DMEM Dulbeco’s modified  eagles medium  
EEF  exo-erythrocytic form 
FCS  Foetal calf serum 
FADD  Fas-associated death domain 
GFP  green fluorescence protein 
Hepa 1-6 mouse hepatoma cell line  
HepG2 human hepatoma cell line  
HGF  hepatocyte growth factor 
HSP  heat shock protein 
IFN  interferon 
IL  interleukin 
i.p.  intraperitoneal 
i.v.  intravenous 
MAPK  mitogen-activated protein kinase 
MET  tyrosine kinase receptor  
MHC  major histocompatibility complex 
NFkB  nuclear factor kappa B 
NK  natural killer cell 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PFA   paraformaldehyde  
PI3K   phosphoinositide 3-Kinase 
RT   room temperature 
RT-PCR reverse transcriptase polymerase chain reaction 
Spz  Sporozoite 
TNF  tumour necrosis factor 





Table of Contents 
Preface            iii 
 
Aknowledgements         v 
 
Sumário           vii 
 
Abstract           ix 
 
Abbreviations          xi 
 
Table of Contents          xiii 
 
Index of Figures          xv  
 
Index of Tables          xvi 
 
 
Chapter one                  
Background, Significance & Objectives       1  
 
1.1 Background and Significance          3 




General Introduction         7 
 
2.1 Malaria: historical aspects and current global picture     9 
2.2 Plasmodium life cycle         11 
2.3 Liver stage biology          12 
     2.3.1 From skin to liver         13 
     2.3.2 Reaching the liver         14 
     2.3.3 Hepatocyte invasion         16 
     2.3.4 Intrahepatic development        17 
2.4 Immunity to malaria liver stage        17 
     2.4.1 Natural infection versus immunization      18 
     2.4.2 Exo-erythrocytic antigens        19 
     2.4.3 Initiation of host immune response       20 
     2.4.4 Host immune responses after immunization      20 
2.5 Apoptosis at the host-pathogen interface       23 
     2.5.1 Cell death          23 
     2.5.2 Pathways of apoptosis        25 
     2.5.3 Intracellular living          27 
     2.5.4 Modulation of apoptosis and parasite survival/death     27  
     2.5.5 Modulation of apoptosis and immunity       30 
Table of Contents|xiii 
 
Chapter Three  
Materials and Methods         31 
 
3.1 Cells       33 
3.2 Parasites, mosquitoes and mice      33 
3.3 Sporozoite isolation and purification        33 
3.4 In vitro infections            33 
3.5 Immunofluorescence assays        34  
3.6 Cell treatment during sporozoite infection   35 
3.7 Apoptosis induction assays   35 
3.8 Detection of apoptosis            35 
3.9 Dendritic cell recruitment to the liver       36 
3.10 In vivo infection, isolation and staining of liver mononuclear cells   36 
3.11 Detection and quantification of in vivo Plasmodium sporozoite infection using Reverse       
        Transcription and Real-Time PCR       37 
3.12 Inhibition of PI3-kinase pathway during Plasmodium infection     37 
3.13 Analysis of AKT expression during Plasmodium infection     37  
3.14 Immunopreciptitation and Western blot analysis      38 
3.15 MET down-modulation by siRNA in hepatoma cell line     38 
3.16 Assembly of DN MET-GFP hepatoma cell line      39 
3.17 Isolation of plasmid DNA        39 
3.18 DNA restriction enzyme digestion        39 
3.19 DNA Electrophoresis         40 
3.20 DNA Extraction from agarose gels       40 
3.21 Cloning PCR products         40 
3.22 HSP70 construct          40 




Results I - Role of dendritic cells during liver stage malaria and the initiation of  
                     an immune response        41 
 
4.1 Introduction           43 
4.2 Results           45 
     4.2.1 Irradiated Plasmodium sporozoites induce infected hepatocytes apoptosis in vitro 45 
     4.2.2 The role of dendritic cells during P. yoelii infection     48 
               4.2.2.1 Recruitment of dendritic cells to the liver after malaria infection   49 
  4.2.2.2 Plasmodium antigens are phagocytosed by dendritic cells and macrophages 50 
  4.2.2.3 Establishment of a cross-presentation assay      53 
4.3 Discussion           54 
 
 
Chapter Five           
Results II - Anti-Apoptotic HGF/MET signalling in malaria infection   59 
 
5.1 Introduction           61 
5.2 Results           63 
     5.2.1 Sporozoite infection protects cells from apoptosis      63 
    5.2.2 HGF/MET signalling enhances infection and confers protection   64 




      5.2.4 MET down-regulation leads to apoptosis during infection    68 
     5.2.5 Anti-apoptotic effect of HGF/MET signalling is mediated via  
             activation of PI3K pathway        69 
     5.2.6 Inhibition of PI3K pathway decreases Plasmodium infection in vivo   70 
5.3 Discussion           70 
 
 
Chapter Six            
Results III - Does PyHSP70 inhibit infected hepatocyte apoptosis?    73 
 
6.1 Introduction           75 
6.2 Results           78 
     6.2.1 PyHSP70 expression protects hepatocytes from death    78  
     6.2.2 PyHSP70 knock out parasite         79 
6.3 Discussion           79 
 
 
Chapter Seven           
Final Discussion & Conclusion        81 
 
7.1 Final Discussion and Conclusion        83 
7.2 Perspectives          91 
 
 
Bibliography          93 
 
 






Index of Figures 
 
Fig. 2.1|Global distribution of malaria.       11  
Fig. 2.2|Plasmodium life cycle.       12  
Fig. 2.3|Pathways of apoptosis.       26 
Fig. 3.1|Schematic representation of the in vitro sporozoite infection system.   34  
Fig. 4.1|Time-course of an in vitro infection with non-irradiated or  
irradiated P. yoelii sporozoites.       46 
Fig. 4.2|Irradiated P. yoelii sporozoites lead to the apoptosis of the infected hepatocyte. 47 
Fig. 4.3|Quantification of apoptosis at early time points after infection.   47 
Fig. 4.4|Apoptotic cell infected with irradiated P. yoelii sporozoites.    48 
Fig. 4.5|Dendritic cells are present in the liver after infection with Plasmodium sporozoites. 49 
Table of Contents|xv 
 
Fig. 4.6|Dendritic cells are recruited to the liver after infection with P. yoelii sporozoites. 50 
Fig. 4.7|Phagocytosis of apoptotic hepatocytes containing Plasmodium antigens by  
             dendritic cells and macrophages.       51 
Fig. 4.8|Hepatocyte proteins are found in P. yoelii phagocytosed vesicles.   52 
Fig. 4.9|Caspase-3 is active in P. yoelii phagocytosed apoptotic bodies.   52 
Fig. 5.1|Schematic representation of the different pathways that are activated  
             by HGF/MET signalling.       62 
Fig. 5.2|Plasmodium infection protects from death.      63 
Fig. 5.3|Infected cells are more resistant to apoptosis.     64 
Fig. 5.4|HGF-induced MET activation enhances infection and protects  
              infected cells from apoptosis.       65 
Fig. 5.5|HGF agonists induce infection and host cell protection.    66 
Fig. 5.6|Inhibition of caspase activity increases infection.     66 
Fig. 5.7|MET inactivation leads to early apoptosis of infected cells.    67 
Fig. 5.8|Dominant negative MET-GFP infected cell undergoing apoptosis.   68 
Fig. 5.9|MET expression on short interfering RNA cell line.     68 
Fig. 5.10|Down-modulation of HGF/MET signaling leads to early apoptosis of  
                infected cells.       68 
Fig. 5.11|Inhibition of PI3K/AKT pathway in vitro leads to a decrease in infection.  69  
Fig. 5.12|In vivo inhibition of PI3K/AKT pathway during infection.    70 
Fig. 6.1|Events regulated by HSPs in the mitochondrial and death  
              receptor-mediated apoptotic pathways.       76 
Fig. 6.2|P. yoelii HSP70 protects hepatocytes from apoptosis.    79 
 
 
Index of Tables 
 



























1.1 Background and Significance 
Malaria is one of the most prevalent and severe human infectious diseases in the world. Recently its 
incidence has increased and it is estimated more than 300 million episodes of acute illness occur in 
endemic countries and at least 1 million people die per year from this disease (WHO, 2003). With 
41% of the world’s population exposed to this threat, malaria also imposes an extreme burden onto 
affected populations as economy and development are deeply impaired resulting from the 
symptoms experienced by infected individuals. Applicable measures to control the disease vary 
according to each country’s endemicity but several factors contribute to malaria resurgence such as 
drug-resistant parasite strains and insecticide-resistant mosquitoes (Greenwood et al., 2005; WHO, 
2003). 
After decades of a relative lack of attention, new efforts are presently being made to address these 
challenges, such as new strategies that are being applied to the development of an effective vaccine 
(Moorthy et al., 2004; Tongren et al., 2004). Although in terms of public health vaccination has 
always been a priority, it still remains an elusive and complex research field. A comprehensive 
knowledge of the host-parasite interface would constitute a reinsured guarantee for attaining this 
goal successfully.   
Malaria is caused by the intracellular Apicomplexan parasite Plasmodium spp., which holds a complex 
life cycle involving different hosts and stages of infection. The first step in malaria infection is the 
invasion of the liver by Plasmodium sporozoites. These are the infective form of the parasite, 
transmitted by female anopheline mosquitoes during a blood meal. Inside hepatocytes, sporozoites 
replicate and develop into a merozoite state, a process that constitutes the hepatic stage of the 
parasite life cycle. Although, being an obligatory step towards the establishment of a successful 
malaria infection, this stage of Plasmodium life cycle is poorly understood. This parasite specificity 
towards the liver cells indicates that parasite-encoded surface proteins and host surface receptors 
are implicated in the process of invasion and development, playing a key role in the establishment 
of infection. However, the mechanisms, as well as the host and parasite molecules, at play during 
the course of infection in the mammalian host by malaria sporozoites are not entirely known 
(Gruner et al., 2003; Miller et al., 2002; Plebanski and Hill, 2000). 
The full requirements for Plasmodium development inside hepatocytes are still unknown. The lack of 
an adequate in vitro system capable of delivering sufficient material has deeply impeded research 
within the study of host/parasite interactions. Currently, in vitro cultivation methods have been 
developed, and hepatoma cell lines are being used as in vitro models for Plasmodium infection to 
study the molecular and cellular basis of invasion mechanisms and intracellular development of the 
parasite. Nevertheless, infection yields remain very low and the limited number of infective 
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mosquitoes available impairs a swift progress in the understanding of malaria liver stage biology 
(Mota and Rodriguez, 2000; Calvo-Calle et al., 1994; Hollingdale et al., 1983b). 
The availability of the genome sequence of both several Plasmodium species and their host provides 
a genetic tool that greatly increases the possibilities of research in this area (Cooke and Coppel, 
2004). 
The liver, besides being the place where amplification and molecular changes of Plasmodium 
parasites take place, is also a unique organ in what regards the host’s immune responses (Knolle and 
Gerken, 2000). The antigenic pool generated within this organ is required for the induction and 
maintenance of a protective anti-malaria immune response. Thus, the hepatic stage may well hold 
the secret for understanding the parasite’s preference for this organ within the mammalian host and, 
simultaneously, providing effective immune targets against the disease (Baldacci and Ménard, 2004; 
Frevert, 2004; Krzych et al., 2000). 
Unlike many other diseases in which a lifelong resistance to re-infection is induced, malaria causes 
only partial immunity after several years of recurring infections and illness. Nonetheless, a complete 
resistance to malaria can be achieved by vaccination with radiation-attenuated sporozoites in both 
mice and humans (Doolan and Hoffman, 2000; Weiss, 1990; Clyde et al., 1975; Nussenzweig et al., 
1972; Nussenzweig et al., 1967). 
Irradiated sporozoites infect hepatocytes as normal sporozoites, but they do not reach a merozoite 
stage (Scheller et al., 1995; Sigler et al., 1984). Additionally, it is known that it is essential that a 
hepatic stage occurs during infection for the effectiveness of irradiated-sporozoite protection 
(Scheller and Azad, 1995). Although, until now this is the only vaccine that confers complete 
protection, the mechanism behind the process of the establishment of the immune response 
associated is still unclear (Doolan and Hoffman, 2000). 
Intracellular pathogens have the capacity to modulate the host cell response and exploit its resources 
in order to develop and replicate. Parasites can manipulate host cell behavior, including immune 
modulation and regulation of apoptosis (James and Green, 2004). While infected cells are capable of 
initiating their own death, a process called apoptosis, which can be used by the organism as a 
defense mechanism against pathogens, inhibition of host cell apoptosis is frequently used by 
parasites as a strategy for survival (Heussler et al., 2001; Luder et al., 2001). 
During the course of infection, apoptosis of infected host cells may either be induced by the host 
cell response or be a direct result of pathogen invasion. In both cases, apoptotic death results in the 
formation of apoptotic bodies. These apoptotic bodies are taken up by phagocytes that rapidly 
recognize and phagocytose them, eliminating the parasite together with the remains of the infected 
cell. The pathogen-derived antigens included in apoptotic bodies can be presented by dendritic cells 
in the context of both class I and class II molecules, which are recognized by CD8+ and CD4+ T 
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cells respectively, and activate naïve lymphocytes for the initiation of an immune response (Schaible 
et al., 2003; Savill et al., 2002; Rodriguez et al., 1999; Albert et al., 1998a). 
Dendritic cells are key players in initiating immune responses because they are the only cell type that 
are able to prime naïve T cells efficiently as well as cross-present exogenous antigens (Banchereau et 
al., 2000; Mellman et al., 1998).  
It has been shown that dendritic cells are able to induce P. yoelii-specific CD8+ and CD4+ T cells 
(Bruna-Romero and Rodriguez, 2001). Additionally, dendritic cells-depleted mice failed to induce 
cytotoxic T cell responses with a result in the loss of priming potential of dendritic cells during P. 
yoelii infection (Jung et al., 2002). 
Altogether, these observations suggest an important role of dendritic cells during the immune 
response initiated against liver stages. An extended comprehensive knowledge of these molecular 
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1.2 Objectives 
Hepatocyte infection by gamma-irradiated Plasmodium sporozoites is required to achieve complete 
protection against malaria. The basic trigger of this conferred immunity is still unknown. Conversely, 
apoptotic bodies derived from infected cells enclose a source of antigens that are processed by 
dendritic cells, which efficiently present pathogen antigens for the initiation of immune responses. 
The major goal of this project is to elucidate the role of hepatocyte apoptosis in the course of a 
malaria liver infection. 
For this purpose, we focused on two main aspects. First, it was determined whether apoptotic death 
of hepatocytes infected with irradiated sporozoites would play a role in the initiation of an anti-
malarial immune response. The immunological mechanisms that mediate this protection were 
studied, namely the origin of Plasmodium antigens, and the way in which its processing and 
presentation occur. Furthermore, the involvement of dendritic cells as key mediators of the 
protective immunity conferred by irradiated-sporozoites immunization was also examined.  
Secondly, molecular aspects of parasite survival and development during the establishment of a 
successful liver infection were also addressed. The hypothesis of hepatocyte apoptosis modulation 
by the parasite was studied as well as the involvement of a host cell pathway. 
Additionally, an attempt was made at identifying a Plasmodium gene product as a candidate 
responsible for the inhibition of apoptosis of hepatocytes. In this context, the role played by the 
































2.1 Malaria: historical aspects and current global picture 
The malaria situation deteriorated during the 90’s and recent estimates have shown an increase in 
numbers of morbidity and mortality as a result of overlooked prevention measures together with the 
widespread of resistance to drugs and insecticides. To overcome this situation new efforts are being 
undertaken with a focus on both cure and prevention of this disease. Attempts to address these 
challenges include the use of new technologies in research and the combination of different 
therapies in the field (Breman et al., 2004; Nchinda, 1998). 
The fight against this menace is currently being pursuit by an international partnership launched by 
the World Health Organization (WHO), the Roll Back Malaria, whose goal is to attain a 50% 
reduction of the burden of malaria by 2010. The impact of this achievement will reach far beyond 
the disease burden itself since it will implicate several factors and success will result in a global 
development for the countries at risk and the world’s populations in general (WHO, 2003; Fig. 2.1). 
Malaria is a parasitic disease caused by the intracellular pathogen Plasmodium and transmitted by a 
mosquito vector. In ancient times it was believed that the disease had its origin in the injurious air 
inhaled from swamps and marshes, thus the name ‘mal aria’ (bad air). In 1880, Lavern’s discovery of 
the unicellular parasite P. falciparum in the blood of a French soldier put an end to this belief 
(Laveran, 1880). In 1897, the mode of transmission to humans was uncovered and attributed to the 
female Anopheles mosquito bite by Ronald Ross (Ross, 1897). The missing part of the malaria 
parasite’s cycle, the exo-erythrocytic liver schizont, was only elucidated in 1948 by Shortt and 
Garnham, when malaria parasites where found developing in livers of sporozoite-infected monkeys 
and, subsequently, in livers of human volunteers infected by mosquitoes carrying P. vivax (Shortt and 
Garnham, 1948).  
Presently, around 40% of the world’s population is at risk of infection and more than a million 
people die each year, mostly children under five years of age and pregnant women. Symptoms 
appear within a week or two after transmission and consist of fever, nausea, vomiting, fatigue and 
headaches. They can progress into organ failure, coma and death, 90% of which occurs in tropical 
sub-Saharan African countries. Eradication of malaria from western European countries was 
achieved after the World War II when the anti-malarial drug chloroquine and the insecticide DDT 
became widely available (Hay et al., 2004; Greenwood and Mutabingwa, 2002). 
The search for a safe and effective vaccine against malaria has become a case of endless failures. 
Years of vaccine research have produced few hopeful candidates and although scientists are 
doubling research efforts, an effective vaccine is, at best, years away. In terms of epidemiology, 
human malaria is extremely complex, depending on transmission levels and acquired immunity. The 
relationship between the prevalence of severe malaria phenotypes and higher transmission rates is 
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not linear. In fact, exposure during early childhood could account for a lower risk of severity as 
protection is stimulated against subsequent attacks (Snow et al., 1997).     
There are four Plasmodium species that infect humans: P. vivax, P. falciparum, P.malariae, and P. ovale. 
The first two are the most common, with P. falciparum being the most deadly form of the parasite 
and responsible for the majority of the worst case scenarios of severe malaria infection. P. vivax 
accounts for the major cause of morbidity but is no longer a significant cause of mortality. A wide 
range of clinical symptoms, including fever, life threatening anemia, and coma in children and naïve 
adults characterize infection with P. falciparum (Greenwood et al., 2005; Trigg and Kondrachine, 
1998). 
The present crisis is mainly due to resistance developed against drugs by Plasmodium parasites and 
against insecticides by Anopheline mosquitoes. Additionally, national transmission control programs 
have weakened and increased migration and tourism contribute to the current situation (Greenwood 
and Mutabingwa, 2002). Malaria’s burden has an impact on the economical and political prospects 
of developing countries in which disease is endemic; therefore concerted funding for interventions 
and research priorities such as drug/vaccine development are being used to overcome this 
deteriorating situation (Sachs and Malaney, 2002).   
In particular, vaccine development requires the achievement of several goals: induction of strong, 
durable and strain-transcending immune responses; identification of protective antigens for stage-
specific immunity; and successful combination of candidate immunogens (Greenwood, 2005; 
Carvalho et al., 2002). 
In humans, the first report of protection induced by a vaccine occurred in 1973 when volunteers 
where being submitted to infected-gamma-irradiated mosquito bites (Hoffman et al., 2002; Clyde et 
al., 1973a). However, this approach was impracticable at a large-scale, and so a search for molecules-
based vaccines was initiated. Throughout the last two decades, success in protection of animal 
experimental models raised the enthusiasm about a few candidate molecules, but these met with 
failure during human trials. More recently, efforts were translated in a pack of potential candidates 






































Fig. 2.1|Global distribution of malaria. (A) World’s malaria transmission risk in 2003 and (B) the estimated incidence of 
clinical malaria episodes caused by any Plasmodium species, resulting from local transmission, country level averages in 2004. 
(adapted from Roll Back Malaria partnership report, 2005) 
 
 
2.2 Plasmodium life cycle 
Plasmodium presents an extremely complex life cycle involving two hosts, a vertebrate host, and the 
invertebrate host, the female Anopheles mosquito vector. Interaction between them results in 
transmission and allows the infection to endure. Parasites enter the mammalian host through the 
bite of an infected female Anopheles mosquito during a blood meal. During such a meal, 
approximately five to twenty sporozoites will be injected into the host, which reach the liver within 
minutes (Vanderberg and Frevert, 2004; Ponnudurai et al., 1991; Rosenberg et al., 1990; Vanderberg, 
1977). The sporozoites are deposited under the skin of the host, migrate into the bloodstream and 
aim directly to the liver, where they infect and develop inside hepatocytes (Matsuoka et al., 2002; 
Sidjanski and Vanderberg, 1997; Shin et al., 1982). This is known as the asexual exo-erythrocytic or 
hepatic stage of the parasite’s life cycle. For human malaria, this stage lasts 5 to 7 days on average 
while in rodent malaria it lasts only 2 days (Meis and Verhave, 1988). This is also the asymptomatic 
stage of the disease. At the end of the hepatic stage, 10.000 to 30.000 merozoites per invading 
sporozoite will be released into the blood-stream from where they disseminate systemically. Each 
merozoite invades an erythrocyte and divides mitotically to form an erythrocytic schizont, 
containing up to 20 daughter merozoites. These merozoites can re-infect fresh erythrocytes, giving 
rise to a cyclical blood stage infection with a periodicity of 48-72 hours, depending on the Plasmodium 
species. This constitutes the asexual blood stage of a malaria infection. In this stage, disease 
symptoms occur and infected individuals can get sick. In order to complete the cycle, there are some 
merozoites that develop into sexual parasite stages, the male and female gametocytes, which will be 
taken up by mosquitoes during blood meals. Gametocytes undergo fertilization and maturation in 
the mosquito midgut, forming an infective ookinete form that migrates into the mosquito hemocele 
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and develops into an oocyst form where sporozoites are developed (Miller et al., 2002; Gysin, 1998; 
Landau and Gautret, 1998).  When fully matured, oocysts burst and release sporozoites which 











Fig. 2.2|Plasmodium life cycle. 
When an infected female anopheline 
mosquito takes a blood meal, 
sporozoites enter the host 
bloodstream and travel through the 
circulation to the liver (A). 
Sporozoites invade hepatocytes and 
enter a phase of asexual 
reproduction in which they amplify 
their number thousands of times by 
the production of merozoites (B). 
The liver cell ruptures and the 
merozoites are released into the 
blood, attaching to and invading 
erythrocytes, beginning the 
erythrocytic cycle. Each merozoite invades an erythrocyte and replicates initiating a cycle that ends with the burst of the mature 
erythrocytic schizont and the release of new merozoites, which will infect new erythrocytes. Illness starts when the mature 
asexual erythrocytic schizont, ruptures (C). Other blood stages differentiate into male and female sexual stages parasites called 
gametocytes. These gametocytes enter a mosquito as it takes a blood meal. Sexual reproduction occurs in the mosquito midgut, 
and gametes fuse forming a motile zygote, the ookinet, that mature and migrates through the mosquito midgut developing into 
an oocyst, within which sporozoites develop. After being released, novel sporozoites travel to the salivary glands, making the 






2.3 Liver stage biology  
The discovery of a mammalian malaria exo-erythrocytic stage was the last missing piece to be filled 
in the parasite’s life cycle, when liver schizogony was described in African monkeys (Shortt and 
Garnham, 1948). Since no symptoms are associated with this parasite stage, little attention was given 
to the events that occur during sporozoite invasion of hepatocyte and the intrahepatic development. 
However, this scenario changed when in 1967, Nussenzweig reported that immunizing mice with 
radiation-attenuated Plasmodium berghei sporozoites protected them against challenge with fully 
infectious sporozoites (Nussenzweig et al, 1967). These rodent studies provided the impetus for 
human studies, and, during the 1970s, Clyde, Rieckmann and colleagues established that immunizing 
human volunteers with the bites of irradiated mosquitoes carrying P. falciparum sporozoites in their 
salivary glands could protect volunteers against challenge with fully infectious P. falciparum 
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sporozoites (Edelman et al., 1993; Herrington et al., 1991; Rieckmann, 1990; Rieckman et al., 1979; 
Clyde et al., 1975; Rieckman et al., 1974; Clyde et al., 1973 a, b) 
Still until the mid-1980s, knowledge of the biology of malaria liver stage was restricted to the fact 
that these forms of the parasite could arrest in the liver and later be responsible for relapses during 
infections with certain Plasmodium species, the so-called uninucleated “hypnozoite” form (Cogswell et 
al., 1991; Krotoski et al., 1980). 
Since then, experimental data from several laboratories began to elucidate the numerous steps taken 
by sporozoites from the starting point of invasion to their development inside the liver as well as the 
immune response that occurs during different immunization strategies with special emphasis for the 
immunization with attenuated parasites (Engwerda and Good, 2005; Baldacci and Menard, 2004). 
The study of the cell biology of the Plasmodium liver stage is particularly difficult due to lack of a high 
infectious in vitro culture system, isolation and number of sporozoites needed. Still, the recent 
advance in direct live observation of parasites within the liver represents a useful resource, 
promising an outbreak of insights into this field (Frevert et al., 2005; Hollingdale et al., 1998; Calvo-
Calle et al., 1994; Hollingdale et al., 1983b). 
The reasons why Plasmodium has elected the liver and the hepatocyte as a first cellular home inside 
mammalian hosts are not fully elucidated. However, it is possible that the reason is related to the 
hepatocyte’s highly complex metabolism, which is capable of fulfilling all parasite replication needs 
(Frevert et al., 2004; Saliba and Kirk, 2001). Others support the idea that the immunologic 
characteristics of this organ allow parasites to survive and pursue infection, either by minimal 
immune responses that are thought to occur or by the induction of immune tolerance. In addition, 
hepatocytes are capable of expressing major histocompatibility complex (MHC) class I and class II, 
while erythrocytes are not (Crispe, 2003; Krzych et al., 2000; Rajan, 1997). Another aspect to take 
into account is the morphology of the liver itself and the fact that hepatocytes are heterogeneous 
and allow easy access to venules and arteries separated by the space of Disse (Enomoto et al., 2004; 
Wisse et al., 1985).  
 
2.3.1 From skin to liver  
To reach the first and essential stop of its journey, the hepatocyte, Plasmodium sporozoites have to 
travel from the skin inoculation site to the liver. Being a highly vascularized organ, the skin is the 
perfect place for a mosquito blood meal, which usually last for 30s in Anopheles and occurs after a 
single probe of blood taken in small pools originated by capillary damage. Mosquito injections are 
accompanied by saliva, which has an anti-coagulant activity, facilitating blood digestion. In spite of 
the hundreds of sporozoites present in the mosquito’s salivary glands only a small number are 
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transmitted during the bite of an infected mosquito (Matsuoka et al., 2002; Ponnudurai et al., 1991; 
Rosenbergh et al., 1990; Vanderberg, 1977; Griffiths and Gordon, 1952; Boyd and Kitchen, 1939). 
The migration of the sporozoite from the site of bite to the liver has been an issue under discussion. 
Previous studies with P. yoelii-infected mosquitoes allowed to feed in mice, provided evidence that 
mosquitoes deposit sporozoites in an avascular skin tissue area and, within 10 minutes post-
inoculation, sporozoites could be found in the host’s bloodstream, long enough to find a blood 
vessel (Sidjanski and Vanderberg, 1997). A recent study applying intravital observations of P. berghei-
infected mice at the site of mosquito bite revealed that parasites migrate widely across the skin 
covering distances of many micrometers for several minutes before reaching circulation (Vanderberg 
and Frevert, 2004). Anti-sporozoite acquired immunity reduces motility speed and could interfere 
with skin crossing (Frevert et al., 2005; Vanderberg and Frevert, 2004). Either because they find 
themselves in a new rough environment when they change from salivary glands to connective tissue 
or to prevent hostile encounters with the host immune system defenses, sporozoites have a short life 
span of approximately of 20 minutes to leave circulation in liver sinusoids and enter the parenchyma 
to infect hepatocytes.  
The gliding motility presented by sporozoites is used during infections in vivo for their migration 
through the dermis, as was previously demonstrated in vitro (Vanderberg and Frevert, 2004; 
Vanderberg, 1974). Plasmodium gliding movement in host cells is characterized by trails of 
circumsporozoite (CS) protein that are left behind, similar to what occurs when they are placed in 
contact with artificial surfaces (Frevert et al., 1998; Stewart and Vanderberg, 1991). The released CS 
protein is distributed throughout the cytoplasm of the cell and it has been proposed that is capable 
of inhibiting translation at the initiation step of protein synthesis, as it binds to RNA-associated 
binding sites on ribosomes (Frevert et al., 1998; Hugel et al., 1996). Nevertheless, mosquito-
transmitted sporozoites are more infective than sporozoites injected intravenously, and are even 
capable of avoiding the antibody response mounted against them (Krettli and Dantas, 1999; 
Vaughan et al., 1999; Beier et al., 1991; Ponnudurai et al., 1991).  
 
2.3.2 Reaching the liver  
The liver is organized in lobules formed by connective tissue with branches for the portal venule 
and the hepatic arteriole. It possesses a diverse population of cells such as specialized endothelial 
cells, Kupffer cells (liver resident macrophages) and stellate cells (fat-storing cells) (Enomoto et al., 
2004; Sinnis, 1996). 
There are several interactions established between sporozoite proteins and the liver cells 
components. Malaria sporozoites possess an apical complex constituted by secretory organelles, 




the surface coat of Plasmodium sporozoites is the CS protein, which is responsible for the oocyst 
maturation and sporozoite morphogenesis (Kappe et al., 2004; Nussenzweig and Nussenzweig, 
1989). It is mainly stored in the micronemes (sporozoites secretory organelles) and is continuously 
exported to the cell surface and discarded at the parasite posterior pole (Thathy et al., 2002; Stewart 
and Vanderberg, 1991; Posthuma et al., 1989). It also possesses a glycosyl-phosphatidylinositol (GPI) 
sequence as anchor at the C-terminus of the CS protein, which also contains a species-specific 
central repeat region and two conserved motifs. Specific regions within these motifs are responsible 
for the linkage to the glycosaminoglycan of liver sulfated proteoglycans and sporozoite motility and 
invasion (Tewari et al., 2002; Ying et al., 1997). 
Another protein present in the micronemes that is also expressed at the sporozoite membrane 
surface upon secretion induced by cell-contact is the thrombospodin-related adhesive protein 
(TRAP) (Bhanot et al., 2003; Gantt et al., 2000; Templeton and Kaslow, 1997). Besides being 
involved in sporozoite invasion of salivary glands and the hepatocyte, its vital role was assessed 
when P. berghei mutant TRAP parasites were shown to lose their gliding motility (Matuschewski et al., 
2002; Wengelnik et al., 1999; Sultan et al., 1997). 
On the host side, the molecules that seem to play an important role during infection by allowing 
sporozoites to recognize and reach the liver are the proteoglycans. These molecules, which are 
highly sulfated and abundant, are involved in the molecular mechanism of sporozoite adhesion, 
where CS protein binds to hepatocyte membranes (Frevert et al., 1993; Cerami et al., 1992). Both CS 
and TRAP are capable of recognizing in particular the glycosaminoglycan chains (GAG) in the 
sulfated proteoglycans expressed by liver cells (Ying et al., 1997; Robson et al., 1995). 
When entering the liver sinusoids either via the hepatic arteriole or the portal venule, sporozoites 
glide along the endothelial cell layer through the endothelia, interacting with extracellular matrix 
proteoglycans that protrude from the space of Disse until they encounter a Kupffer cell and 
recognize the proteoglycans expressed on its surface (Pradel et al., 2002; Pradel and Frevert, 2001). 
Although previous work with P. berghei in rats suggested that these cells were responsible for parasite 
phagocytosis removing them from circulation, recently Kupffer cells were shown to be the liver 
portal entry to sporozoites from a set of experimental data based on in vitro models with P. berghei 
and P. yoelii sporozoite infections and Kupffer cells isolated from rat livers (Pradel and Frevert, 2001; 
Meis et al., 1983). Moreover, the development of most exo-erythrocytic forms close to the liver 
portal venules, where the Kupffer cells are located, also suggests that the these cells could well 
function as access gates to the liver (Verhave et al., 1985; Sleyster and Knook, 1982).  
Thus, the current model proposes that sporozoites recognize and bind to proteoglycans expressed 
on the surface of Kupffer cells using their major surface proteins, CS protein and TRAP (Pinzon-
Ortiz et al., 2001; Cerami et al., 1992). They actively invade, safely traverse and successfully exit 
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Kupffer cells protected by a non-fusogenic vacuole through the space of Disse (Frevert et al., 2005; 
Meis et al., 1983c).  
 
2.3.3 Hepatocyte invasion  
Hepatocyte infection occurs after sporozoites exit the space of Disse and gain access to the liver 
parenchyma. Sporozoites first migrate through several hepatocytes before invading a final one 
within a parasitophorous vacuole. The traversed cells have their plasma membrane wounded by the 
parasite and can either survive, undergoing a resealing process, or die (Mota et al., 2001). 
Experimental evidence demonstrates that when sporozoites invade host cells without formation of a 
vacuole the parasites do not develop, meaning that migration is a feature that precedes infection 
(Mota et al., 2001). This migration of parasites leaves behind wounded cells that could be needed to 
potentiate infection, which would be beneficial for the parasite’s development within infected 
hepatocytes. On the other hand, one could also suppose that wounding would increase the 
generalized inflammation detectable shortly after inoculation (Khan and Vanderberg, 1992). This 
particular sporozoite feature can be observed either in vitro or in vivo in mice livers, and it is 
unspecific as is shown by the fact that a range of cell types are suitable for hosting Plasmodium 
migration (Mota et al., 2001). Moreover, during parasites in vivo journey from the skin to the liver 
they encounter different tissues and probably migrate through them (Mota and Rodriguez, 2004). 
The molecular mechanism is still not fully elucidated, but recent reports revealed a newly discovered 
sporozoite protein that plays a role in migration. The SPECT protein (sporozoite microneme 
protein essential for cell traversal), which is localized in sporozoites micronemes, is required for the 
parasite’s migration in vitro. Yet, exo-erythrocytic development was maintained, and a lower 
infectivity was shown in vivo, suggesting that host cell migration is mandatory for sporozoite access 
into the liver parenchyma (Ishino et al., 2004). Recently, another SPECT protein was described and a 
similar function was shown for a protein present in mosquito ookinete invasion into the midgut 
epithelium (Ishino et al., 2005a; Kadota et al., 2004). 
The final invasion is accompanied by the secretion of TRAP and the parasite finds itself surrounded 
by a parasitophorous vacuole, inside which it replicates and develops (Silvie et al., 2004; Mota et al., 
2001; Meis et al., 1983b). Detailed information about how this event takes place is scarce, in part 
because of the low infectivity of sporozoites in vitro. By analogy with related parasites such as 
Toxoplasma gondii, it is believed that sporozoite internalization with formation of a parasitophorous 
vacuole occurs within a few seconds and is dependent on the plasma membrane-associated motor 
that also drives parasite gliding motility (Soldati and Meissner, 2004). In addition, there is an 




molecules from within the apical organelles, or a regulated exocytosis restricted to the formation of a 
cap (Mota and Rodriguez, 2004; Mota et al., 2002). 
Moreover, migration induces secretion of “hepatocyte growth factor” (HGF) that render the 
surroundings more adequate to parasite growth and are imperative in order to obtain a successful 
infection (Carrolo et al., 2003). Experimental evidence has suggested that other host cell factors are 
involved in sporozoite infection in the liver, for example, the interaction of the CS protein with the 
low-density lipoprotein-related protein receptor or the requirement of CD81 tetraspanin for P. 
falciparum and P. yoelii sporozoites to invade hepatocytes (Silvie et al., 2003; Shabkibaei and Frevert, 
1996).  
 
2.3.4 Intrahepatic development  
Knowledge concerning parasite development inside hepatocytes is still very limited considering the 
large range of morphological characteristics that occurs during this intrahepatic development. 
Hepatic schizogony, where parasites grow, maturate and replicate, lasts 2 days for rodent species and 
5 to 7 days for primates, resulting in 10.000 to 30.000 of merozoites from each invading sporozoite 
(Meis et al., 1985 a, b; Meis et al., 1983 a, b). From seize a single generation, merozoites individualize 
in the cytoplasm, and then separate as islets within which membrane formation occurs before 
rupture into the bloodstream. An infective mosquito bite leads to the formation of around 12 exo-
erythrocytic schizonts in a few days, reaching 100 µm in size, contrasting with blood stages that only 
enlarge up to 12 µm, replicating into 8 to 24 erythrocytic schizonts. Thus, the parasite’s needs for 
membrane and nucleic acid synthesis during the liver stage are enormous, almost three times more 
than for blood stages schizogony (Hollingdale, 1985). Nutrients are obtained from the hepatocyte 
which as it harbors glycogen and serum protein factories, allowing the maturation process to 
progress ending in the release of merozoites that will invade erythrocytes (Frevert, 2004; Meis et al., 
1985 a, b). 
However, sporozoites are able to undergo partial development to early exo-erythrocytic forms in the 
absence of host cells or other cell types, and preserve some morphological and molecular features 
presented by regular ones (Wang et al., 2004; Kaiser et al., 2003). 
 
 
2.4 Immunity to malaria liver stage  
When naturally exposed to malaria, humans gradually acquire immunity to the parasite, although 
repeated infections are required in order to maintain it. Naturally acquired immunity is characterized 
by being short-lived and strain-specific (Hviid, 2005; Day and Marsh, 1991). The reasons for such 
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scarce protection are not known. It is mediated by blood-stage specific antibodies and is partially T 
cell-based (Stevenson and Riley, 2004; Good and Doolan, 1999). But the contribution of each of the 
different stages to the general immunity-related protection remains poorly understood. During the 
blood stages it is clear that the host develops mechanisms either to neutralize the effects of parasite-
released toxins or to kill the parasite or even to inhibit its replication. The reduced acquisition of 
malaria immunity in naturally exposed populations has also been explained by the fact that the 
parasite actively modulates the immune system of the host during blood stages, preventing the 
development of specific immune responses (Ocana-Morgner et al., 2003; Urban et al., 1999; 
Plebanski et al., 1997). Concerning the liver, the fact that the gut is located close to the liver is one of 
the reasons why this organ has such a peculiar immunologic profile, predominantly tolerogenic 
when responding to foreign antigens. Liver dendritic cells, Kupffer cells and sinusoidal endothelia 
are mature antigen-presenting cells that undertake the task of maintaining this immune environment 
(Doherty and O’Farrelly, 2001; Knolle and Gerken, 2000; Lohse et al., 1996). Together with anti-
inflammatory cytokine secretion, the liver controls the inflammation induced by influx of bacteria 
and endotoxins from intestines, and reaches a state of portal vein tolerance. Antigen-specific 
activated CD8+ T cells are eliminated by Fas-induced apoptosis considering the model of activation-
induced cell death, thus accounting for liver tolerance (Crispe, 2003). 
Nevertheless, naturally acquired protection observed in infected individuals and several experimental 
data records, raised hopes for the development and feasibility of an effective vaccine against this 
disease (Carvalho et al., 2002).  
In what regards the liver stage of infection, major hopes were raised based on the fact that sterile 
protective immunity was obtained both in mice, monkeys and humans; against P. berghei, P. yoelli, P. 
knowlesi, P. falciparum or P. vivax sporozoite challenge induced by immunization with radiation-
attenuated sporozoites (Hoffman et al., 2002; Gwadz et al., 1979; Clyde, 1975; Clyde et al., 1973 a, b; 
Nussenzweig et al., 1969; 1967). 
Protective mechanisms against the liver stage of malaria infection have been the aim of many studies, 
since knowledge concerning the type of immune responses induced towards the infected hepatocyte 
are still very limited. The advantages of inducing exo-erythrocytic stage immunity would not only be 
a decrease in mortality and disease transmission, but also a prevention of symptoms, since the 
parasite would be arrested before reaching the erythrocytic stage (Tdryk and Walther, 2005; Tsuji 
and Zavala, 2003). 
 
2.4.1 Natural infection versus immunization  
Mimicking features occurring in naturally infected individuals is the general aim of vaccines which, 




more than one antigen. In particular, a greater magnitude in responses than the one achieved in 
individuals that have been infected, together with transcendence both in time and strains, would be 
desirable for the development of a vaccine against malaria. Administration of a cocktail of several 
antigens has been the prevailing hypothesis for many years now, but an expensive and complex 
product would be the likely result. Ideally, a vaccine against the exo-erythrocytic stage of the parasite 
should fulfill two roles: the induction of high titers of functional antibodies against sporozoites 
inoculated by the infectious mosquito, in order to stop them from entering the liver; the 
establishment of potent cytotoxic T lymphocyte immunogenicity against the liver stage to kill all 
infected hepatocytes while not harming the host (Hill, 2006; Doolan and Hoffman, 2000; Doolan 
and Hoffman, 1997). 
In that respect, the discovery that immunization with radiation-attenuated sporozoites could lead to 
full protection paved the way to determine the full range of factors involved in this protection, 
namely Plasmodium antigens, initiation of host immune response and immune response types (Nardin 
et al., 1999). Gamma-irradiated sporozoites infect the liver but are arrested there without pursing to 
blood stages. Later, it was also found that the targets of this protection were not only the sporozoite 
but mainly the infected hepatocyte (Scheller and Azad, 1995; Suhrbier et al., 1990; Weiss, 1990; 
Hoffman et al., 1989). In fact, sporozoites irradiated with a dose that did not allow them to reach the 
liver were not protective any more (Silvie et al., 2002; Nussler et al., 1989). Still, is not clear if this 
relies on the presentation of different and specific antigens or on the way that antigens are presented 
to the host immune system (Langhorne et al., 2004; Krzych et al., 2000). 
 
2.4.2 Exo-erythrocytic antigens  
Some sporozoite antigens are also expressed within the newly formed liver stage forms. In fact, a 
limited number have been already identified and characterized as targets for CD8+ T cell responses. 
Among these are the CS protein and the TRAP protein (Khusmith et al., 1994; Rogers et al., 1992; 
Weiss et al., 1992). Another protein that has also been shown to be a target for T cells is the P. yoelii 
hepatocyte exported protein 17 (PyHEP17), an homolog of the P. falciparum exported protein 1 
(PfEXP) (Doolan et al., 1996).   
The first strictly specific malaria liver stage antigen discovered was the P. falciparum liver stage 
antigen 1 (PfLSA-1), which is expressed in the vacuole lumen and is solely expressed during the 
hepatic stage (Guerin-Marchand et al., 1987). The LSA-3 antigen was characterized through antibody 
recognition in immunized and non-immunized individuals (Daubersies et al., 2000; Connelly et al., 
1997). A few other parasite proteins appear at this stage of the parasite’s life cycle, such as 
glutamine-rich protein and parasite heat shock protein 70 (Kumar et al., 1993). More parasite 
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proteins are being identified through recent new genomic approaches, leading to an increase in the 
number of the antigenic repertoire known in malaria (Gruner et al., 2003).  
Recently, several Plasmodium genes, which are not expressed in the blood stages and some are also 
not expressed in the sporozoites, were shown to possess a vital role for parasite liver development 
(Ishino et al., 2005b; Mueller et al., 2005; van Dijk et al., 2005; Kraiser et al., 2003).  
 
2.4.3 Initiation of host immune response  
Naïve T cell priming by sporozoites can occur by specialized presenting cells, macrophages, 
dendritic cells, and B cells (Riley, 1999; Druilhe et al., 1998; Pape et al., 1997). There is evidence that 
sporozoites are able to avoid destruction by macrophages, from which they can exit and induce 
death (Vanderberg et al., 1990; Seguin et al., 1989; Danforth et al., 1980). In fact, sporozoites are too 
large to be internalized by B cells, but released material might be taken up by specific B cells, thereby 
initiating activation of a T cell response (Link et al., 1993; Stewart and Vanderberg, 1992). Although 
it has been shown that the infected liver cell can present parasite-derived peptides on its surface, 
expressed on MHC class I or class II molecules and recognized by CD8+ and CD4+ T cells, 
respectively, the hepatocyte does not normally express co-stimulatory molecules necessary for naïve 
T cell activation, which the high levels of Interleukin-10 (IL-10) present in the liver, may further 
delay (Renia et al., 1993; Weiss et al., 1993; Weiss, 1990; Hoffman et al., 1989). Thus, the possibility 
that infected hepatocytes can activate naïve T cells is unlikely (Krzych et al., 2000; Vanderberg et al., 
1993). Furthermore, the existence of a parasitophorous vacuole between the parasite and the host 
cell poses some questions. Trafficking of Plasmodium antigens inside the hepatocyte between the 
parasitophorous vacuole and the host cell membrane is still an unclear issue. This double biological 
membrane constitutes a barrier to the transport of malarial peptide epitopes by MHC molecules 
(Frevert, 2004; Gruner et al., 2003; Mellman et al., 1998).  
 
2.4.4 Host immune responses after immunization  
The protective mechanisms induced by immunization with irradiated sporozoites were extensively 
studied. Since the liver is an immune privileged site, the infected hepatocyte was for decades 
considered to be protected from the immune system and, therefore, immunity was thought to be 
anti-sporozoite only. However, later was shown that this immune response is mounted against the 
infected liver cell (Lau et al., 2001; Hoffman and Doolan, 2000; Hoffman et al., 1998).  
The first line of effector mechanisms triggered by malaria infection is antibody response.  CS protein 
is a target for the production of neutralizing antibodies that induce protection as conservation within 
each plasmodial species is very high (Hollingdale et al., 1998; McCutchan et al., 1996; Hollingdale et 




by either blocking sporozoite invasion or by killing sporozoites themselves, ultimately leading to 
immunity. This immune response mechanism against sporozoites is described in the literature for 
different parasite species: P. berghei, P. yoelli and P. vivax (Charoenvit et al., 1991; Wirtz et al., 1991; 
Weber et al., 1987; Potocnjak et al., 1980; Yoshida et al., 1980). In rodent models there are examples 
of antibody production against single epitopes of different proteins, like the P. yoelii HEP17 that is 
capable of removing infected hepatocytes in culture (Charoenvit et al., 1995). Hepatocyte invasion 
and development of P. falciparum was prevented when an anti-Pf-CS protein repeats monoclonal 
antibody was used in vitro (Mazier et al., 1986; Hollingdale et al., 1984). However, protection does not 
consistently correlate with anti-CS antibody levels in malaria-exposed individuals or immunized 
volunteers. Besides, no vaccine has been shown to induce a strong sterile immunity based on the 
induction of anti-CS antibodies alone (Herrington et al., 1987; Hoffman et al., 1987). 
The role of T cells was first demonstrated when irradiated sporozoites conferred protection in mice, 
which were not capable of making antibodies (Chen et al., 1977). Additionally, spleen cells or 
immune T cells from sporozoite-immunized mice could confer protection against malaria, when 
adoptive transfer was performed in vivo into naïve mice (Egan et al., 1987; Verhave et al., 1978). 
Protective immunity induced by irradiated sporozoites is completely dependent on the presence of 
CD8+ T cells while a requirement for CD4+ T cells has only been demonstrated in a few strains 
(Tsuji and Zavala, 2003; Doolan and Hoffman, 2000; Weiss et al., 1993; Tsujii et al., 1990).  
CD8+ T cells have been implicated as critical effector cells in this protection, thus being the core of 
several immunologic studies, which provided the following observations. Induction of IFN-γ is a 
direct consequence of the CD8+ T cell activation, IFN-γ production precedes and initiates 
production of IL-12, and then IL-12 in turn induces IFN-γ production by APCs and/or natural 
killer cells (NK) in a positive feedback loop that represents an important amplifying mechanism. 
The IFN-γ then activates inducible nitric oxide (NO) synthase and induces the L-arginine-dependent 
NO pathway, subsequently eliminating the infected hepatocyte or the intrahepatic schizont (Morrot 
and Zavala, 2004b; Krzych et al., 2000; Doolan and Hoffman, 1999; Sedegah et al., 1994; Nussler et 
al., 1993; Nussler et al., 1991; Schofield et al., 1987a). Nevertheless, irradiated sporozoite 
immunization induces distinct mechanisms of protection in different hosts (Doolan and Hoffman, 
2000). 
In vitro, CD8+ T cells against a single epitope in the carboxyl terminus of the P. yoelii CS protein 
eliminated infected hepatocytes from culture in an antigen-specific, MHC-restricted manner (Weiss, 
1990). Protection against infection in mice was also achieved by using CD8+ T cells that are specific 
for an epitope of the CS protein either for P. berghei CS or P. yoelii CS, which could, in some cases, be 
abolished by in vivo treatment with anti-IFN-γ (Weiss et al., 1992; Rodrigues et al., 1991; Romero et al., 
1989). Besides CS protein, other clones against different proteins could protect mice such as TRAP, 
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which conferred protection in a CD4+ T cell, IFN-γ dependent manner (Wang et al., 1996; Khusmith 
et al., 1994). CD4+ T cells directed against a single epitope in the amino terminus of the P. yoelli CS 
protein eliminated infected hepatocytes from culture in an IFN-γ-independent manner (Renia et al., 
1993; Renia et al., 1991). A heat-shock-like protein (PfHSP70) on the hepatocyte surface was a target 
for in vitro antibody-dependent cell-mediated cytotoxic mechanisms by liver non-parenchymal cells 
(Renia et al., 1990). 
Besides antibodies and T cells contributions to immunity, the effect and the role of the most 
important cytokines in malaria infection have also been studied. Regarding IFN-γ, a systemic 
administration of this cytokine is capable of partly protect against P. berghei and P. cynomolgi 
sporozoite challenge in mice and in monkeys, respectively (Ferreira et al., 1986, Schofield et al., 1987b; 
Maheshwari et al., 1986). On the other hand, in vivo IFN-γ depletion leads to abrogation of irradiated 
P. berghei and P. yoelii sporozoites-induced immunity (Rodrigues et al., 1991; Hoffman et al., 1989; 
Weiss et al., 1988; Schofield et al., 1987a). When treated with IFN-γ, Plasmodium spp.-infected 
hepatocytes were eliminated from in vitro cultures. IFN-γ’s activity was also shown to be nitric oxide-
dependent (Mellouk et al., 1994; Mellouk et al., 1991; Ferreira et al., 1986). Another important 
cytokine that is able to modulate hepatic stage development during malaria infection is tumour 
necrosis factor-α (TNF-α). Inhibition of development is obtained in P. berghei-infected HepG2 cells 
(Schofield et al., 1987b). In vivo administration of murine recombinant TNF-α induced high 
protection in mice challenged with P. yoelii sporozoites (Nussler et al., 1991). However, when purified 
cultures of primary hepatocytes infected with P. berghei or P. yoelii were used, no effect was observed 
(Mellouk et al., 1991). Nevertheless, the addition of non-parenchymal cells to the hepatocytes 
restored TNF-α-induced parasite inhibition. Subsequently, it was shown that this was due to IL-6 
secretion from non-parenchymal cells (Nussler et al., 1991). Administration of recombinant 
interleukin-12 (IL-12) protects mice from sporozoite challenge with P. yoelii and P. cynomolgi in 
monkeys (Hoffman et al., 1997; Sedegah et al., 1994). Other reports have also mentioned the 
inhibitory effect of IL-1 on intrahepatic development of P. yoelii and P. falciparum, in this case when 
applied before sporozoite inoculation (Pied et al., 1992; Mellouk et al., 1987). 
Still, doubts subsist regarding the differences induced by irradiated and live sporozoites especially in 
what concerns how antigen presentation occurs, which given the opposed outcome have necessarily 
to hold divergences. Within it for sure is the mediated switch from tolerogenic immune status to a 
local inflammatory one, accomplishing malaria exo-erythrocytic forms clearance (Stevenson and 
Riley, 2004).  
Immunization with blood stage antigens, heat-killed, formalin-inactivated or lysed sporozoites, or 




irradiated sporozoites were used (Plebanski and Hill, 2000). Instead, live sporozoites and 
chloroquine-treated mice immunizations, were capable of preventing erythrocyte infection (Belnoue 
et al., 2004). These data provided further insights to the fact that immunity conferred by irradiated 
sporozoites is triggered by the infected hepatocyte as a first target and sporozoite liver development 
is required for it to occur. Moreover, live sporozoites have to target the liver for protection to occur.  
Additionally, sporozoites last 30 min or less in the mammalian host, so any immune response 
targeting this stage has to be activated and completed within minutes of infection. On the other 
hand, the liver stage is much more extended both in rodents, where parasite develops for 24h-48h, 
and in humans, where, depending on Plasmodium species, development can last for 5-14 days 
(Doolan and Hoffman, 2000).  
How the knowledge obtained with study of the immunizations with irradiated sporozoites 
conciliates with the field observations is also crucial to fully understand the potential of the liver 
stages. T cells specific for both variant and conserved pre-erythrocytic malaria antigens are not 
found consistently in naturally exposed individuals and T cell responses are generally suppressed 
during the course of malaria infection (Good and Doolan, 1999; Hviid et al., 1991; Ho et al., 1986; 
Troye-Blomberg et al., 1984). 
A complete description of the mechanisms involved in this protection could drive adequate 
strategies for the development of a vaccine capable of conferring complete immunity (Hill, 2006). 
 
 
2.5 Apoptosis at the host-pathogen interface 
2.5.1 Cell death  
In humans, approximately 10 billion cells die per day during its maintenance. The need of 
eliminating excess cells or potentially dangerous ones, protecting the organism from threats to its 
homeostasis and simultaneously allowing the control of cell numbers and tissue size, confers cell 
death an importance comparable to the cellular processes of cell division or migration. This is a 
highly complex molecular process of cellular destruction, and is defined as programmed cell death or 
apoptosis (Gavrilescu and Denkers, 2003). 
Apoptosis is a genetically controlled biological event, characterized by a pattern of molecular and 
morphological changes that typically take place in multicellular organisms when they undergo death. 
It holds a major role in development, proliferation, maintenance, perpetuation of cellular integrity 
and tissue homeostasis. It plays a central role in the normal development and function of the 
immune system of higher vertebrates (Vaux and Strasser, 1996; Raff, 1992). 
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Such a powerful process has to be tightly regulated as abnormalities in the apoptotic progression 
commonly lead to pathology, including development of autoimmune diseases, ageing, cancer and 
neurodegenerative disorders (Strasser et al., 1997; Thompson, 1995). 
Over the years, apoptosis and its regulation became an essential area of research, allowing significant 
progress in the understanding of this cellular process. Programmed cell death was first described by 
Carl Vogt in 1842 and, since then, acquired several names. The term apoptosis was created in 1972 
by Kerr and collaborators to describe the morphological appearance of the dying cells observed in 
various tissues and cell types (Kerr et al., 1972). These dying cells presented and shared many 
morphological features distinct from the ones observed in cells undergoing necrotic cell death and 
suggestions were made that these belonged to a conserved, common and endogenous cell death 
program (Wyllie et al., 1980). 
Since those early days, the nematode Caenorhadditis elegans was used as a model to uncover the 
apoptotic machinery and its molecular components allowing the identification of several molecules 
involved in this process (Hengartner and Horvitz, 1994; Ellis and Horvitz, 1986). Mammalian 
orthologs were also described and it is now generally accepted that the apoptotic process involves a 
shared biochemical suicide program that exists in most cells and is turned on by a variety of normal 
developmental and pathogenic triggers (Fink and Cookson, 2005; James and Green, 2002).  
This process of self-destruction is a direct consequence of the activation of a large number of 
conserved gene and protein families. Apoptosis differs from other types of cell death, such as 
necrosis, and is characterized by a unique range of morphological and biochemical features that are 
commonly present in a dying cell and which constitute the basis for the identification of this 
biological event (Hengartner, 2000). Nuclear chromatin condensation and fragmentation, 
vacuolization of the cytoplasm, cell shrinkage with organelle preservation, membrane blebbing, 
DNA degradation followed by detachment from the substrate and formation of membrane-bound 
apoptotic bodies, are features that determine apoptotic cell fate, a process that cannot be reversed 
once it has been initiated (Hacker, 2000). The lack of inflammatory response is also a hallmark of 
death by apoptosis as apoptotic bodies are rapidly engulfed by phagocytes without causing 
inflammation (Savill and Fadok, 2000).  
Conversely, necrosis results from a physical injury and is not genetically controlled. Cellular swelling 
with disruption of organelles and rupture of the plasma membrane are marks that typify a non-
apoptotic death. Thus, cells dying by apoptosis or necrosis present large differences in their 
appearance. Furthermore, necrosis contrary to apoptosis is usually associated with inflammation. 
Although apoptosis and necrosis are independent processes they can be related since an event that 
produces necrosis may trigger apoptosis in the surrounding tissue. On the other hand the induction 




A number of cysteine proteases that are specifically activated in apoptotic cells are responsible for 
the morphological changes observed. These death proteases are homologous to each other, and are 
part of a large protein family known as caspases (Thornberry and Lazebnik, 1998; Alnemri, 1997). 
They are highly conserved throughout evolution and can be found in organisms ranging from 
worms to mammals, including insects and nematodes. Caspases are synthesized as precursors that 
have almost no catalytic activity. When activated, they are known to be the central executioners of 
the apoptotic process and are capable of regulating their own activity. Caspase-mediated proteolytic 
reactions are very specific, recognizing and cleaving aspartic acid-containing recognition sequences 
(Thomberry et al., 1997). When caspase-activity is abrogated, either by inhibitors or through 
mutations, prevention or reduction of cell death occurs (Hengarther, 2000).  
 
2.5.2 Pathways of apoptosis  
Apoptosis is triggered by a stimulus that is responsible for initiating the whole cascade process. 
Several types of stimuli are capable of initiating cell death by apoptosis. These include internal 
stimuli like death ligands binding to specific cell surface receptors, such as Fas or tumor necrosis 
factor receptor, and external stimuli like chemotherapeutic agents, irradiation, reactive oxygen 
species, and growth factors (Chipuk and Green, 2005). Transduction of these pro-apoptotic signals 
via different pathways results either in activation of caspases or in the release of cytochrome c from 
the mitochondria into the cytosol, leading to the formation of the apoptosome and to the activation 
of a caspase cascade, which ultimately results in cell death. Depending on whether the trigger for 
apoptosis is internal or external, two main pathways, the extrinsic (death receptors) and intrinsic 
(mitochondria) pathways, can be used by the organism (Hengartner, 2000).  
The extrinsic pathway is initiated by the interaction of specific ligands with appropriate cell-surface 
receptors, like the Fas-FasL and the TNF-α, and TNF-α receptor (TNFR). These are receptor-ligand 
interactions in which both members are part of the death receptor families of proteins. When FasL 
binds to Fas at the cell surface, a death-inducing signaling complex (DISC) is formed. The DISC 
incorporates one or more adapter molecules like the Fas-adapter death domain (FADD), which bind 
the receptor on one side, and the pro-initiator caspase-8 or -10 on the other, through their death 
domains. Subsequently, activated caspase-8 cleaves and activates the effectors caspases -3, -6, -7 
from their precursor state thereby completing the cascade. Caspase-8 can also cleave Bid, a pro-
apoptotic cytosolic Bcl-2 family protein that, in its truncated form, translocates to the mitochondria 
allowing the bridge between pathways and eliciting the intrinsic course (Nagata, 1997). 
The latter pathway has is centered in the mitochondrial changes that are limited to the breaking of 
the outer membrane integrity with the release of cytochrome c and other mitochondrial 
intramembrane components into the cytosol. Cytochrome c interacts with apoptosis-activating factor 
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(Apaf)-1 from the cytosol, inducing its oligomerization into a complex structure named apoptosome 
which also includes pro-caspase-9. Once activated, this structure is capable of activating the 
downstream effector caspases, leading to apoptosis through the mitochondrial pathway. At certain 
key points there are other molecules that allow this catalytic cascade to be regulated by either 
positive or negative feedbacks. The Bcl-2 family proteins, that include the anti-apoptotic Bcl-2, Bcl-
xl, Bcl-w, Mcl-1 constitute an example of this. These proteins prevent apoptosis by protecting 
mitochondria from permeabilization and inhibiting the action of the pro-apoptotic Bcl-2 family 
members (Bax, Bak, Bad, Bid), which are responsible for inducing cytochrome c release from the 
mitochondria triggering the apoptotic cascade (Kroemer and Reed, 2000; Adams and Cory, 1998). 
In addition to these two major pathways, there are other alternative routes to caspase activation. The 
release of perforin and granzymes by NK cells or antigen specific CTLs, which, through endocytosis 
and pore formation, give access to the cytosol where Bid and/or caspase-3 is activated and 
apoptosis is induced in target cells (Kojima et al., 1994; Shi et al., 1992; Odake et al., 1991; Poe et al., 

























Fig. 2.3| Pathways of apoptosis. (A) Extrinsic or death receptor-mediated pathway. Extracellular molecules (TNF-α and 
FasL) bind to TNFR family members (TNFRI and Fas, respectively). Recruitment of FADD to the receptors leads to Casp-8 
activation, which in turn results in activation of Casp-3, Casp-6, and Casp-7. (B) Intrinsic or mitochondrial pathway. Stress, 
irradiation and inflammation act on mitochondrial through intermediary pro-apoptotic Bcl-2 family members such as Bax, 
resulting in blocking of the anti-apoptotic activity of Bcl-2 (red lines). As a result, cytochrome c translocates into the cytoplasm 
and activates Casp-9 through APAF-1. Casp-8 may also trigger the mitochondrial pathway through the activation of Bid, which 
like Bax, inhibits the anti-apoptotic activity of Bcl-2. (C) Cytotoxic cells introduce granzyme molecules into the target cell in a 
process mediated by multimerization of the perforin molecule. Granzymes cleave various substractes, including caspases, 
resulting in cell death. The dashed arrows indicate secondary effectors of activated caspases, and the green arrows indicate 




2.5.3 Intracellular living 
Intracellular organisms invade cells in order to exploit cellular resources and multiply, ensuring the 
perpetuation of the pathogen’s life cycle. The relationship between a host and a pathogen has a 
dynamic nature that has evolved to enable coexistence between the two entities. Pathogens use 
different strategies to make use of the host’s resources that determine the fate of the interaction 
established between host and pathogen. A successful infection results in a considerable cellular 
reorganization with clear advantages for the infectious agent. Therefore, obligatory intracellular 
parasitism requires a close regulation of crucial events like a successful entry, intracellular replication 
and exit from the host cell (Alonso and Garcia-del Portillo, 2004; Nyalwidhe et al., 2003; Kahn et al., 
2002).  
Pathogens encounter different environments along their way, which lead to changes in 
microorganism responses through signal transduction pathways which have to adapt to the 
surrounding conditions. This lifestyle demands a subversion and exploitation of the host cell at 
various levels, from using host resources to evading the host’s defense system (Ploegh, 1998). 
Probably the most obvious potential outcome of host-pathogen interactions is the death of host 
cells (James and Green, 2002). It has long been known that this can result from an infection, either 
as a direct effect of the pathogen or through pathogen-produced products. Pathogen-induced cell 
death seems like a simple infection outcome, but undergoing research has demonstrated that is 
rather complicated as it may occur by a variety of complex mechanisms. When a cell detects that has 
been invaded and is fated to die, it is capable of accelerating the dying process in order to arrest 
parasite growth, limiting the damage to the host organism and thereby protecting the uninfected 
cells and ultimately preventing infection (Luder et al., 2001).  
Pathogens have developed mechanisms to prevent host cell death by disabling the host’s apoptotic 
machinery and thereby promoting its own survival and replication. Descriptions of such behaviors 
can be found in the literature for several pathogens like viruses, bacteria, parasites, and fungi, where 
modulation includes prevention of apoptosis in parasitized host cells and also promotes the death of 
immune cells that are targeted to them (Hasnain et al., 2003; DosReis and Barcinski, 2001). 
Thus, uncovering mechanisms responsible for pathogenesis is critically dependent on elucidating 
factors required by a pathogen to kill or preserve the host’s life. Such knowledge may ultimately 
contribute towards the discovery of novel therapeutic targets with potential use in various diseases 
(Fink and Cookson, 2005). 
 
2.5.4 Modulation of apoptosis and parasite survival/death  
Upon infection there is a complex interaction of parasite proteins with cellular host proteins 
originating a variety of responses from both of them. Phagocytosis of the pathogen, release of 
General Introduction|27  
 
cytokines, secretion of toxins, production of reactive oxygen species, are common outcomes of this 
type of relationship. Many examples of strategies used by viruses and bacteria preventing the death 
of the host cell through either of the apoptotic pathways have been reported (Gao and Kwaik, 2000; 
Granville et al., 1998; Liles, 1997). 
Analogous mechanisms have been proposed for protozoa including receptor-mediated apoptotic 
triggers and stress-mediated apoptosis stimuli, suggesting that a close interaction at different check 
points is established with the apoptotic machinery of the host cell. Therefore, the abrogation of host 
cell apoptosis often turns out to be beneficial for the pathogen and to result in a successful invasion 
(Heussler et al., 2001).  
While in many cases the mechanisms for resistance to apoptosis are still unknown, in others there 
appear to be a variety of ways in which the pathogen ensures cellular survival. These include 
production of molecules that resemble and mimic Bcl-2 protein, the expression of inhibitors for 
death receptor signaling pathway, the generation of caspase inhibitors and interference with nuclear 
factor kB (NFkB) pathway. So, several studies point out to parasite-produced molecules that are 
capable of directly activating apoptotic pathways in the target cells (Gavrilescu and Denkers, 2003; 
Hasnain et al., 2003). 
Among these are examples of parasitic infections conferring protection to induced-apoptosis in 
infected-host cells. Decreased caspase activation and reduced levels of poly (ADP-ribose) 
polymerase expression were described in Toxoplasma-infected cells (Goebel et al., 2001; Nash et al., 
1998). On the other hand, cell viability in the absence of growth factors was shown to be induced 
when Leishmania-infected macrophages soluble mediators were released (Moore et al., 1994). 
Both induction and inhibition mechanisms were described in Trypanosoma cruzi-infected cells, 
depending on the stimulus elicited. Hence, an apoptotic pathway can be induced during infection by 
radiation and chemicals and when a different pathway, like Fas or TNF-α, was triggered, host cells 
became protected and resistant to death (Nakajima-Shimada et al., 2000; Nunes et al., 1998; Lopes et 
al., 1995).  In addition, Trypanosoma is able to produce a trans-sialidase that can interact with the host 
cell PI3K-Akt pathway to promote survival in the peripheral nervous system and also seems to be 
responsible for cell depletion in the thymus during infection (Mucci et al., 2002; Chen et al., 2001; 
Chuenkova et al., 2001).  
Theileria is another parasitic pathogen that is able to subvert the host for its own benefit, making use 
of remarkable approaches, resembling a cancer cell. This parasite places a huge pressure on the host 
cell by taking control of both the cell cycle and the apoptosis process through several mechanisms 
that involve the activaction of transcription factors like AP-1, ATF-2, which are implicated in JNK 
and MAPK pathways (Heussler et al., 1999; Romashkova and Makarov, 1999; Palmer et al., 1997). 




and resistance to infection. However, it can also induce expression of several anti-apoptotic proteins, 
including IAPs and c-FLIP, which blocks caspase-8 activity leading to survival (Barkett and Gilmore, 
1999). Theileria-infected cells show an activated phenotype as the inhibitor molecule (IkB) is 
degraded by phosphorylation, maintaining the nuclear translocation leading to immortalized-infected 
cells. Consequently, these modulations of the biology of Theileria-infected cells lead to death-
resistance to both extrinsic and intrinsic apoptotic triggers (Kuenzi et al., 2003; Heussler et al., 2002; 
Heussler et al., 1999). 
Other examples of mitochondrial pathway induced-death are also found in the literature, although 
not directly involving the infected cell. During acute T. gondii infection, CD4+ and CD8+ T cells 
accumulate in the brain and express high mRNA levels of Bax and Bad, while in chronic infection T 
lymphocyte expression of pro-apoptotic molecules is downregulated and anti-apoptotic levels of 
Bcl-2 and Bcl-xl are increased (Schluter et al., 2001; Khan et al., 1996). 
Similar processes occur with P. berghei lethal infection (a model for rodent cerebral malaria), where 
increased levels of Bax, Bcl-2, p53, and cytoplasmic cytochrome c in the brain were measured. 
Furthermore, alterations on mitochondria morphology were detected, suggesting that the 
dysfunction of this organelle may play a role in cerebral malaria phenotypes, although it is not clear 
which apoptotic pathway was followed (Kumar and Babu, 2002). 
For extracellular parasites the induction of apoptosis occurs in cells that constitute their diet or 
appear along their pathway of invasion. Entamoeba histolytica-infected cells undergo apoptosis through 
a cell lectin-binding surface contact mechanism while evidence shows helminths parasites targeting 
for host cells mobilized to attack them using also Fas-FasL interaction (Lopez-Briones et al., 2003; 
Chen et al., 2002; Jenson et al., 2002; Kuroda et al., 2002; Rumbley et al., 2001; Huston et al., 2000).  
Similar events occur in a virus-host relationship. Upon viral infection many cells undergo apoptosis, 
thereby reducing the viral load. Therefore, interfering with host cell apoptosis would lead to 
replication and spreading of progeny. For this purpose, strategic points in the apoptotic pathways 
are targets for viral proteins that evolved to be able to inhibit or delay the host’s protective actions 
by targeting cells of the immune system or the host cell itself (Granville et al., 1998; Ploegh, 1998). 
The anti-apoptotic members of the Bcl-2 family, the inactivation of tumor suppressor p53 and 
caspases inhibition are examples of targets for this modulation (Tabakin-Fix et al ., 2005; Li et al., 
2002; Yang et al., 2002; Bertin et al., 1996; Shen and Shenk, 1995). In latent viral infections, the host 
protein translation machinery is controlled by the virus. Initiation of a viral infection leads to the 
shutting down of the host’s protein synthesis, which in turn leads to a decline of metabolic processes 
and apoptosis induction (Clemens, 2005). 
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2.5.5 Modulation of apoptosis and immunity 
Cell-specific apoptosis contributes to the regulation of pathogen-induced immune responses (Luder 
et al., 2001). As the Fas-FasL signaling pathway is specifically involved in apoptosis, disruption of the 
Fas-FasL pathways can be directly related to an alteration in apoptosis steady-state (Dockrell, 2003). 
Studies with knockout mice infected with different protozoa showed that FasL-triggered apoptosis 
plays a role in resistance to infection as the lack of function of this molecules induced higher levels 
of parasitemia and lesions that the mice failed to resolve (Lopes et al., 1999; Conceicao-Silva et al., 
1998). However, it is not known if this outcome results from infected cell lysis or prevention of 
uncontrolled inflammatory reactions at the lesion site.   
Production of FasL, which, through interaction with its receptor Fas will initiate the apoptosis 
cascade, for instance in T- and B-cells, leading to lymphocytopenia, occurs in Plasmodium, T. gondii 
and Leishmania (Eidsmo et al., 2002; Nishikawa et al., 2002; Wipasa et al., 2001; Matsumoto et al., 
2000). 
When ovalbumin- or parasite-specific T cells were adoptively transferred into P. yoelii-infected T cell-
deficient nude mice, only the P. yoelii-specific T cells underwent apoptosis and demonstrated signs of 
increased Fas expression. These data suggest a mechanism to eliminate anti-Plasmodium T-cell 
effectors. Moreover, in an acute blood stage infection with P. chabaudi, 60% of the spleen cells 
express the Fas molecule (Wipasa et al., 2001; Helmby et al., 2000). In human malaria, infected 
individuals express high levels of apoptotic markers in peripheral blood mononuclear cells, which in 
vitro are sensitive to apoptosis induction and have elevated soluble Fas levels in serum. Thus, this 
apoptotic pathway may also play a role in infection. In addition, FasL levels have been shown to 
decrease with malaria chemotherapy (Kemp et al., 2002). 
CTLs employ perforin and granzyme molecules to directly trigger apoptosis in infected target cells. 
Several intracellular protozoans elicit MHC class I-restricted CD8+ CTL activity; these parasites 
include Toxoplasma gondii, Plasmodium spp., Trypanosoma cruzi and Leishmania major (Bonelo et al., 2000; 
da Conceicao-Silva et al., 1994; Grazzinelli et al., 1993; Nickell et al., 1993; Rodrigues et al., 1991). 
However, it seems that perforin-mediated CTL activity does not protect the host, as perforin-
knockout mice were resistant to infection with T. gondii and T. cruzi (Nickell and Sharma, 2000; 
Denkers et al., 1997).  
Reports concerning immunity-related apoptosis describe additional immunologic factors that 
possess a significant role in the outcome phenotype. Pro-inflammatory cytokines are able to mediate 
apoptosis process during pathogenic infections. However, it is difficult to determine the biological 
significance of apoptosis driven by mediators such as IFN-γ, IL-12, NO and TNF-α; because these 
molecules are, in addition, involved in resistance to pathogens and are needed for host survival 


























Two hepatoma cell lines were used for in vitro culture experiments: a human hepatoma cell line, 
HepG2 (ATCC, HB8065) and a mouse hepatoma cell line Hepa 1-6 (ATCC, CRL-1830) (Darlington 
et al., 1980). Both cell lines are efficiently infected by rodent malaria parasites which are capable of 
undergoing complete development (Mota and Rodriguez, 2000; Hollingdale et al., 1983 a,b). This 
constitutes the in vitro model system used to reproduce a malaria liver stage infection during the 
experimental studies performed.  
 
3.2 Parasites, mosquitoes and mice 
Plasmodium yoelii (17XNL, non-lethal strain) or Plasmodium berghei (NK65 or ANKA strains) 
sporozoites were obtained from infected mosquitoes and were used either for in vitro or in vivo 
experiments. Parasites were maintained by alternate cyclic passages in mosquitoes and mice 
(Vanderberg and Gwadz, 1980). 
Additionally, Anopheles stephensi infected mosquitoes were also obtained from the Centro de Malária e 
outras Doenças Tropicais (Lisboa, Portugal) and the University Medical Center St. Radbound 
(Nijmegen, The Netherlands), and further maintained in our departments under adequate conditions 
(Benedict, 1997). BALB/c or C57/BL6 mouse strains aged between 6-8 weeks were purchased from 
Taconic Farms (Germantown, New York, US) or Instituto Gulbenkian de Ciência (Oeiras, Portugal). 
Animals were bred and maintained in a pathogen-free animal facility. 
 
3.3 Sporozoite isolation and purification  
Female Anopheles stephensi mosquitoes were fed on infected Plasmodium spp. mice. Sporozoites were 
obtained by dissection from their salivary glands at days 18-21 post feeding. Dissections of mosquito 
salivary glands were performed in RPMI 1640 medium (Gibco) containing 1% mouse serum 
(Gibco). The glands were mechanically disrupted and homogenized to free the parasites. The debris 
was pelleted after spinning at 20g for 5 min at 4ºC. Sporozoites were then collected, counted and 
maintained on ice until use (adapted from Ozaki et al., 1984). Sporozoites infectivity was dependent 
on the parasite strain in use. The number of sporozoites per infected mosquito was determined 
using a hemacytometer (Neubauer chamber). Irradiated sporozoites were submitted to gamma-
source radiation equivalent to 20 Krad dose (137Cs source). Heat-killed sporozoites were submitted 
to a heat shock treatment of 56º C for 15-30 min. 
 
3.4 In vitro infections  
One day prior to infection, 2×105 Hepa 1-6 (or HepG2 cells) were harvested in 24-well plates over a 
glass coversilp in complete Dulbecco’s MEM medium (DMEM; Sigma) supplemented with 10% 
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heat-inactivated fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2mM 
glutamine and grown at 37ºC with 5% CO2. 
P. yoelii sporozoites (105/well) or P. berghei sporozoites (3×104/well) were added to the monolayers of 
Hepa 1-6 or HepG2 cells respectively, centrifuged for 5 min at 1800g and incubated at 37ºC with 5% 
CO2. At different time points after infection, cells were washed twice with Phosphate Buffered 










Fig. 3.1|Schematic representation of the 
in vitro sporozoite infection system. 
Hepatoma cells were seeded in 24-well plates 
over glass coverslips and allowed to grow 
overnight at 37ºC in a 5% CO2 atmosphere. On 
the next day sporozoites are added to the cells 
and allowed to develop into exo-erythrocytic 
forms (EEFs) for 24h (A). The number of EEFs 
in a coverslip was counted under a fluorescence 
microscope (Plasmodium exo-erythrocytic form, 





3.5 Immunofluorescence assays  
After fixation with PFA, hepatoma cells were washed with PBS and incubated for at least 1h in a 
protein blocking solution (3% Bovine Serum Albumin, 100mM Glycine, 10% Goat serum; Sigma) to 
avoid unspecific reaction, containing 0.1% Saponin (Sigma) for permeabilization. Cells were then 
kept for 45 min at RT with the primary antibody against parasite heat shock protein 70 (HSP70) 
(Tsuji et al., 1994). After washing twice with PBS, cells were incubated for 45 min at RT with 
secondary anti-mouse IgG fluorescein (FITC)-conjugated antibody (Sigma) diluted in blocking 
solution. Hepatoma cells were then washed twice in PBS and incubated with 4'6-diamidino-2-
phenylindole (DAPI, Sigma) diluted in PBS during 1 min for staining the nuclei. Afterwards, cells 
were washed 3 times with PBS and the coverslip was mounted on a slide with mounting medium 
Mowiol (Calbiochem) and observed in a fluorescence microscope (Leica DM LB2). All the 
immunofluorescence assays (IFA) were performed following the procedure described above using 
the antibodies relevant for each assay as listed in Table 3.1. 




Table 3.1|Antibodies used in immunofluorescence stainings. 
Designation Staining feature Origin 
NYSI  P. yoelii CS protein (Charoenvit et al., 1987) 
Anti- Mouse IgG FITC or R-PE Mouse IgG Sigma  
2E6 P. yoelii HSP70 (Tsuji et al., 1994) 
Anti-NFkB p65 (relA) NFkB Santa Cruz Biotecnology 
Anti-albumin Mouse albumin Cappel / ICN  Irvine 
PE-Anti-CD11c Dendritic cell Pharmingen 
FITC-Anti-Mac3 Macrophages Pharmingen 
Anti-Rabbit IgG FITC or Texas Red Rabbit IgG Jackson BioLabs 
Anti-Active Caspase-3 p18 fragment of caspase-3 Promega 
 
 
3.6 Cell treatment during sporozoite infection 
The study of the effect of different treatments during the course of in vitro Plasmodium sporozoites 
infection was carried out according to the effect under study. Therefore, (i) hepatocyte growth factor 
(HGF) (500 ng/ml, Calbiochem) was added to cells 1h prior infection; (ii) carbobenzoxy-valyl-
alanyl-aspartyl-[O-methyl]- fluoromethylketone (Z-VAD-FMK) (20µM, Promega) was also added to 
cells 1h prior infection; (iii) the agonist antibodies DN-30 and DO-24 (1µg/ml) (Prat et al.,1998) 
were added to cells 90 min post infection; (iv) and LY294002 (25µM, Sigma) and PD98059 (30µM, 
Sigma) were added to cells 1h prior infection and followed by washes with PBS before addition of 
Plasmodium sporozoites. Reagents were diluted in serum-free DMEM, which was used under the 
same conditions as the control. 
 
3.7 Apoptosis induction assays 
For the apoptosis induction assays, Hepa1-6 or HepG2 cells were treated with Tumor Necrosis 
Factor- α (TNF-α, 10ng/ml, R&D Systems) and Cycloheximide (CHX, 10µg/ml, Sigma) or 
exposed to UV light in order to induce apoptosis 18h after sporozoite infection. Heat killed parasites 
(30min; 56ºC) were used as control. Six hours later cells were fixed and stained for parasite detection 
and host cell apoptosis quantification.  
 
3.8 Detection of apoptosis     
Apoptotic cells were detected and quantified by different methods based on features that a cell 
commonly displays during the apoptotic cascade process (Chipuk and Green, 2005). 
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The TUNEL assay using In Situ Cell Death Detection reagent (Roche) was performed according to 
the manufacturer instructions in order to examine DNA breaks in cells undergoing apoptosis. 
Briefly, after apoptosis induction cells were fixed with 4% PFA and permeabilized with 0.1% Triton 
X-100 in 0.1% sodium citrate. After washing with PBS, cells were incubated with the reaction 
mixture for 60 min at 37°C. Stained cells were mounted with Mowiol and analyzed under a 
fluorescence microscope (Leica DM LB2). 
Apoptosis was also detected by immunofluorescence assays (see section 3.5). Cells were stained with 
anti-NFkB p65 (relA) (Santa Cruz) antibody to observe the translocation of the transcription factor 
NFkB from the cytoplasm to the nucleus of the cell (Barkett and Gilmore, 1999), and caspase 
activity was measured with anti-active-caspase-3 antibody (Promega). Both NFkB translocation and 
caspase activity are characteristic features of apoptosis (Thornberry and Lazebnik, 1998). 
Simultaneously, all cells were incubated with DAPI for nuclear morphology assessment (see section 
3.5). 
 
3.9 Dendritic cell recruitment to the liver     
Groups of 3 mice were infected by mosquito bite (each anesthetized mouse was in contact with 50 P. 
yoelii-infected mosquitoes for 20 min) or by intravenous (i.v.) administration with 105 P. yoelii 
sporozoites in a total volume of 100 µl (gamma-irradiated or non-irradiated) or with salivary glands 
of uninfected mosquitoes as control. At different times after infection, livers were collected and 
frozen in Tissue-Tek (Sakura), and 15 histological sections (10 µm) from each mouse liver were 
examined with PE-anti-CD11c mouse antibody (Pharmigen) for detection and quantification of 
dendritic cells. 
 
3.10 In vivo infection, isolation and staining of liver mononuclear cells 
BALB/c female mice of 6-8 weeks of age were infected with P. yoelii gamma-irradiated (20 Krad), 
non-irradiated, or heat-killed (15 min; 56ºC) sporozoites by i.v. injection (1×106 sporozoites/mouse).  
Six hours after infection the liver of each animal was collected, manually homogenized, and passed 
through a cell strainer in DMEM medium. The cell suspension was washed and resuspended in a 
35% Percoll (Pharmacia Biotech) gradient solution and centrifuged (500g; 10 min). The 
mononuclear-cell pellet was resuspended in 1ml erythrocyte lysis buffer (Cappel) for 1 min and 
washed 3 times with PBS. Isolated cells were counted and placed for 1h on poly-L-lysine coated 
coverslips (~1.5×106 cells/liver were obtained). After fixation with 2% PFA, mononuclear cells were 
stained with PE-anti-CD11c and FITC-anti-Mac3 antibodies (Pharmigen) for dendritic cell and 
macrophage labeling, respectively. Parasites were stained with anti-P. yoelii HSP70 monoclonal 
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antibody (2E6). Cells were also stained with anti-albumin (Cappel/ICN Irvine) and anti-active 
caspase-3 (Promega). Quantification was performed with a fluorescence microscope. 
 
3.11 Detection and quantification of in vivo Plasmodium sporozoite infection 
using Reverse Transcription and Real-Time PCR 
 
Forty hours post infection, livers of mice inoculated with 50.000 Plasmodium sporozoites by i.v. 
injection were mechanically homogenized (Tissue Tearer Blader) in 4 ml denaturing solution (4M 
Guanidium Thiocyanate, 25 mM Sodium Citrate pH 7, 0.5% N-Laurosyl-sarcosine, 0.1% β-
mercaptoethanol; Sigma) and processed for RNA isolation using RNeasy Mini kit (Qiagen) 
according to the protocol supplied by the manufacturer. Total RNA (1 µg) was reverse-transcribed 
to cDNA by using a first strand cDNA synthesis kit (Roche) in a 20 µl reaction volume on a PTC 
100 programmable Thermal Controller (MJ Research, Inc). 
A 4 µl sample of the resulting product was used for real-time PCR amplification of P. berghei 18S 
rRNA sequence using SYBRGreen I (Light cycler-FastStart DNA master SYBRGreen I, Roche) as 
fluorogenic probe and specific primers (5’-AAGCATTAAATAAAGCGAATACATCCTTAC-3’ 
and 5’-GGAGATTGGTTTTGACGTTTATGTG-3’). Amplification was performed in Roche 
LightCycler Quantitative Realtime PCR system (Roche) with the following temperature profile: 95ºC 
for 10 min, and 40 cycles of denaturation at 95ºC for 15 sec, annealing at 60ºC for 5 sec and 
extension at 72ºC for 20 sec. Control plasmids with standard concentrations of 18S rRNA gene 
were used as described elsewhere (Bruña-Romero et al., 2001). The amount of parasite 18S rRNA 
molecules detected in each sample is represented as the number of plasmid-equivalent in 
comparison with a standard curve generated with plasmid DNA (Bruña-Romero et al., 2001).    
 
3.12 Inhibition of PI3-kinase pathway during Plasmodium infection  
LY294002 (2.5 mg, PI3-kinase inhibitor, Calbiochem) in DMSO was injected intraperitonealy (i.p.). 
The control group was injected with the same volume of DMSO. Thirty minutes later, mice were 
infected by i.v. injection with P. berghei (5x104) sporozoites. Real-time PCR was used for 
quantification of parasite load (see section 3.11). 
 
3.13 Analysis of AKT expression during Plasmodium infection   
Mice were injected with LY294002 or DMSO (control) 30 min prior to infection with P. berghei 
sporozoites. Three hours after infection, livers were collected and cell lysates were separated by 
sodium dodecyl sulfate-palyacrylamide gel electrophoresis (SDS-PAGE) and probed with polyclonal 
anti-phospho-Akt (phospho-Ser-473) and total Akt antibodies (Cell Signalling). Detection was 
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performed with the enhanced chemiluminescence system (ECL; Amersham International) following 
the manufacturer’s instructions.  
 
3.14 Immunopreciptitation and Western blot analysis  
Cells were lysed on ice in EB buffer (20 mM Tris-HCl, pH 7.4, 5 mM EDTA, 150 mM NaCl, 10% 
glycerol, 1% Triton X-100) and in the presence of a cocktail mixture of protease and phosphatase 
inhibitors. Immunoprecipitation was performed according to standard protocols and with the 
appropriate antibodies (Celis et al., 1994). When amounts of the same protein in different samples 
were compared, the total protein in the lysates was determined using the BCA Protein Assay Kit 
(Pierce) according to the manufacturer’s protocol.  
Immunoprecipitated or total lysate proteins were resolved by SDS-PAGE and transferred to 
nitrocellulose membrane. Membranes were then probed with specific antibodies and binding was 
detected by Western blotting, which was performed according to standard methods. Final detection 
was performed with the enhanced chemiluminescence system (ECL; Amersham International) 
following the supplier’s instructions.  
 
3.15 MET down-modulation by siRNA in hepatoma cell line 
MET expression was down-modulated in HepG2 cells by transduction with the lentiviral vector 
PCCLsin.PPT.hPGK.GFP.Wpre, engineered to carry either the required sequence for synthesizing 
MET-targeted siRNA or a control siRNA, under the transcriptional control of the H1 promoter. 
siRNAs were produced as previously described (Pennacchietti et al., 2003). Two different siRNAs 
against Met were used as well as for the control siRNA. 
The sequences used were the follwing: for MET (5’-
GATCCCCGTCATAGGAAGAGGGCATTTTCAAGAGAAATGCCCTCTTCCTATGACTTTT
TGGAAA-3’ and 5’-AGCTTTTCCAAAAAGTCATAGGAAGAGGGCA 
TTTCTCTTGAAAATGCCCTCTTCCTATGACGGG-3’) and for the control (5’-
GATCCCCCTCATAGGAAGACCCCATTTTCAAGAGAAATGGTGGTCTTCCTATGACTTT
TTGGAAA-3’ and 5’-AGCTTTTCCAAAAACTCATAGGAAGACCCCAT 
TTCTCTTGAAAATGGGGTCTTCCTATGAGGGG-3’).  
Lentivirus production and infection of HepG2 cells were performed as previously described (Vigna 
and Naldini, 2000). Briefly, lentiviruses were produced by transient transfection of 293T cells. 
Transfections (200nM of each oligo) were done with Oligofectamine reagent (Invitrogen) follwing 
supplier’s instructions. HepG2 cells were transduced by overnight incubation with lentiviruses 
collected from 24 h supernatants, in Iscove supplemented medium (Gibco) with 8 µg/mL Polybrene 
(Sigma). Selection was done with G418 (1 µg/ml; Sigma) and the resistant cells were pooled and 
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assayed for the expression of MET protein by Western blot analysis, as follows. After selection, cells 
were kept in culture for 72h and then extracted with boiling Laemmli buffer (Laemmli, 1970). Equal 
amounts of proteins evaluated by BCA method (Pierce) were loaded in each lane. Western blots 
were probed with antibodies against human MET (C12; Santa Cruz Biotechnology) and standard 
protocols used (Vigna and Naldini, 2000). 
 
3.16 Assembly of DN MET-GFP hepatoma cell line 
For virus production, Met cDNA was subcloned in pLXSN plasmid. Dominant-negative Met was 
produced by fusing the extracellular and transmembrane portions of Met with GFP sequence in the 
pEGFP-N1 vector. A KpnI site was introduced at position 2962 of the Met coding sequence by PCR 
(forward oligonucleotide: 5’-GGAGCACAATAACAGGTGTTG-3; reverse oligonucleotide: 5’-
TTCCGGTACCCAATCTTTAATTTGCTTTCTCTTTTTC-3’). The sequences coding for the 
extracellular and transmembrane portions of Met were subcloned as a SacI–KpnI fragment into the 
pEGFP-N1 vector. This chimeric construct was then sequenced and subcloned in the lentiviral 
vector p156RRLsin-PPT-hCMV-MCS-pre. The transfections were performed by the calcium 
phosphate and DEAE dextran methods using 2-5 µg of each construct (Giordano et al., 2002; Vigna 
and Naldini, 2000). 
In vitro infection of hepatocytes was done by incubating the cells overnight in the presence of virus-
containing supernatant. Efficiency of infection was evaluated using GFP fluorescence and infected 
hepatoma cell lines expressing the Met-GFP construct were sorted by FACS to select positive cells. 
A control cell line was made with equal amounts of viral particles containing GFP alone (Carrolo et 
al., 2003; Giordano et al., 2002; Vigna and Naldini, 2000). 
 
3.17 Isolation of plasmid DNA 
All plasmid DNA were isolated either on a small scale (minipreps) using the QIAprep spin Kit 
(Qiagen) or on a large scale (maxipreps) with the Plasmid Maxi Kit (Qiagen). In both procedures the 
manufacturer’s protocols were followed.  
 
3.18 DNA restriction enzyme digestion  
The digestion of plasmid DNA was performed according with the dilution advised by the supplier 
using suitable volumes of the buffer specific for each enzyme used, according to standard 
procedures (Sambrook and Russell, 2001). 
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3.19 DNA Electrophoresis 
DNA samples smaller than 20Kbp were resolved in 1-3% (w/v) agarose gels in TE buffer (10 mM 
Tris-Cl, 1 mM EDTA, pH 7.5) using conventional submarine methods and apparatus. 
 
3.20 DNA Extraction from agarose gels 
DNA samples were extracted from agarose gels using a QIAquick gel Extraction Kit (Qiagen) 
according to the manufacturer’s instructions. 
 
3.21 Cloning PCR products 
PCR products larger than 3 Kb were cloned into pCR 2.1-TOPO (Invitrogen) vector and 
transformed into TOP10 One Shot cells following the manufacturer’s instructions. 
 
3.22 HSP 70 construct 
The DNA sequence of interest (P. yoelii HSP70) was amplified by PCR using specific primers 
(forward 5’-CCGCTCGAGATGGCTAACGCAAAAGCATCAAAGCCA-3 and reverse 5’-
ATAAGAATGCGGCCGCTTAATCAACTTCTTCAACAGTTGGTCC-3). Results were analyzed 
in 1% (w/v) agarose gel in TE buffer and PCR products cloned in PCR 2.1 TOPO vector 
(Invitrogen). The fragments were subsequently digested with the appropriate restriction enzymes 
and subcloned into a mammalian expression vector, pCI-neo (Promega) (see section 3.18). 
 
3.23 In vitro transient transfection system  
Plasmids were introduced into hepatocytes using a cationic polymer transfection reagent, jetPEI-Gal 
(PolyPlus). Transfection was performed according to the manufacturer’s protocol. For stable 






























Role of dendritic cells during liver stage malaria 










































Legend|Model of anti-malaria immune responses induced by irradiated sporozoites. Protective 
immune responses to malaria can be induced in humans and mice by injection of irradiated sporozoites. These infect 
hepatocytes as well as non irradiated sporozoites do, but they are not capable to develop into merozoites. The 
decrease observed in the number of infected hepatocytes suggests that these cells are dying during this period of 
development. Our working hypothesis predicts that the apoptotic bodies originate from infected hepatocytes by 
irradiated sporozoites are phagocytosed by dendritic cells. After migration to the lymph nodes, DCs have the ability 
to present Plasmodium antigens included in these apoptotic bodies and activate T lymphocytes, initiating an immune 
response against malaria.     
4.1 Introduction 
A large variety of strategies are being followed in the quest for a vaccine against Malaria. Complete 
protection against the disease is based on attempts to exploit any existing checkpoints throughout 
the complex life cycle of the Plasmodium parasite. Although several infection-blocking candidates, 
aiming at specific stages of the cycle, are under scrutiny, none of them are able to induce protection 
and long term immunity comparable to the levels achieved with irradiated-attenuated sporozoites 
(Greenwood, 2005). 
As mentioned before, full protection to malaria is only achieved in mice, monkeys and humans by 
immunization with irradiated-attenuated Plasmodium sporozoites (Doolan and Hoffman, 2000; 
Chatterjee et al., 1996; Nussenzweig et al., 1967). 
Protection was at first attributed to the antibody response mounted against Plasmodium 
circumsporozoite protein (CS), mainly because these antibodies were capable of neutralizing 
sporozoite infectivity and high levels of anti-CS led to protection against a sporozoite challenge in 
humans (Mazier et al., 1988; Herrington et al., 1987). Currently, it is well established that the 
sporozoite-infected hepatocyte is the main target of this response generated by irradiated 
sporozoites and that the strong cytotoxic T lymphocyte (CTL) activity parasite-specific elicited has a 
pivotal role in immunity (Hoffman et al., 1989; Weiss et al., 1988; Schofield et al., 1987 a, b). Taken 
together with the acquisition of effective antimalarial immunity in endemic populations, these data 
provide reasons to hope that a malaria vaccine conferring protective immunity is feasible (Carvalho 
et al., 2002). Thus, revealing the mechanism behind the initiation of the immune response generated 
with this immunization is of extreme importance to the development of vaccine delivery systems 
that can induce such protection (Stevenson and Riley, 2004). 
Irradiated sporozoites fail to establish a blood-stage infection. They are capable of invading the liver 
and infect hepatocytes as normal sporozoites do, but then growth is abrogated when a trophozoite 
stage is reached and schizogony is aborted (Ngonseu et al., 1998; Chatterjee et al., 1996; Scheller et al., 
1995; Sigler et al., 1984). Although this is a short term intrahepatocytic development, the profile of 
liver antigens expressed is enough for inducing immunity (Suhrbier et al., 1990). In fact, the 
development inside the hepatocytes appears to be a requisite for protection since infected 
hepatocytes were able to induce partial protection once grafted in the spleen after infectious 
sporozoite challenge, while inactivated sporozoites and their extracts where shown to be incapable 
of inducing any effect (Scheller and Azad, 1995; Renia et al., 1994; Mazier et al., 1988; Alger and 
Harant, 1976). 
Hepatocytes are the most abundant cells in the liver and the only cell population that can sustain 
complete Plasmodium exo-erythrocytic form (EEF) development (Meis et al., 1983 a, b). Thus, besides 
being important for the parasite’s survival, the liver has a crucial role on the anti-Plasmodium 
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immunity establishment and maintenance as it harbours the source of parasite antigens that initiate 
an immune response in the host, the infected hepatocyte (Krzych et al., 2000; Scheller and Azad, 
1995).    
This irradiated sporozoites immune response has been characterized as being dependent of CD8+ T 
cells as they recognize an epitope in the CS protein and, upon passive transfer of these cytotoxic T 
cell clones, a high degree of protection was obtained (Romero et al., 1989). On the other hand, in vivo 
depletion of these T cells decreases drastically the protective immunity against live sporozoite 
challenge (Weiss et al., 1988; Schofield et al., 1987a). 
The target of these malaria specific CD8+ T cells is the infected hepatocyte (Hoffman and Doolan, 
2000; Suhrbier et al., 1990; Hoffman et al., 1989). Since T cells only recognize antigens after they 
have been processed and presented on cell surfaces along with major histocompatibility complex 
(MHC) molecules, CD8+ T cells would exclusively be activated by parasite-derived epitopes in 
association with MHC class I molecules, given that lymphocytes are antigen recognition-restricted 
concerning MHC molecules (Townsend and Bodmer, 1989). 
As the hepatocyte is the only cell type that can bear parasite development and is able to express 
MHC class I molecules on its surface, it is only when the hepatic stage occurs that this type of 
immunity is established (Doolan and Hoffman, 2000; Suhrbier et al., 1990). However, in order to 
have a CD8+ T cell response it is required to have efficient priming of naïve T cells that will be 
responsible for the initiation of the immune response itself. In subsequent infections, a stimulation 
of memory T cells resident in the liver also has to occur (Morrot and Zavala, 2004b; Chatterjee et al., 
1999; Riley, 1999). 
CD8+ T lymphocyte responses are primed by MHC class I-associated peptides usually generated 
from endogenous proteins in the cytosol of professional antigen-presenting cells (APC), the 
dendritic cells. They are known to be highly efficient modulators of the immune system uniquely 
specialized in initiating T cell immunity either in vitro or in vivo (Larsson et al., 2001; Banchereau and 
Steinman, 1998). During malaria infection, no dendritic cells are infected by Plasmodium sporozoites 
as they can only replicate in hepatocytes. However, specific CD8+ T cells reactive to Plasmodium 
antigens were found in irradiated sporozoite-immunized hosts, suggesting that parasite antigens are 
transferred to APCs (Krzych et al., 2000; Rodrigues et al., 1991; Hoffman et al., 1989; Romero et al., 
1989; Weiss et al., 1988). This phenomenon in which dendritic cells can also present exogenous 
antigens associated with MHC class I molecules generating CD8+ T cell epitopes has been 
denominated as “cross-presentation” (Heath and Carborne, 2001). In addition, recent data 
demonstrated that dendritic cells are required for induction of this specific anti-malaria CD8+ T cells 
response after immunization with irradiated sporozoites as in vivo depletion of these APCs led to the 
abrogation of Plasmodium specific CD8+ T priming (Jung et al., 2002).   
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Infection is often accompanied by the apoptotic death of the infected host cell, which normally 
leads to the formation of apoptotic bodies that carry pathogen antigens within. Several studies have 
now demonstrated that cross-presentation of antigens in apoptotic bodies is an alternative way used 
by dendritic cells of cross-priming cytotoxic immune responses against intracellular pathogens which 
do not infect directly professional APCs (Winau et al., 2005; Schaible et al., 2003; Yrlid and Wick, 
2000; Albert et al., 1998b). This mechanism of antigen presentation via uptake of apoptotic infected 
cells has turned out to be a tool through which immunity is modulated (Albert, 2004; Fonteneau et 
al., 2002). Recently, it has been proposed that apoptosis of host cells contributes to immunity 
induced by irradiated-parasite vaccines. Irradiation is a potent inducer of apoptosis and for decades 
irradiated-attenuate parasites have been used as live vaccines which in case of Plasmodium resulted in 
the achievement of full protection against the disease (James and Green, 2004; Hoffman et al., 2002). 
The data presented in this chapter elucidates one mechanism behind the protection reached with 
Plasmodium irradiated-sporozoites immunization, highlighting one source of parasite antigen that 
mediates the immune response. Evidence showed that hepatocytes infected with irradiated 
Plasmodium sporozoites undergo apoptosis shortly after infection. In addition, infection with 
irradiated sporozoites induces the recruitment of dendritic cells to the liver of the host, where they 
phagocytose the apoptotic infected hepatocytes. Moreover, it is proposed that these apoptotic 
Plasmodium-infected hepatocytes constitute a source of parasite antigens responsible for the initiation 




4.2.1 Irradiated Plasmodium sporozoites induce infected hepatocytes apoptosis 
in vitro 
 
Although it is a fact known for some years now that irradiated sporozoites induce protection, the 
mechanism behind this effect is still not understood. Given the outstanding results concerning the 
immune responses obtained with irradiated sporozoites, its importance in the development of a 
hepatic stage vaccine is a clear requirement. The scrutiny of how this immunity is established is the 
focus of intense research efforts and an essential task for the control of the malaria parasite (Krzych 
and Schwenk, 2005).  
Since the first description of the malaria exo-erythrocytic stage that attempts were made to establish 
EEF cultures in vitro (Hollingdale et al., 1983 a, b). Several studies were carried out, using different in 
vitro methods and parasite strains, pursuing a culture system where the parasite fully develops into 
mature infectious EEFs (Mota and Rodriguez, 2000; Calvo-Calle et al., 1994). 
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It is known that even high doses of radiation do not affect hepatocyte’s invasion by sporozoites in 
vitro (Nussler et al., 1989). It was also described previously that at early time points in culture the 
EEFs from both irradiated and non-irradiated sporozoites are indistinguishable. However, at time 
points 1-2 days post-infection, a pronounced decrease in the number of irradiated EEFs was 
observed (Suhrbier et al., 1990; Suhrbier et al., 1987; Hollingdale, 1985; Sigler et al., 1984). 
In order to study the survival of hepatocytes infected with irradiated Plasmodium sporozoites at 
earlier times after infection, a murine hepatoma cell line, Hepa 1-6 (or a human equivalent, HepG2), 
was incubated with either irradiated or non-irradiated P. yoelii (or P. berghei) sporozoites and infected 
cells were counted at different time points post-infection. Infected cultures were stained with an 
antibody against HSP70, a protein that is highly expressed in developing parasites inside hepatocytes 
but not in sporozoites (Kumar et al., 1993). 
The result revealed that the number of EEFs found in culture for both non-irradiated and irradiated 
sporozoites decreases with the course of time and this reduction is more marked in Hepa 1-6 
hepatoma cells infected with P. yoelii irradiated sporozoites (squares, Fig. 4.1) rather than when non-
irradiated sporozoites were used (circles; Fig. 4.1). This decrease starts occurring shortly after 
infection and in the 24h-48h time frame the number of EEFs in hepatocytes infected with non-






Fig. 4.1|Time-course of an in vitro 
infection with non-irradiated or 
irradiated P. yoelii sporozoites. Hepa 1-6 
cells were infected with non-irradiated 
(circles) or irradiated P.yoelii sporozoites 
(squares) during different incubation periods. 
The cells were fixed and EEFs were stained 
with anti-HSP70 antibody for quantification 

















The reason for this decrease in the number of infected cells has been attributed to the degeneration 
of intracellular parasites shortly after invasion (Suhrbier et al., 1990; Sigler et al., 1984). We tested 
whether this was the case or whether, alternatively, hepatocytes infected with irradiated sporozoites 
were dying by apoptosis of the infected cells. To evaluate this hypothesis, infected cells were 
examined for nuclear morphology and activation of NFkB p65 (relA), a transcription factor that is 






















Fig. 4.2|Irradiated P. yoelii sporozoites lead to the apoptosis of the infected hepatocyte. Hepa 1-6 cells were 
incubated with P. yoelii irradiated (a,b) or non-irradiated (c,d) P. yoelii sporozoites. Cells were fixed after 6h and stained with 
anti-PyHSP70 Ab to detect EEFs (green), anti-NFkB to observe the transcription factor translocation from the cytoplasm to the 
nucleus of the cell (red) and DAPI to evaluate nuclear morphology (blue).  
 
Both the staining with DAPI (blue; Fig. 4.2), showing the irregular nuclear shape, and the 
translocation of the transcription factor NFkB (red; Fig. 4.2) from the cytoplasm to the nucleus, 
constitute evidence of apoptosis in cells infected with irradiated sporozoites (Fig. 4.2 a,b), while 
infection with non-irradiated sporozoites results in no signs of apoptotic cells (Fig. 4.2 c,d). 
Apoptotic cells were quantified for infection with each type of sporozoite and the results are shown 
below (Fig.  4.3). Apoptosis level is higher in cells infected with irradiated sporozoites in both 
methods used for detection.  
 




































Fig. 4.3|Quantification of apoptosis at early time 
points after infection. Hepa 1-6 cells were incubated with 
irradiated or non-irradiated P. yoelii sporozoites. Apoptosis 
was monitored by assessment of nuclear morphology (black 
bars) and nuclear translocation of NFkB p65 (white bars). 
Error bars represent the standard deviation of triplicate 
samples. Asterisks (*) indicate a significant difference between 
control and irradiated sporozoites (P<0.05). 
 
 
It could also be observed that EEFs formed by irradiated sporozoites are much smaller than those 
formed by non-irradiated ones (Fig. 4.2). It has previously been reported that although irradiation 
leaves the sporozoites capable of invading and transforming into trophozoites, development is 
compromised resulting in a smaller EEF size. The rapid growth and replication observed in normal 
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sporozoite infections is limited when sporozoite irradiation takes place (Scheller et al., 1995; Nussler 
et al., 1989; Sigler et al., 1984). Comparing parasite strains and host cell types, it is evident that the 
pair formed by host cell/parasite is of extreme importance for achieving normal rates of 
development when in vitro cultures of hepatoma cells are used and could also account for differences 
in EEFs size (Scheller et al., 1994; Hollingdale et al., 1983a). 
Apoptotic cell death is mediated by molecular pathways that culminate in the activation of a family 
of cysteine proteases denominated caspases. These proteases orchestrate the dismantling and 
clearance of the dying cell. Caspase-3 plays a central role in the apoptosis cascade and its activation 
is a conserved feature of the apoptotic process (Chipuk and Green, 2005; Thornberry and Lazebnik, 
1998). Therefore, apoptosis in hepatocytes infected with irradiated sporozoites was also confirmed 
by detection of caspase-3 activation (Fig. 4.4). The high degree of caspase-3 activation (red; Fig 4.4) 
seen in cells infected with irradiated spororozoites (green; Fig. 4.4) coincides with apoptotic cells 







Fig. 4.4|Apoptotic cell infected with irradiated P. yoelii 
sporozoites. Hepa 1-6 cells were incubated with P. yoelii irradiated 
sporozoites. 6h post-infection cells were fixed and stained with anti- 
PyHSP70 Ab to detect EEFs (green), anti-active-caspase-3 (red) and DAPI to 





Parasite irradiation probably reduces the ability of de novo synthesis of parasite molecules responsible 
for inhibition of apoptosis of the infected cell, eventually leading to the abrogation of infection and 
cell death. However, a lower but significant amount of apoptosis also occurs during a non-irradiated 
sporozoite infection, suggesting that, in some cases or at certain level, the normal parasite cannot 
prevent the apoptosis of their host. This observation raises some questions about whether this 
phenomenon could play a role during the establishment of infection and, specifically, in generating 
immunity.   
 
4.2.2 The role of dendritic cells during P.  yoelii infection 
Dendritic cells are antigen-presenting cells, capable of initiating and modulating immune responses. 
In their immature form, they traffic from blood into peripheral tissues, which they scan like sentinels 
looking for antigens that they can capture and process. They subsequently migrate to draining lymph 
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nodes, where they are converted into mature and fully activated cells and present antigens to resting 
lymphocytes (Figdor et al., 2004; Banchereau and Steinman, 1998).  
 
 
4.2.2.1 Recruitment of dendritic cells to the liver after malaria infection  
In order to determine if dendritic cells are implicated in the process of establishing a liver-stage 
immune response, in vivo assessment of whether dendritic cells were present in the liver during 
infection was done. 
Livers of mice injected with irradiated and non-irradiated P. yoelii sporozoites were collected at 
different time points post-injection. Histological sections stained with antibody against mouse 
myeloid dendritic cell marker, anti-CD11c, constitute evidence of the presence of dendritic cells in 
















Fig. 4.5|Dendritic cells are present in the liver after infection with Plasmodium sporozoites. Histological liver 
sections of mice infected with malaria by mosquito bite were stained with antibodies against mouse dendritic cell marker anti-
CD11c (green)(a, transmitted light overlay; b). There is evidence of dendritic cell presence near a blood vessel.  
 
 
The quantification of these histological sections showed that during malaria infection the number of 
dendritic cells increases in the liver (Fig. 4.6a). Similar results were obtained when mice were 
subjected to bites from infected mosquitoes (Fig. 4.6b). In both cases an increased recruitment of 
dendritic cells early after infection was observed, which was independent of sporozoite irradiation 
and infection route used. However, when the recruitment was induced by bites from infected 
mosquitoes, a lower amount of dendritic cells was detected, probably because of the smaller 
numbers of sporozoites injected by mosquito bite (Medica and Sinnis, 2005; Vaughan et al., 1999; 
Vanderberg, 1977).  
The recruitment of these antigen presenting cells in the liver indicates that they might play a specific 
role during Plasmodium infections. The increase in the number of dendritic cells in the liver during 
malaria infection would allow these cells to rapidly capture parasite antigens. However, in order to 
be able to present those antigens, these cells have to receive a maturation signal and become fully 
activated. The source for these signals may have various origins. Among them are the pathogen itself 
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or inflammatory cytokines (Guermonprez et al., 2002; Medzhitov and Janeway, 2000; Albert et al., 
1998b). The fact that Plasmodium sporozoites migrate through several hepatocytes in the liver before 
choosing one to infect, and, in this process, disrupt plasma membranes, causing cell wounding and 
necrotic death, could account for the origin of this maturation signal (Mota et al., 2001; Meis et al., 
1985a). In fact, wounded and dying cells induce local inflammatory responses that can be 
responsible for mediating the dendritic cell recruitment to the tissues and, consequently cause 
maturation (Shi et al., 2000; Dieu-Nosjean et al., 1999). It was also described that Plasmodium hepatic 
stages lead to specific inflammatory responses with recruitment of mononuclear cells (Khan and 
Vanderberg, 1992). In addition, the release of uric acid from dying cells would, likewise, provide 

































































































Fig. 4.6|Dendritic cells are recruited to the liver after infection with P. yoelii sporozoites. Quantification of 
dendritic cells in histological sections of mice livers by anti-CD11c staining. (a) Dendritic cell number in livers of non-infected 
mice (black bars) and in mice injected with non-irradiated (white bars) or irradiated (striped bars) P. yoelii sporozoites, at 
different times post-infection. (b) Dendritic cell number in livers of mice bitten by 50 uninfected (black bars) or infected (white 
bars) mosquitoes obtained at different times post feeding. Error bars represent the standard deviation of triplicate histological 
samples, each composed of ≥5 liver sections to cover 10 mm2. Asterisks (*) indicate a significant difference between the sample 
and the control (P<0.02).  
 
 
4.2.2.2 Plasmodium antigens are phagocytosed by dendritic cells and macrophages 
As shown above infected hepatocytes undergo apoptosis during infection. In this process, they 
originate apoptotic bodies, which have to be cleared from the liver. Dendritic cells and macrophages 
are professional antigen-presenting phagocytes capable of large-scale phagocytosis of apoptotic cells 
and clearance of microbial pathogens (Savill et al., 2002; Rubartelli et al., 1997). To determine 
whether apoptotic hepatocytes containing P. yoelii antigens are phagocytosed by antigen presenting 
cells in the liver, we isolated non-parenchymal mononuclear cells from the livers of mice immunized 
with irradiated sporozoites at different times after injection. P. yoelli antigen-carrying dendritic cells 
and macrophages were found at 6h post-infection, demonstrating the uptake of Plasmodium antigens 






Fig. 4.7|Phagocytosis of 
apoptotic hepatocytes 
containing Plasmodium 
antigens by dendritic cells 
and macrophages. Liver non-
parenchymal mononuclear cells 
obtained 6h after injection of mice 
with irradiated P. yoelii sporozoites 
and stained with different antibodies: dendritic cell (anti-CD11c, red; a and b), macrophage (anti-Mac3, green; c) and P. yoelii 




An average of 3 macrophages and 2 dendritic cells in each PyHSP70 vacuole-containing liver were 
found in 3 different experiments. The number of dendritic cells containing these vesicles is probably 
higher in the mouse, but after dendritic cells have internalized and processed the apoptotic bodies, 
they leave peripheral organs and migrate to the lymph nodes, subsequently to having received an 
activation signal. As a result, the time that they remain in the liver is very short. Therefore, the 
quantification obtained 6h after immunization might, in fact, correspond to what would be expected, 
because it corresponds to the number of phagocytic cells that were still in the liver and have not yet 
migrated to the lymph node. Thus, the time frame for detection of phagocytic cells carrying parasite 
antigens is very short and restricted as the time gap between these two events is of approximately 1 
h (Sallusto and Lanzavecchia, 2000). 
The HSP70-positive vesicles found inside macrophages and dendritic cells must be derived from 
infected hepatocytes, since this protein is not expressed in sporozoites and appears only in infected 
hepatocytes, approximately 6 h post-infection (Kumar et al., 1993).  
In order to evaluate the origin of the phagocytosed Plasmodium antigens, phagocytic cells were also 
stained for mouse albumin, a common protein known to be found in the cytosol of hepatocytes 
(Doweiko and Nompleggi, 1991). The results demonstrated that albumin is present in the 
phagocytosed vesicles, confirming that infected hepatocytes, and not dead sporozoites, are the 
source of uptaken antigens, corresponding to the colocalization observed between the parasite and 
albumin (Fig. 4.8). As a control, non-parenchymal liver mononuclear cells were isolated from non-
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Fig. 4.8|Hepatocyte proteins are found in P. yoelii phagocytosed vesicles. Liver non-parenchymal mononuclear cells 
obtained 6h after injection of mice with irradiated P. yoelii sporozoites were stained with anti-P. yoelii HSP70 (blue; b) and anti-
albumin (red; c) antibodies. Plasmodium vesicles colocalized with albumin, a protein abundant in the liver (b and c overlay; d). 
Transmitted light view (a). Cells isolated from livers of non-infected control mice did not present any albumin staining. 
 
 
To confirm if these HSP70-positive vesicles were derived from apoptotic cells, phagocytic cells were 
stained with anti-active-capase-3 antibody. Phagocytes showed evidence that, indeed, there is 
activation of caspase-3 in the Plasmodium antigen-containing vesicles implicating that dendritic cells 
phagocytose apoptotic infected hepatocytes during malaria infections in vivo (Fig. 4.9). Non-infected 
control mice did not exhibit any positive staining for capase-3 activation. 
 
a b c d
 
Fig. 4.9|Caspase-3 is active in P. yoelii phagocytosed apoptotic bodies. Liver non-parenchymal mononuclear cells 
obtained 6h after injection of mice with irradiated P. yoelii sporozoites were stained with anti-P. yoelii HSP70 (green; b) and anti-
active-caspase-3 (red; c) antibodies. Plasmodium vesicles colocalized with activated caspase-3 indicating an apoptotic origin (b and 




When liver non-parenchymal mononuclear cells were analyzed 12 h post-infection, no cells were 
found containing P. yoelii HSP70, suggesting that infected hepatocyte death and clearance occurs 
early during in vivo infections with irradiated sporozoites. This is consistent with the observation that 
Plasmodium sporozoite infection and initiation of the immune response occurs rapidly, since 
activation of specific anti-P. yoelii CD8+ T cells is detected as soon as 8 h after inoculation of 





4.2.2.3 Establishment of a cross-presentation assay  
To initiate immune responses, dendritic cells need to activate naïve T lymphocytes into cytotoxic T 
lymphocytes by taking up, processing and degrading antigens into peptides which can then be 
presented on MHC class I molecules. Dendritic cells can present antigens acquired either by 
internalization or synthesized in their cytosol. When pathogens do not infect these professional 
antigen-presentation cells, antigens are acquired via an exogenous route, transported into the cytosol 
and presented by MHC class I molecules through a cross-presentation process (Gil-Torregrosa et al., 
2004; Albert et al., 1998 a, b). 
Since Plasmodium-infected apoptotic hepatocytes are phagocytosed by dendritic cells and apoptotic 
cells constitute an efficient exogenous source for antigens, able to induce a malaria immune 
response, a cross-presentation assay capable of proving that dendritic cells are the ones responsible 
for this cross-presentation, after the antigen uptake provided by the apoptotic infected hepatocytes, 
was necessary.     
Several attempts were made pursing this aim but the results obtained were either inconclusive and 
inconsistent or irreproducible between different experiments for an array of different reasons. For 
example, the total cell number present in a liver (109) and the small proportion of these that were 
potentially infected and antigen-providing was a huge disadvantage on setting up such an assay.  
Therefore, the positive results obtained constitute preliminary data only and are not shown here. 
Nevertheless, the approaches followed in this process are described next. 
 
Plasmodium circumsporozoite protein construct  
A genetic approach was undertaken to evaluate if dendritic cells are capable of cross-presenting 
Plasmodium antigens derived from apoptotic bodies. A plasmid construct was made using the P. yoelii 
CS protein (kindly supplied by Dr. Oscar Bruña-Romero). Hepa 1-6 cells were transfected with this 
construct and apoptosis was induced by UV light. The apoptotic bodies generated in the process 
were incubated with dendritic cells for 6h to allow phagocytosis. These cells were then injected into 
mice and an ELISPOT assay was performed nine days post injection for determination of activated 
CD8+ T cells specific for Plasmodium CS protein through the quantification of IFN-γ production 
(Carvalho et al., 2001).  
 
CD8+ T cell clone specific for Plasmodium CS 
Another approach that was carried out was based on the use of an immunologic tool for detection 
of P. yoelii-specific antigen presentation. To observe if dendritic cells were able to activate T cells 
after phagocytosing the parasite antigens in the liver, mice were injected with irradiated and heat-
killed sporozoites (used as negative control). Liver cells were isolated and placed together with the 
CD8+ T cell clone (Y26) specific for an epitope from P. yoelii CS protein (Rodrigues et al., 1991). 
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After an incubation period of 24h the T cells were stained with anti-IFN-γ antibody (Molecular 
Probes) to analyze T cell activation. Although this would not prove that dendritic cells mediate 
cross-presentation of Plasmodium antigens in vivo, it could have suggested that they had the capacity 
to do so.  
 
CD11c+ depleted transgenic mouse 
A novel diphteria toxin-based system that allows the inducible, short-term ablation of dendritic cells 
in vivo was lately reported (Jung et al., 2002). The loss of T cell activation using this system would 
implicate dendritic cells in the process of presenting Plasmodium antigens to T cells. 
To determine whether liver dendritic cells were the ones responsible for the observed T cell 
activation, transgenic mice expressing the diphtheria toxin receptor under the control of CD11c+ 
promoter were used. These mice can be depleted of CD11c+ dendritic cells by a diphtheria toxin 
injection 24h prior malaria infection. Irradiated and non-irradiated sporozoites were injected and 
livers were removed 6h later. Liver mononuclear cells were incubated with the T cell clone specific 
for an epitope from P. yoelii CS protein (Y26) and activation was detected by IFN-γ expression 24h 
later. 
 
Further antigen presentation assays will have to be performed to establish and confirm the 
preliminary data already obtained with these approaches. The search for a more accurate cross-





It has been over 30 years since the first successful human malaria vaccine trial (Clyde et al., 1973a). 
Bites of hundreds of irradiated infected mosquitoes where then used to immunize volunteers, and 
established that protection against malaria could also be achieved in humans as had been shown for 
mice by Nussenweig and colleagues (Nussenzweig et al., 1967). However, such approach was 
dismissed for large-scale vaccinations due to safety and logistics problems. 
Nevertheless, it is important to understand the mechanisms behind irradiated sporozoite-induced 
protection, as their efficiency has not yet been replicated by other forms of human anti-malaria 
vaccines. In fact, consecutive drawbacks have been reported when subunit vaccine strategies were 
applied, although very promising candidates are presently on trial (Hill, 2006; Stoute et al., 1997). 
Thus, whole parasite approaches are still being considered, either by pursuing a doable protocol with 
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irradiated sporozoite immunization or by making use of genetically modified parasites that are being 
shown to be capable of inducing protection in mice (Mueller et al., 2005; Luke and Hoffman, 2003). 
Protection was attributed to a continuous supply of antigen provided by the intracellular hepatic 
parasites that remained in the liver for extended periods of time (Scheller and Azad, 1995). 
Furthermore, it is known that irradiated sporozoite-induced immunity is mediated by CD8+ T cells 
and dendritic cells, although the mechanisms underneath antigen presentation to T cells remain 
unclear, since the low number of Plasmodium-infected hepatocytes in the liver has prevented the 
development of direct observation of this process (Morrot and Zavala, 2004b; Jung et al., 2002; 
Bruña-Romero and Rodriguez, 2001; Weiss et al., 1988). 
The results presented in this chapter show that in the P. yoelii experimental malaria model, there is an 
increase in the apoptotic death of hepatocytes infected with irradiated sporozoites when compared 
with normal sporozoite infection. The apoptotic bodies originated from infected hepatocytes were 
shown to be phagocytosed by both dendritic cells and macrophages present in the liver, implying 
that presentation from these cells would be responsible for the protection induced by irradiated 
sporozoites. However, it was previously established that only dendritic cells are required for 
activation of Plasmodium-specific CD8+ T cells in vivo (Jung et al., 2002). Dendritic cells are 
professional antigen-presenting cells with the unique ability to capture exogenous antigens within 
the phagosome and to present them on MHC class I molecules to antigen-specific CD8+ T cells 
inducing its activation (Guermonprez et al., 2003; Houde et al., 2003).  
The low number of vesicles containing material derived from apoptotic Plasmodium-infected 
hepatocytes detected 6h post-sporozoite inoculation is explained by the restricted time frame within 
dendritic cells migration. These cells take approximately 1h to leave the liver and travel to the lymph 
nodes, after antigen uptake (Sallusto and Lanzavecchia, 2000). Thus, at 6h post-immunization we 
could only find the cells that had phagocytosed parasite material but that had not yet left the liver. 
Therefore, we could not exclude the possibility that more cells acquire antigens from apoptotic 
hepatocytes during Plasmodium infection. Still, low numbers of dendritic cells that migrated to the 
lymph nodes could activate T cells and, therefore, initiate efficient T cells responses (Martin-
Fontecha et al., 2003). In addition, protective CD8+ T cells are generated within the first 8h post 
irradiated sporozoite-infection, suggesting that only the antigens delivered before this time 
contribute to immunity (Hafalla et al., 2002). 
Apoptotic hepatocytes containing Plasmodium antigens provide an optimal source of antigens for 
dendritic cells cross-presentation, as was observed for viral antigens presentation originated from 
virus-induced apoptosis (Albert et al., 1998a). Besides, apoptotic hepatocytes possess the appropriate 
size, which ranges approximately between 1 and 10 µm, to be internalized by phagocytosis. A cross-
presentation mechanism would also provide an explanation for the fact that liver infection is a 
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requisite for protection against this stage of the parasite’s life cycle, as well as for the activation of 
CD8+ T cells by an obligate intracellular parasite that can develop only inside hepatocytes, which are 
non-professional antigen-presenting cells. Moreover, the inflammatory environment induced during 
sporozoite infection of the liver, mediated either by Kupffer cells or by wounded hepatocytes 
traversed during sporozoite migration, may also favour the recruitment of large numbers of 
dendritic cells and provide maturation signals for them (Frevert, 2004; Mota et al., 2002; Khan and 
Vanderberg, 1992).  
Apoptotic cells originated as a consequence of a physiological cell death that occurs during growth 
or development do not release maturation signals nor induce immunity during clearance (Gallucci et 
al., 1999). On the other hand, apoptotic cells expressing HSPs are very effective stimulators of 
dendritic cells and T cell activators (Masse et al., 2004; Feng et al., 2003). Indeed, this could be 
applied to hepatocytes infected with irradiated sporozoites, since besides being stressed cells they 
also express Plasmodium HSP70. 
Invasion of hepatocytes is essential for protection to occur. The decrease observed in the number of 
host cells infected with normal sporozoites 48h after infection suggests that normal sporozoites may 
also use this mechanism to generate CD8+ T cells and protective immune responses that are 
observed when blood-stage infection is inhibited (Belnoue et al., 2004; Ocana-Morgner et al., 2003; 
Orjih et al., 1982; Alger and Harant, 1976; Spitalny and Nussenzweig, 1972). 
The apoptotic pathway that determines hepatocyte death during infection is not yet fully understood. 
However, it seems likely that the mitochondrial pathway would be used instead of the death 
receptor-mediated or the granzyme/perforin pathway. The fact that our results show activation of 
caspase-3 does not exclude or confirm any of these routes since this enzyme is a final player of the 
apoptosis cascade (Hengartner, 2000). Additionally, since the immune response to liver stage 
parasites occurs in either perforin-deficient or Fas-deficient mice, it is unlikely that these pathways 
are involved (Doolan and Hoffman, 2000). 
Dendritic cells use virus-infected dead or dying cells as exogenous sources of antigens for 
presentation on MHC class I and class II molecules to initiate T cell responses. This pathway is 
thought to be critical for the development of effective antiviral immunity in vivo (Albert, 2004; 
Fonteneau et al., 2002; Norbury et al., 2002; Albert et al., 1998a). 
Recently, dendritic cell presentation of Mycobacterium tuberculosis antigens derived from apoptotic 
infected macrophages has been described as an alternative pathway of T cell activation (Schaible et 
al., 2003). Like Plasmodium sporozoites in hepatocytes, Mycobaterium is secluded in an intracellular 
compartment during infection, which suggests that presentation of antigens from apoptotic infected 
cells may represent a common mechanism of immune activation for vesicle-contained pathogens 
(Winau et al., 2005; Winau et al., 2004).  
56|Chapter Four 
 
Experimental live vaccines based on irradiated parasites have been used as a model for protection in 
malaria and schistosomiasis (Bergquist et al., 2002; Nussenzweig and Long, 1994). It is possible that 
irradiation of these parasites blocks the ability to neutralize the apoptotic machinery of host cells 
allowing them to resume their natural tendency to undergo apoptosis upon being infected (James 
and Green, 2004).  
Even though the existence of cross-presentation has been proposed, it had not yet been shown for 
malaria infection (White et al., 1996). Nevertheless, further work is required in order to demonstrate 
that phagocytosis of apoptotic infected host cells results in efficient presentation of parasite antigens 
to T cells. 
 























Anti-Apoptotic HGF/MET signalling  











































Legend|Model of hepatocyte infection by Plasmodium sporozoites. Sporozoites traverse several 
hepatocytes, disrupting their plasma membranes. This induces the activation of sporozoite exocytosis and the 
secretion of HGF from hepatocytes. Within 2 to 4h, HGF binds to its receptor MET, in neighbouring hepatocytes, 
transducing signals that lead to actin cytoskeleton reorganization and inhibition of infected host cell apoptosis. As a 
result, parasite development occurs successufully. 
5.1 Introduction 
Once they reach the liver, Plasmodium sporozoites can invade hepatocytes in two distinct ways: either 
by disrupting their plasma membrane or by inducing the formation of a parasitophorous vacuole 
around themselves. The first mode of entry allows the parasite to migrate through hepatocytes, 
experiencing a direct contact with the host cytoplasm and is followed by rapid exit of the 
sporozoites using the same mechanism. Thus, sporozoites traverse several hepatocytes before 
invading a final one where a vacuole is formed by invagination of the host plasma membrane and 
liver infection starts (Mota et al., 2001; Mota and Rodriguez, 2001). This feature of Plasmodium’s 
invasion process is essential since parasites become activated during the migration process, inducing 
exocytosis of apical organelles, a requirement for vacuole formation when the final hepatocyte is 
infected (Mota et al., 2002). Most of the sporozoite-traversed hepatocytes survive by resealing their 
plasma membrane and avoid death, but for as long as rupture persists, growth factors and other 
proteins stored in the cytosol are released into the extracellular environment. Moreover, after 
resealing, wounded cells express and secrete growth factors, like the hepatocyte growth factor 
(HGF), which render neighbouring hepatocytes more susceptible to infection (Carrolo et al., 2003).  
HGF, also known as scatter factor, was first described as a potent mitogen for hepatocytes during 
liver regeneration as well as motility factor inducing “scattering activity” in polarized epithelia cells 
(Bussolino et al., 1992; Bottaro et al., 1991; Stoker et al., 1987; Nakamura et al., 1986). This 
glycoprotein is secreted as a biologically inert precursor (pro-HGF) that, under specific conditions, 
such as tissue damage, and through a proteolytic digestion becomes a bioactive heterodimer mature 
HGF form (Zarnegar and Michalopoulos, 1995). 
The receptor for HGF was identified as a c-met proto-oncogene product encoding a receptor 
tyrosine kinase (Bottaro et al., 1991; Naldini et al., 1991; Park et al., 1986; Cooper et al., 1984). 
The MET receptor has two main structural characteristics: a unique multifunctional docking site 
through which recruitment of all the downstream signalling molecules occurs, and one single large 
adaptor protein with multiple substrates, known as Gab1, that mediate most of the complex cellular 
responses subsequent to activation (Birchmeier et al., 2003; Furge et al., 2000). Like its ligand, MET 
is also a heterodimer with an entirely extracellular alpha chain and a polypeptide chain with an 
intracellular tyrosine kinase domain. The stimulation of MET results in a series of biological and 
biochemical effects within the cell, leading to scattering, proliferation and growth, enhanced cell 
motility, angiogenesis, survival and the invasion of extracellular matrices (Trusolino and Comoglio, 
2002). 
MET expression occurs in the normal epithelium of almost every tissue, although other cell types 
such as endothelial cells, hematopoietic cells, microglial cells, neurons, and a variety of tumor cell 
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lines also express this receptor (Zarnegar and Michalopoulos, 1995). Alterations in the HGF/MET 
signalling have emerged as crucial features of many human malignancies suggesting that interfering 
with activation of this pathway might hold therapeutic value. Thus, several strategies have been 
developed in order to manipulate the transduction signals involved, either by constitutive activation 





Fig. 5.1|Schematic representation of the 
different pathways that are activated by 
HGF/MET signalling.  Upon HGF stimulation, 
two receptor molecules dimerize and cross-
phosphorylate each other, thereby creating binding 
sites for signalling molecules within the cell. From 
the activation of each transducer results an array of 
biological activities that are here summarized 




HGF/MET signalling enhances Plasmodium liver infection and is required not for invasion but rather 
at early stages of parasite development within the host cell. In vivo inactivation of MET inhibits P. 
berghei liver infection, confirming the relevance of this mechanism for infection. Furthermore, MET 
signals induce the reorganization of host cell’s actin cytoskeleton which is believed to have a 
contribution for the final outcome of Plasmodium sporozoite infection (Mota and Rodriguez, 2004; 
Carrolo et al., 2003). 
A host-pathogen interaction triggers a variety of responses that force the pathogen to develop 
strategies to manipulate the host. As already mention, direct, as well as indirect, effects of pathogens 
and their products modulate host cell death (Luder et al., 2001). The induction of apoptosis upon 
infection results from a complex interaction of parasite proteins with cellular host proteins. Infected 
cells constitute a threat to the host and therefore are normally destroyed. On the other hand, 
abrogation of host cell apoptosis is often beneficial for the pathogens as they are able to exploit host 
resources in order to satisfy their needs and extending their life inside the host, which outcomes in a 
successful invasion (Hasnain et al., 2003).  
Inhibition of apoptosis by bacteria and other intracellular parasites such as Leishmania and 
Toxoplasma is well documented (Heussler et al., 2001; Gao and Kwaik, 2000; Nash et al., 1998; Moore 
and Matlashewski, 1994). However, the genes involved in this process have not yet been identified 




Although the mechanism through which the HGF/MET axis elicits inhibition of apoptosis is not 
completely understood, there is no doubt that HGF is a strong promoter of cell survival, since this 
biological response was observed in liver development through gene ablation or overexpression 
studies in transgenic mice (Amicone et al., 1997; Maina et al., 1996; Schmidt et al., 1995). In addition, 
the anti-apoptotic effect of HGF has also been reported on various cell types, from epithelia to 
tumors (Xiau et al., 2001; Bardelli et al., 1999; Fan et al., 1998).   
In this chapter, an additional role is proposed for HGF in the maintenance of Plasmodium infection: 
protection from apoptosis. The results showed that apoptosis inhibition on infected cells is 
mediated by HGF/MET signalling via the PI3K pathway and allows parasite persistence within the 
liver until full development is reached.    
 
5.2 Results 
5.2.1 Sporozoite infection protects cells from apoptosis 
To determine whether Plasmodium infected cells were protected from apoptosis, HepG2 cells were 
incubated with P. berghei sporozoites (live or heat-killed, as control) and treated 18h later with TNF 
and Cycloheximide (CHX) to induce apoptosis. Six hours post-induction, apoptosis was quantified 
using different methods to evaluate distinct apoptosis features. Infected cells are more protected 
from apoptosis than non-infected ones, as shown when activation of caspase-3 is measured (red; 
Fig. 5.2) and nuclear morphology analyzed after staining with DAPI (blue; Fig. 5.2). Apoptosis was 
also quantified by TUNEL assay for assessment of DNA breaks, a common apoptotic mark (striped 
bars; Fig. 5.3). Similar data were obtained using a different cell type (Hepa 1-6 cells) and a different 
inductor of apoptosis (UV light; Fig. 5.3 b). In this case a higher level of protection than the one 
observed when infected cells were induced with TNF and CHX was observed. Taken together, these 





Fig. 5.2|Plasmodium infection protects from death. A host cell infected with 
P. berghei sporozoites not showing signs of apoptosis and surrounded by apoptotic 
non-infected cells, as detected by anti-PyHSP70 (green), DAPI (blue) and anti-
active-caspase-3 antibody (red)  
 















used as control) and treated 18h later with TNF and Cicloheximide to induce apoptosis. (a) Apoptosis was quantified 6h post-
induction by nuclear morphology following DAPI staining (black bars), active caspase-3 (white bars) and TUNEL detection (strip 
bars). (b) Hepa 1-6 cells were incubated with P. berghei sporozoites (heat-killed sporozoites were used as control) and exposed to 
UV light 18h post-infection. After 6h, apoptotic cells were counted by TUNEL detection. (a, b) Infected cells were stained with 





































































































5.2.2 HGF/MET signalling enhances infection and confers protection from 
apoptosis 
 
Several cytokines and growth factors are capable of inducing different cell mechanisms and essential 
cell functions such as proliferation, differentiation, chemotaxis and survival. One of these molecules 
is the hepatocyte growth factor (HGF) (Trusolino and Comoglio, 2002). Binding of HGF to its 
receptor c-Met induces the activation of a tyrosine kinase-dependent cascade of events that results in 
phosphorylation of a series of residues and leads to the recruitment of intracellular signaling 
molecules which trigger a range of biological responses within the cell (Mota et al., 2004). The 
presence of this growth factor during a malaria infection enhances the infection outcome and is 
mediated by HGF-induced MET activation (Carrolo et al., 2003). 
Taking this into account, it was hypothesized that the increase in the infection is caused by HGF-
induced protection from apoptosis. To test this possibility, first, the HGF effect on Plasmodium-
sporozoite infected cells was determined. In order to do so, HepG2 cells were treated with HGF 
(500 ng/ml) 1h prior to infection with P. berghei sporozoites. Control cells did not undergo HGF 
treatment. After 6h, cells were stained for parasite detection (anti-HSP70 antibody) and apoptosis 
quantification by nuclear morphology (DAPI) of infected hepatocytes. The results showed that the 
presence of HGF leads to an increase in infection and to a reduction in the number of apoptotic 




































































































Fig. 5.4|HGF-induced MET activation enhances infection and protects infected cells from apoptosis. (a, b) 
HepG2 cells were treated with HGF for 1h, and incubated with P. berghei sporozoites. Hepatocytes were fixed after 24h 
(infection, a) or 6h (apoptosis, b), and stained with anti-HSP70 antibody (to visualize the parasite) and with DAPI (nuclear 
morphology) to quantify apoptosis. 
 
In addition, two monoclonal antibodies, DO-24 and DO-30, that act on the extracellular domain of 
the MET receptor were used to assess the same question with a different approach. These agonist 
monoclonal antibodies have been described to have diverse effects on cells and to activate various 
pathways (Prat et al., 1998). While DO-24 is a full agonist, capable of inducing a strong response 
from the receptor and trigger what is known as the complete invasive growth program, including cell 
survival, the DO-30 antibody has a partial effect, causing a weak activation of MET and inducing 
motility only (Prat et al., 1998). 
To evaluate the effect of these agonists on infection, HepG2 cells were infected with P. berghei 
sporozoites 2h after addition of the antibodies. The number of EEFs was quantified by 
immunofluorescence staining with anti-HSP70 antibody for parasite detection. Results show that 
both antibodies lead to an increase in infection, although to different extents. Apoptosis 
quantification either by nuclear morphology and caspase-3 activity revealed a correlation between 
the increment in infection and a reduction of infected hepatocyte death (Fig. 5.5). The full agonist 
DO-24 had a stronger effect than the partial agonist DN-30. The caspase-3 activity is involved in 
late stage apoptosis justifying why this percentage is lower although showing the same trend 
(Thromberry and Lazebnick, 1998). These results demonstrate that signaling through HGF/MET 
pathway during a malaria infection is directly implicated in the protection from apoptosis of the 




















































































Fig. 5.5|HGF agonists induce infection and host cell protection. HepG2 cells were pre-treated for 2h with the agonist 
anti-MET monoclonal antibodies DN-30 or DO-24 (1µg/ml) and afterwards infected with P. berghei sporozoites. (a) The number 
of infected cells (EEFs) was quantified 24h post infection by counting anti-Plasmodium-HSP70 positive cells. (b) Apoptosis was 
quantified 6h post infection by DAPI (black bars) and caspase-3 activity (white bars). Untreated-infected cells were used as 
control. 
 
In order to analyze the behavior of infected cells in the presence of an apoptosis inhibitor, we used 
Z-VAD-FMK, a cell permeable broad-spectrum caspase inhibitor that binds covalently to active 
caspases in living cells, is non-cytotoxic and has been shown to inhibit apoptosis randomly (Chipuk 
and Green, 2005; Al-Olayan et al., 2002). HepG2 cells were treated with Z-VAD-FMK (20µM) or 
with HGF (500 ng/ml) 1h prior to infection with P. berghei sporozoites. The chemically induced 
inhibition of apoptosis led to a higher infection than that observed either with HGF or with 














Fig. 5.6|Inhibition of caspase activity 
increases infection. 1h prior to infection 
with P. berghei sporozoites, HepG2 cells were 
treated either with Z-VAD-FMK (20µM) or 
with HGF (500 ng/ml). The number of 
infected cells (EEFs) was determined 24h post 
infection after staining with anti-HSP70 





5.2.3 MET inactivation leads to apoptosis during infection 
The HGF-mediated signaling cascade occurs through a tyrosine kinase receptor, c-Met. Its activity is 
essential for the progress of the downstream catalytic processes. In order to determine the effect of 
MET signaling impairment on infected hepatocytes, a stable transfected HepG2 MET-dominant-




chimeric construct containing the extracellular and transmembrane domains of met fused to gfp 
sequences was transfected into HepG2 cells. The product of this construct is expressed at the 
plasma membrane and binds to HGF but it is unable to transduce signals into the cell since it lacks 
the kinase domain and the tyrosines acting as docking sites for intracellular substrates. This chimeric 
receptor behaves as a dominant negative, because it dimerizes with endogenous MET and 
consequently prevents its activation (Carrolo et al., 2003; Giordano et al., 2002; Vigna and Giordano, 
2000). Because cells transfected with this lentivirus become fluorescent, it is possible to determine 
the infection level of single-transduced cells 24h after infection. 
As previously mentioned, the activation of the MET receptor is essential for the infection of 
hepatocytes by Plasmodium sporozoites (Carrolo et al., 2003). The impairment of the signal abolishes 
completely the infection 24h post-transduction, as no individual cells transduced with MET-GFP 
were found to be infected with Plasmodium (Fig. 5.7a). The number of apoptotic cells correlates with 
MET inactivation as in these cells apoptosis increased to 68% while control cells (GFP-transduced 
only) show a 21% level of death, as determined by observation of nuclear morphology 6h post-
infection following DAPI staining clearly shows apoptosis features in MET-GFP transduced cells 
(Fig. 5.7b; Fig. 5.8).  These results strongly suggest that MET signaling is required for host cell 
apoptosis inhibition and in that way for host cell survival and infection success through an anti-

























































































Fig. 5.7|MET inactivation leads to early apoptosis of infected cells. HepG2 cells were transduced with a lentivirus 
expressing MET-GFP or GPF alone (control). The dominant negative hepatocyte MET mutant cell and control lines were 
infected with P. berghei sporozoites. 24h post-infection the number of EEFs was determined (a) and 6h post-infection apoptosis 
was quantified by nuclear morphology observation (b). All P ≤ 0,001. 
 
 
It is likely that all infected cells undergo apoptosis in the absence of a functional MET receptor 
within 24h, as no infected cells were found at this time point. No increase in apoptosis of non-
infected transduced cells was observed. 
 
 





Fig. 5.8|Dominant negative MET-GFP infected cell undergoing 
apoptosis. (a) HepG2 cell 6h after infection with P. berghei sporozoites (red, 
anti-HSP70) with a normal nuclear morphology (blue, DAPI). (b) Infected cell 
expressing MET-GFP (green) 6h post-infection with a parasite starting to 
develop (red, anti-HSP70) and exhibiting apoptosis features detected by nuclear 
morphology with DAPI (blue).  
 
5.2.4 MET down-regulation leads to apoptosis during infection 
As shown above the impairment of HGF/MET signaling using a dominant negative form of MET 
leads to higher levels of apoptosis and promotes the early death of the infected cell. To confirm 
these results we also abrogated MET expression using RNA interference. HepG2 cells were 
transduced with a lentivirus vector expressing a short interfering RNA (siRNA) oligonucleotide 
targeted at MET. A control sequence was used that did not cause any reduction on MET expression 
as detected by Western blot analysis (Fig. 5.9). 
 
Control siRNA MET siRNA
Fig. 5.9|MET expression on short interfering RNA cell line. Western 
blot analysis of MET expression in HepG2 cells transduced with lentiviruses 
expressing control siRNA oligonucleotide (left lane) or MET siRNA 
oligonucleotide (right lane) to knockdown met. 
 
The down-modulation of MET activity showed similar results as the ones obtained for the dominant 
negative cell line, that is, an inverse correlation between a decrease in infection (Fig. 5.10a) and an 
increase in apoptosis of infected cells (Fig. 5.10b). This evidence confirms the relation between 
hepatocyte survival and HGF/MET activation, indicating that its anti-apoptotic activity is essential 
during Plasmodium infection. 
 























































































Fig. 5.10|Down-modulation of HGF/MET signaling leads to early apoptosis of infected cells. Lentivirus 
engineered to express MET-specific siRNA oligonucleotides were used to transduce HepG2 cells. Hepatocytes transfected with a 
siRNA specific for the met gene were infected with P. berghei sporozoites. As control, hepatocytes were transfected with a siRNA 
of an unrelated sequence. (a) Infection was quantified 24h post-sporozoite addition by counting the number of EEFs and (b) 6h 




5.2.5 Anti-apoptotic effect of HGF/MET signalling is mediated via activation of 
PI3K pathway  
In a signalling cascade, a series of subsequently biological events take part in the process of reaching 
a target or accomplishing a certain level of activation or induction. In HGF cascade the survival 
pathway is mediated by a phosphoinositide 3-Kinase (PI3K)/Akt, whose activity directs the cell to a 
death inhibition state (Webster and Anwer, 2001; Xiau et al., 2001).  
To determine if this pathway is implicated in malaria infection, HepG2 cells were treated with a 
specific PI3K inhibitor (LY294002) 1h prior infection with P. berghei sporozoites. Additionally, a 
mitogen-activated protein kinase (MAPK) inhibitor (PD98059) was used to evaluate if this pathway 
was involved in protection from apoptosis. An anti-apoptotic role has also been described for 
MAPK pathway, since once activated by HGF, it was capable of rescuing cells from apoptosis, 
although to much smaller extent (Xiau et al., 2001). 
As shown below in Figure 5.11 when cells are treated with either of these inhibitors there is a 
significant decrease in infection. This effect is stronger when the PI3K activity is inhibited. When 
apoptosis was quantified after 6h on the same infection experiment, a significant increase was 
detected in the apoptotic cells number, only when cells were pretreated with the PI3K inhibitor. 
These results show that, although both PI3K and MAPK pathways seem to be involved in 



















































































Fig. 5.11|Inhibition of PI3K/AKT pathway in vitro leads to a decrease in infection. HepG2 cells were pretreated 
with LY294002 (25µM, PI3K inhibitor) and with PD98059 (30µM, MAPK inhibitor) for 1h. Inhibitors were washed before 
infection with P. berghei sporozoites. Control cells were incubated with DMSO. (a) 24h post-infection cells were fixed, stained 
and EEFs were counted (PLY ≤ 0,001; PPD = 0,003). (b) 6h post-infection cells were fixed and apoptotic cells quantified by DAPI 
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5.2.6 Inhibition of PI3K pathway decreases Plasmodium infection in vivo 
In vivo assays with PI3K inhibitor have previously been performed, demonstrating its activity in 
mouse models (Hu et al., 2002; Semba et al., 2002). To determine if the effect observed in vitro, could 
also be extrapolated to a natural infection in vivo, mice were injected with 2.5 mg of LY294002, 30 
minutes prior to sporozoites infection. Livers (from 4 animals in each experimental group) were 
collected 40h later and the parasite load was determined by real-time RT-PCR with primers specific 
for P. berghei.  Data obtained reveal a significant reduction in liver infection observed in animals 
pretreated with the PI3K inhibitor (Fig. 5.12a). A Western blot analysis was also performed to 
confirm whether the inhibitory treatment applied was targeting the PI3K pathway. As shown below 
the phosphorylation of Akt was reduced in the treated animals. Since this molecule is located 
downstream of PI3K, its decreased phosphorylation state expresses the inhibition level obtained 
(Fig. 5.12b). 
Taken together, the in vitro and in vivo results reveal that the anti-apoptotic effect exerted by 



































































Fig. 5.12|In vivo inhibition of PI3K/AKT pathway during infection. (a) Mice were injected with LY294002 or DMSO 
(control), 30 min prior i.v. injection of P. berghei sporozoites. Livers were removed and real time RT-PCR was performed 40h 
post-infection with parasite specific primers to quantify infection (P≤ 0,005). (b) Mice were injected with LY294002 or DMSO, 
30 min prior to infection with P. berghei sporozoites. Livers were extracted 3h post-infection and phospho-Ser473-Akt and total 





Plasmodium infection is initiated by the inoculation of sporozoites in the skin of the host, from where 
they migrate towards the liver, which is the first obligatory step crucial for parasite development and 




by breaching their plasma membrane before infecting a final one surrounded by a parasitophorous 
vacuole where the intrahepatic form of the parasite grows and multiplies (Mota et al., 2001). 
Although during this period there is an extensive parasite multiplication in the liver each one giving 
rise to 10-30 thousand new parasites in 2-10 days, depending on the parasite species not much is 
known about its requirements and strategies used to survive and to accomplish a successful 
development (Baldacci and Menard, 2004). 
It is known that intracellular pathogens have developed powerful strategies to manipulate host cell 
functions. Many of them have evolved to exploit the host cell machinery involved in normal cell 
proliferation, development and cell death to their own advantage (Sibley, 2004; Heussler et al., 2001). 
Obligatory life inside a host cell directs the pathogen to induce host cell survival or to prevent its 
death in order to prolong the parasite’s life and ensure its full development. Thus, inhibition of 
apoptosis constitutes a significant advantage for a parasite. Such events have been reported for 
several pathogens, like bacteria and other intracellular parasites, as Leishmania and Toxoplasma (Gao 
and Abu Kwaik, 2000; Nash et al., 1998; Moore and Matlashewski, 1994). 
The results presented in this chapter show that P. berghei sporozoites are no exception and require an 
active process of inhibition of host cell apoptosis in order to reach the next infective stage. 
However, Plasmodium sporozoites seem to use a unique feature since they take advantage of a host 
molecule not secreted by the infected cell but by neighboring ones, previously traversed by the 
parasite, instead. Whether this is the only mechanism used by the parasite to avoid host cell 
apoptosis remains unknown. 
Our results show that PI3-kinase activation is important for the survival of the infected cell. The 
anti-apoptotic effect mediated by HGF uses this signal transduction pathway. However, we cannot 
exclude that the infection inhibition observed both in vitro and in vivo by the specific PI3-kinase 
inhibitor could be due to PI3-kinase mediated survival signals other than those generated through 
HGF/MET signaling.  
While sporozoites migrate through cells by breaching hepatocyte plasma membrane, HGF is 
secreted (Carrolo et al., 2003). This secretion of a factor by the host cell leads to an increase in the 
number of Plasmodium-infected cells. In fact, results showed that infection was dependent on HGF 
receptor MET activation, and HGF/MET signalling was not required for invasion but rather for 
early parasite development. In the liver, hepatocytes do not normally express HGF which is 
produced by non-parenchymal cells, but, the MET receptor is selectively expressed by hepatocytes 
(Ishikawa et al., 2001). 
Since HGF-MET signalling confers resistance to death and infection was higher under its stimulus it 
can be suggested that these events were correlated (Fan et al., 1998; Bardelli et al., 1996). Thus, we 
now report this additional role for HGF in the maintenance of Plasmodium infection, which is the 
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prevention of infected host cell apoptosis, a crucial requirement to elicit the full development of the 
parasite. Moreover, in infected cells a higher level of apoptosis was observed when HGF/MET 
signalling or PI3K/Akt pathway were inhibited, suggesting that these two pathways are connected. 
The earlier work already mentioned also showed that one of the causes of HGF requirement for 
hepatic infection was the remodeling of the host cell actin cytoskeleton (Carrolo et al., 2003). In fact, 
it was observed that pretreatment of host cells with HGF abrogates the negative effect that 
cytochalasin-D has on infection. This strongly suggests that HGF/MET signaling effect on infection 
involves the host cell actin reorganization. 
Upon HGF stimulation, MET mediates the coordination of multiple cellular processes. Thus, it is 
likely that many of these processes might play a role during the development of Plasmodium 
sporozoites inside cells. It is also likely that apoptosis protection and actin reorganization are linked. 
In fact, studies in bacteria have demonstrated that several bacteria interfere with the fate of host cells 
through their activity on Rho GTPases, also favouring survival or death depending on their needs 
(Fiorentini et al., 2003). 
It has also been reported that hepatitis patients, which express high levels of HGF, are more 
susceptible to severe malaria. A requirement for MET signalling might provide an explanation for 
this observation (Thursz et al., 1995; Naoumov and Eddleston, 1994). 
Recently, a protein called SPECT (sporozoite microneme protein essential for cell traversal) was 
characterized in one of the secretory organs of sporozoites, the micronemes (Ishino et al., 2004). 
Transgenic parasites lacking this protein do not migrate through cells in vitro and show a strong 
reduction of infectivity in vivo, indicating that migration through host cells is required in order to 
establish a successful infection in the host. However, these results appear to contradict our 
hypothesis that migration through cells leads to HGF secretion required for infection, as SPECT 
mutants are able to infect host cells in vitro without previous migration through cells. The reason for 
this apparent discrepancy may be found in the particular characteristics of the in vitro cell system 
used for infection. The hepatoma cell line constitutively produces HGF and other factors that 
induce a basal level of activation of MET receptor (Conrotto et al., 2004). This is different from the 
conditions that sporozoites encounter in vivo, since in resting conditions primary hepatocytes do not 
express HGF and MET is not activated (Matsumoto and Nakamura, 1991). These constitutive levels 
of HGF are probably enough to support sporozoite infection at a basal level and therefore the 
additional HGF induced by migration would not be required. 
The outcome of our studies on the anti-apoptotic role of HGF signalling, help understand why 
signalling via HGF/MET is essential for an efficient malaria infection to occur. Further studies on 
parasite requirements inside hepatocytes to achieve successful development, may provide effective 

























Heat shock proteins are highly evolutionarily conserved molecular chaperones that have a wide 
range of functions within the cell. They are classified into several families, according to their 
molecular size. When cells are exposed to stress, such as temperature increase, hypoxia, and 
intoxication with heavy metals, the biosynthesis of these proteins is engaged in order to help 
preserve normal cell functions and to facilitate adaptation to environmental changes (Lindquist, 
1992).  
From bacteria to mammalian cells, these protein families ensure proper folding and function of 
other proteins, allowing them to acquire the correct shape and preventing or reverting stress-
induced protein misfolding (Schlesinger, 1990). Initially, it was thought that these proteins were 
effective only when high temperature was used as a stress inducer, as was described in salivary 
glands of Drosophila in 1962 (Ritossa, 1962). However, these molecules are not only expressed under 
stress conditions but also possess important functions during common physiological processes 
(Bukau and Horwich, 1998; Langer et al., 1992). Moreover, the exposure of cells to damage induces 
signals that are able to mediate cell death or, alternatively, survival pathways that allow cells to 
overcome damage. Therefore, heat shock proteins can act at different sites in the apoptotic cascade, 
inhibiting death and promoting survival (Fig. 6.1) (Beere, 2004). 
Among these families of proteins is the heat shock protein 70 (HSP70) family. This family 
constitutes one of the most abundant and conserved group of chaperones and its members are 
implicated in a large variety of activities within the cell, such as assembly and disassembly of newly 
synthesized protein complexes, refolding of denaturated proteins and protein translocation and 
degradation (Young et al., 2004; Hartl, 1996; Craig et al., 1993). Localized in different cellular 
compartments, they are present in mammalian cells, yeasts, plants, bacteria, and parasites (Mayer and 
Bukau, 1998; Lindquist and Craig, 1988). Typically, HSP70 proteins have three domains: an N-
terminal ATPase domain, a substrate-binding domain and a C-terminal conserved region containing 
a peptide sequence motif, EEVD. At the molecular level, they recognize unstable peptides to which 
they bind in an ATP-dependent process. In addition, their binding to exposed hydrophobic regions, 
facilitates the folding of nascent proteins into a tertiary structure (Mayer et al., 2000; Blatch and 
Lassle, 1999).  
In a variety of infections, HSPs are synthesized by both the host and the pathogen and their role in 
the host-pathogen relationship is very important and diverse.  As a host response to stress, these 
molecules contribute to its defence from toxic stimuli triggered by pathogen invasion. Conversely, 
pathogen’s HSPs help to escape the host defence system and perpetuate infection (Hisaeda and 
Himeno, 1997; Polla, 1991).  
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Virulent strains of some protozoa express higher amounts of HSPs as compared to low virulent 
strains. During Toxoplasma gondii infection, expression of HSP70 is induced in virulent strains, a fact 
that seems to provide protection for these strains since parasites are able to persist as tachyzoites 
without the requirement for the encystations observed in avirulent strains (Dobbin et al., 2002; 
Lyons and Johnson, 1995).  
HSPs are also responsible for the pathogen’s adaptation to the host environment. Parasites that 
possess a biphasic cycle involving two different hosts have to adapt to the temperature changes that 
occur between the vector and the mammalian environments. The response to this temperature shift 
has been shown to involve the production of HSP70, both in Leishmania major and in Trypanosoma 
brucei, which allows the parasite to differentiate into proliferative forms (Polla, 1991; Shapira et al., 


















Fig. 6.1|Events regulated by HSPs in the mitochondrial and death 
receptor-mediated apoptotic pathways. Extracellular signals or 
stresses converge to regulate the mitochondria-mediated pathway to caspase 
activation and cell death. (A) Heat shock proteins intervene at multiple 
points within this pathway both upstream and downstream of the associated 
mitochondrial changes to regulate the engagement and/or progression of 
apoptotic events. (C) Ligation of cell surface death receptors, e.g. Fas and 
TNFR1, by the appropriate ligand engages multiple intracellular signals 
leading to caspase activation and cell death or NFkB-mediated survival. Many 
elements of these pathways are regulated by the activities of HSPs to help 
maintain cellular survival following death receptor ligation. HSP-mediated 
inhibition is indicated (T-bars) and HSP-mediated potentiation of a signaling 
pathway is depicted as a direct interaction between the HSP and its target 




HSPs of malaria parasites were cloned and shown to be extremely similar to homologous 
mammalian ones (Syin and Goldman, 1996; Bonnefoy et al., 1994; Su and Wellems, 1994; Kumar et 
al., 1991). Within the different Plasmodium species several homologs of HSP70 were identified, like 
genes encoded by P. chabaudi and P. cynomolgi that present a 97% of sequence homology, indicating a 
close relation between these molecules (Kumar and Zheng, 1998; Eckert et al., 1992; Mattei et al., 
1989; Sheppard et al., 1989). 
P. berghei (PbHSP70) and P. falciparum (PfHSP70) HSP70s are expressed in the blood and liver stages 
of these parasites, but not in sporozoites (Tsuji et al., 1994; Kumar et al., 1993; Bianco et al., 1986; 
Renia et al., 1990).  
Additional studies have shown that during a natural infection, Plasmodium stress proteins are targets 
of the host immune system. Immune responses to malarial HSPs have been demonstrated in 
patients with malaria (Behr et al., 1992; Kumar et al., 1993; Bianco et al., 1986). PfHSP70 is in fact a 
target to antibody-dependent response and is recognized by T cells from infected individuals (Behr 
et al., 1992; Kumar et al., 1993). Like mammalian HSP70s, the P. falciparum protein has the EEVD 
characteristic motif at its C-terminus. The presence of an additional motif (GGMP repeats) is 
thought to be responsible for inducing this immune response in the host, since this motif is only 
observed in proteins of parasitic origin (Kumar and Zheng, 1998).  
Similar to other parasites, P. falciparum showed a marked increase in HSP70 expression when 
submitted to higher temperatures. This heat shock response was shown to be transient since once 
the stress was removed the induction was repressed. Such behaviour could indicate a protective 
function during malaria fever episodes, resulting in the in vivo survival of the parasite (Biswas and 
Sharma, 1994; Joshi et al., 1992; Kumar et al., 1991). 
However, this cytoprotection of the malaria parasite through its action as a molecular chaperone 
requires further studies, since the biochemical and chaperone properties of PfHSP70 are not totally 
understood. Due to an extremely A/T-rich genome and the usage of codons that are rarely used in 
Eschericia coli, it has been difficult to overexpress Plasmodium proteins (Matambo et al., 2004; Baca and 
Hol, 2000). Recently, further studies were performed to address the activity of PfHSP70 in vivo and 
its role as a chaperone. Data demonstrated the presence of a basal ATPase activity which was 
thermo-inducible and shown to be cytoprotective (Shonhai et al., 2005).  
Other families of heat shock proteins are also present in malaria parasites. HSP90, the most 
abundant chaperone in mammalian cells, plays an essential role in the folding of proteins that act on 
cell cycle regulation and signal transduction. The PyHSP90 is differently expressed throughout the 
life cycle, highly on blood asexual stages and very scarcely on gametocytes (Zhang et al., 1999). 
PfHSP90 was shown to be essential for parasite viability in blood stages, since treatment with 
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geldanamycin, a highly specific inhibitor of HSP90, was able to abrogate parasite growth 
(Banumathy et al., 2003; Kumar et al., 2003).  
Overall, the induction of HSPs upon cellular exposure to stress is clearly related to the involvement 
of these proteins in inducing survival and allowing cells to tolerate and recover from damage (Beere, 
2005). Such evidence has also been implicated in tumour resistance to chemotherapeutic strategies 
and carcinogenesis (Creagh et al., 2000).  
As mentioned in chapter II of this thesis, several records show evidence that cell death is a 
conserved mechanism throughout evolution and is also present in parasitic protozoa (Deponte and 
Becker, 2004). Moreover, Plasmodium infection does lead to host cell death inhibition. However, the 
plasmodial proteins responsible for this inhibitory function are still unknown. Therefore, like other 
pathogens, Plasmodium must carry anti-apoptotic genes with homology to cellular regulators with 
similar functions or genes not directly coding for anti-apoptotic proteins, but able to modulate the 
expression of cellular apoptosis-regulators genes in hepatocytes.  Consequently a search for 
homologues of known apoptotic inhibitors within Plasmodium genome databases could uncover 
possible candidates with this ability in the parasite. Furthermore, members of these families are 
present in a wide range of organisms and all contain defined and conserved motifs (Hurd and 
Carter, 2004). 
This chapter represents a pilot attempt to study the function of PyHSP70 as a possible candidate 
responsible for the inhibition of apoptosis in infected hepatocytes. The preliminary results presented 
here support this hypothesis. Hepatoma cells transfected with a Plasmodium HSP70 gene are 
protected against apoptosis, suggesting that Plasmodium HSPs may account for parasite survival 




6.2.1 PyHSP70 expression protects hepatocytes from death  
As previously shown, Plasmodium sporozoites are capable of protecting the hepatocyte from 
undergoing apoptosis by inhibiting host cell death (see chapter V).  
To evaluate whether a Plasmodium HSP70 has any role during liver infection, apoptosis of 
hepatocytes transfected with a construct expressing PyHSP70 was induced by UV light exposure. 
Results showed a decrease in apoptosis in the presence of HSP70, while cells transfected with a 
green fluorescence protein (gfp) construct or another irrelevant gene (control), presented much 
higher levels of cell death (Fig. 6.2). 
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The inhibition of apoptosis induced by PyHSP70 overexpression in hepatocytes suggests that this 


































Fig. 6.2|P. yoelii HSP70 protects 
hepatocytes from apoptosis. Hepa 1-6 cells 
were transfected with different DNA plasmid 
constructs expressing P. yoelii HSP70 
(PyHSP70), green fluorescence protein (gfp), an 
irrelevant gene (control). 24h post-transfection 
apoptosis was induced by UV light. After 6h, 
cells were stained with DAPI and apoptotic cells 
were quantified.  
 
 
In order to establish a stable cell line expressing this protein that would allow a broader application 
of this tool to further studies, an attempt was made to assemble a construct with a mammalian 
vector that would additionally provide the possibility to control gene expression by induction 
through a Zeocin resistance gene (Invitrogen). After selection the results obtained were not 
satisfactory since the expected appropriate expression was not achieved. A likely explanation for 
these observations is the already known difficulty inherent to the cloning of Plasmodium proteins due 
to its A/T–rich genome that confers problems to protein expression experiments. 
 
6.2.2 PyHSP70 knock out parasite 
To analyze and validate the actual role of HSP70 in apoptosis inhibition, it is essential that 
functional studies are made using parasites in which expression of this protein has been knocked 
out. The first step to achieve this goal, is to produce a construct that will block protein expression, 
which can be accomplished by cloning only a fraction of the gene sequence. This experiment is still 




Many pathogens like schistosomes, leishmania, trypanosomes and malaria plasmodia, have to face 
sudden temperature shifts during transmission from vector to the host. The increase in temperature 
imposes a heat shock to parasites, which leads to the induction of HSPs. Moreover, the host-parasite 
interface is apoptosis dependent since this process can be used by the host as a defence mechanism 
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or by the parasite to perpetuate infection (Polla, 1991). Therefore, the existence of mechanisms able 
to induce or inhibit apoptosis is essential within this dual relationship and the balance between them 
dictates host cell fate. Furthermore, in order to control pathogenesis and regulate homeostatic 
development, it seems intuitive that all species should harbour cellular protective mechanisms and 
conversely members of the apoptotic machinery ready to induce cell death. Several characteristic 
features of apoptosis have already been described for protozoan parasites indicating that they 
possess cellular mechanism of cell death similar to that of multicellular eukaryotes (Arnoult et al., 
2002). For P. berghei, caspase-like activity was detected in the cytoplasm of ookinetes along with 
apoptotic morphological and biochemical features (Al-Olayan et al., 2002). Therefore, together with 
the existence of apoptotic inducers within Plasmodium, there should also be apoptosis inhibitors.  
The presence of HSP70 in Plasmodium species makes it an obvious candidate for this task. In 
addition, one can expect that more cellular processes will be discovered that depend on the 
chaperone activity of HSP70. Its abundance and antigenicity, which triggers potent immune 























7.1 Final Discussion and Conclusion 
When an intracellular parasite depends on a host in order to complete its life cycle, a close 
interaction must be established between the host and the parasite. Confined inside a host cell the 
parasite ensures a source of nutrients and, at the same time, a location where it can avert the host’s 
immune system. Throughout infection, the nature of this relationship is dictated by the different 
parasite-specific requirements along its life cycle. However, host-parasite interactions also reflect the 
balance between the pathogen virulence mechanisms and host defences, which exert a major effect 
in the final outcome of infection as well.  
For malaria parasites, this relationship is highly complex and diverse, in accord with the demands of 
the life cycle of Plasmodium. Since the liver is the first target of Plasmodium parasites and this site of 
infection is obligatory for disease progression, it is essential to reveal and comprehend the basic 
biological interactions established between the parasite and its host cell, the hepatocyte (Lau et al., 
2001; Shin et al., 1982).   
For a long time this was a hard task due to the limited experimental accessibility of the models and 
molecular tools available. However, these difficulties are being overcome and the possibilities of 
research in this area are increasing greatly, as a consequence of the development of new technologies 
and genetic tools (Amino et al., 2005; Frevert et al., 2005; Gardiner et al., 2005). Nevertheless, there 
has always been the problem of obtaining enough quantities of sporozoites that would allow liver 
infection to be mimicked in vitro (Luke and Hoffman, 2003). Together with the low infectivity rates 
that are obtained experimentally, there is a rather remarkable poor knowledge of the mechanisms 
involved in invasion and intracellular development used by the parasite (Kappe et al., 2004; Druilhe 
et al., 1998).  
Usually, it is considered that host manipulation is a strategy used by intracellular parasites. How 
parasites manage to evade host defences has always been a hub under a continuous survey. 
Antigenic variation, resistance to immunological attacks and escape to safe compartments are 
common strategies used (Zambrano-Villa et al., 2002). Moreover, it is becoming common knowledge 
that different parasites make use of similar strategies to subvert host signalling pathways in their own 
benefit, such as activating some in order to exploit them for invasion and development or inhibiting 
others in order to prevent hostile responses (Kahn et al., 2002).   
During its permanence in the liver, sporozoites undergo a process of replication and development 
that exploits resources provided by the hepatocyte. In addition, as is the case with any intracellular 
pathogen, parasites develop ways of controlling host cell behaviour towards increasing their own 
survival and inducing changes in the host that can ultimately elicit effects in immune modulation and 
regulation of apoptosis (James and Green, 2004; Hasnain et al., 2003). For Plasmodium parasites both 
of these effects happen during infection but none of them have been yet completely elucidated. 
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Aiming at clarifying some essential features within Plasmodium-hepatocyte interactions, the main goal 
of the project presented here was to determine the role of hepatocyte apoptosis in the inhibition of 
development of exo-erythrocytic forms and in the initiation of protective immune responses to 
malaria by dendritic cells. 
Plasmodium liver stages are considered to be a singular phase of the parasite life cycle in terms of 
immunity. Besides constituting a crucial step for its survival, they are also imperative for the 
induction, establishment and maintenance of an effector anti-parasitic immune response (Doolan 
and Hoffman, 2000). Although characterized as multi-factorial, this protection is essentially 
dependent on Plasmodium antigen-specific T cells, in particular effector and memory CD8+ T cells, 
which are responsible for the elimination of the infected hepatocyte and, in addition, are 
indispensable for enhancing the efficacy of a long lasting immunity against malaria (Morrot and 
Zavala, 2004a). 
Natural recurrent infections cause only partial immunity, which is mediated by antibodies directed to 
the blood-stage of the parasite (Hviid, 2005; Day and Marsh, 1991). Only irradiated sporozoite 
immunization leads to complete resistance or sterile immunity in both mice and humans after 
repeated immunizations (Hoffman et al., 2002). These attenuated parasites infect hepatocytes in a 
similar way compared to normal ones. However, they fail to complete a full infection, presumably 
because their DNA was damaged upon radiation and protein synthesis was affected (Suhrbier et al., 
1990). Nevertheless, protection is obtained when live attenuated sporozoites reach the liver while 
inactivated sporozoites or their extracts have consistently failed to achieve the same goal. Different 
studies also support the hypothesis that there is a requirement for intra-hepatic development for 
protection to be induced, as removal of liver parasites by primaquine treatment abolishes protection 
(Krzych et al., 2000; Scheller and Azad, 1995; Bates et al., 1990).  
Discovered more than 30 years ago the feasibility of an anti-malaria vaccine through these irradiated 
sporozoites immunizations proved that protection against Plasmodia was possible. Why this is so is 
still under debate. Yet, a broad use of this type of vaccine was considered an impossible approach to 
undertake, because of the impossibility of obtaining high numbers of sporozoites, as they cannot be 
cultured in vitro (Luke and Hoffman, 2003). Thus, reproducing this induced immunity became an 
alternative approach. Consequently, to understanding the mechanisms occurring in the liver either 
during a natural infection or in model systems of protective immunity such as irradiated sporozoites 
immunizations will facilitate the exploitation of these responses to a expedite progress in vaccine 
development. 
Sporozoites preferentially infect the liver, where immune responses tend to be biased towards 
immunological tolerance (Crispe, 2003). This unique feature may contribute to the success of 
Plasmodium infection of this organ, since it allows the parasite to develop and promotes conditions 
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that seem to fit the parasite’s needs. Besides this, several hypotheses were proposed to explain why 
attenuated sporozoites are so efficient. Options are based on sporozoite activity after irradiation, its 
interaction with the hepatocyte, the subsequent initiation of the immune response and its persistence 
within the hepatocyte. As a result there is a high level of IFN-γ production when challenge is 
induced in immunized mice and humans, suggesting that an enhanced efficiency in T cell priming 
events takes place. Gamma-irradiation induces a partial delay in the maturation of the parasite, 
leading to its extended permanence in the liver, and generating a depot of antigen, which seems 
necessary for the establishment of a local antigen-specific protective immunity (Krzych et al., 2000). 
However, different systems such as viral infections present an independency between antigen 
persistence and the maintenance of memory CD8+ T cells responses (Wherry et al., 2004; Mueller et 
al., 2002). 
Nevertheless, in endemic areas, naturally exposed individuals do not acquire long term protection, 
indicating a persistent lack of memory. This issue is still not fully understood and remains a rather 
controversial subject. Yet a few causes are appointed by some authors that could explain such 
evidence. The tolerant environment that dominates on the liver is a key feature, as is the 
sequestration of the liver-stage antigens within hepatocytes, and the relatively short duration of the 
liver infection (Struik and Riley, 2004). Polymorphisms at the regions recognized by the CD8+ T 
cells induce an antagonistic effect that interferes with priming and survival of memory T cells, an 
event designated by altered peptide ligand, which is appointed as another explanation for lack of 
memory (Plebanski et al., 1999; 1997). Furthermore, the mixture of different Plasmodium strains in 
endemic areas can aggravate the dynamic interactions of variant-specific T cell responses resulting in 
immune interference (Zimmerman et al., 2004; Bruce and Day, 2002). 
The initiation of a specific immune response against a disease requires the activation of T cells by 
professional antigen-presenting cells (Mellman et al., 1998). In some biological systems the identity 
of these cells is still to be determined. However, in most cases, dendritic cells are the ones that 
efficiently activate naïve T cells because of their unique ability to induce primary immune responses 
through priming (Sher et al., 2003; Bruña-Romero and Rodriguez, 2001). 
During pathogenic infections, apoptosis of infected cells could either be caused by the host’s 
immune response or be a direct effect induced by the pathogen (Gavrilescu and Denkers, 2003). 
But, in any case, the result is the formation of apoptotic bodies that are loaded with antigens derived 
from the pathogen. In order to reduce the risk of an inflammatory response these apoptotic cells 
have to be removed (Savill and Fadok, 2000). Phagocytes, such as macrophages and immature 
dendritic cells, have the ability to capture these vesicles and present enclosed antigens to activate T 
lymphocytes (Albert et al., 1998 a, b). However, only dendritic cells have the capacity of presenting 
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such antigens in both MHC class I and II contexts, making use of a cross-presentation mechanism, 
and consequently inducing the priming of naïve T lymphocytes (Guermonprez et al., 2003). 
Immunization with irradiated sporozoites induces specific CD8+ T cells against Plasmodium antigens 
which are involved in mounting protection against the disease (Rodrigues et al., 1991; Hoffman et al., 
1989; Romero et al., 1989; Weiss et al., 1988). Moreover, a large number of pathogens do not infect 
or replicate within professional antigen presenting cells, but still their antigens are presented by 
MHC class I molecules since activated-specific cytotoxic T lymphocytes are found in vivo. For this 
activation to occur there is the requirement of a restricted-class I presentation (Gil-Torregrosa et al., 
2004). Plasmodium sporozoites fit in this category since they are only able to fully develop in 
hepatocytes. Consequently, the activation of specific anti-malaria T lymphocytes observed during 
irradiated sporozoite infection must occur through cross-presentation of parasite antigens 
performed by antigen presenting cells, the dendritic cells.  
Several examples of transfer and presentation of cellular antigens can be found in the literature and 
this hypothesis has been already demonstrated for viral proteins, tumour antigens and protein-
coated antigens (Albert, 2004; Shen and Rock, 2004; Fonteneau et al., 2002; Sigal et al., 1999; Huang 
et al., 1994). Because of the immunological relevance of CD8+ T cell activation, cross-presentation 
should undergo some sort of control in terms of specificity and efficiency. These two main 
characteristics can be ensured by receptor-mediated processes. Although both macrophages and 
dendritic cells are skilled cells in terms of antigen phagocytosis, in respect to cross-presentation and 
T cell priming, macrophages are known to be poor stimulators of naïve T cells in vitro. The higher 
efficiency of dendritic cells in the priming of naïve T cells is, at least in part, mediated by the 
presence of co-stimulatory molecules that allow longer and more efficient interactions with T cells 
(Heath et al., 2004). 
The experimental in vitro observation that a decrease in the number of infected hepatocytes in 
culture occurs with time led to the basis of our working hypothesis (Silvie et al., 2002; Suhrbier et al., 
1990; Sigler et al., 1984). Could apoptotic bodies generated from Plasmodium infected hepatocytes 
infected with irradiated sporozoites be phagocytosed in the liver by dendritic cells? And if so, could 
these cells mediate cytotoxic T lymphocyte activation by cross-presentation?  
Thus, in the first part of this project, we accessed our hypothesis by determining whether infected 
hepatocytes were undergoing apoptotic death and therefore decreasing in number during the course 
of infection. Apoptosis was detected in infected hepatocytes which were then shown to be 
phagocytosed by both macrophages and dendritic cells present in the liver. An increased recruitment 
of dendritic cells was observed during in vivo infection which, together with the apoptotic markers 
and hepatic origin evidenced by phagocytosed vesicles, implicates dendritic cells in the uptake of 
Plasmodium antigens present in apoptotic hepatocytes. 
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This model links two key processes in the control of infection: apoptosis of infected cells and 
antigen uptake by antigen presenting cells. Data obtained strongly associate these events, which 
could provide a mechanism for the initiation of immune responses against malaria. 
During the course of our studies, Jung and colleagues showed that during malaria infection there is a 
dendritic cell dependency in order to obtain a CD8+ T cell immune response. This strongly suggests 
that priming takes place via cross-presentation of antigens originated from infected hepatocytes 
provided by dendritic cells. Making use of a conditional knock out mouse that can induce ablation 
of CD11c+ dendritic cells, the essential requirement of these cells to elicit a CD8+ T cell response to 
malaria was revealed. However, in this study, the interface of these cells with sporozoites or infected 
hepatocytes was not analyzed (Jung et al., 2002). 
To initiate the process of antigen presentation to T cells, dendritic cells must be able to phagocytose 
Plasmodium antigens. Thus, size is an important feature in this process. Either the whole sporozoite 
or CS protein that is shed from the parasite surface could be phagocytosed by antigen presenting 
cells (Hugel et al., 1996). Yet, phagocytosis per se is not capable of explaining why for instance heat 
killed sporozoites do not induce T cell responses and why irradiated sporozoites are a better 
immunogen (Alger and Harant, 1976; Spitalny and Nussenzweig, 1972). Although there is a visible 
difference in apoptosis during irradiated versus non-irradiated sporozoite infections, the lower 
amount of apoptotic hepatocytes detected in non-irradiated sporozoite infections indicates that in 
some cases, normal sporozoites are not capable of inhibiting their host death. Such evidence could 
hold an effect in immunity and should be further analyzed.  
As already mentioned, dendritic cells need to mature in order to achieve effective T cell activation. 
Since it is known that apoptotic bodies are unable to induce dendritic cell maturation, sporozoites 
must be responsible for this action (Albert, 2004; Liu et al., 2002; Gallucci et al., 1999; Albert et al., 
1998b). Furthermore, wounded hepatocytes generated during sporozoite migration could lead to 
dendritic cells maturation due to the pro-inflammatory environment induced and the release of 
maturation signals (Frevert, 2004; Khan and Vanderberg, 1992). Endogenous adjuvant activity was 
detected in the cytoplasm of cells undergoing cellular injury or tumor death. The resulting 
components can stimulate immune responses since they constitute a danger signal to the immune 
system (Shi et al., 2003; Shi and Rock, 2002; Shi et al., 2000). 
During malaria liver stages, functional in vivo antigen presentation seems to be limited by time. After 
irradiated sporozoites immunization, the priming of naïve T cells is very fast reaching a maximum 
within the first 8h (Hafalla et al., 2002). Moreover, antigen-specific activated CD8+ T cells are 
inhibited as early as 24 to 48h after priming (Hafalla et al., 2003; Mercado et al., 2000). Extrapolating 
to a natural infection, the rate of exposure and priming of T cell should be dependent on the biting 
by infectious mosquitoes. However, very low frequencies of T cells against liver stage antigens are 
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observed. Therefore, this means that, when the threshold is reached, the CD8+ T cells specific for 
sporozoite-derived antigens will be preserved regardless of the inoculation rates (Hafalla et al., 2002). 
In addition, the discrepancy between irradiated sporozoites and normal sporozoites in inducing 
immunity can be also supported by the subsequent occurrence of a blood stage infection in the 
second and not in the first, since a blood stage infection could lead to an immuno-suppression of 
CD8+ T cell function against the initial liver stages (Ocana-Morgner et al., 2003). 
In the context of the variety of the cellular populations that are present in the liver the full role of 
Kupffer cells remains an unanswered question. Recent studies regarding their involvement and 
immune status during infection revealed that these cells could function as antigen-presenting cells, 
whose activity is much higher in challenged irradiated sporozoite-immunized mice than in normal 
sporozoite-infected mice. In addition, an enhanced expression of MHC classes I and II and 
costimulatory molecules was also a difference observed between these two types of Kupffer cells. 
Further analysis should still be carried out in order to understand the contribution of these cells 
during protection conferred by irradiated sporozoite immunizations. However, the absence of an 
increased expression of class I on Kupffer cells originated from immunized mice in response to in 
vitro normal sporozoite challenge suggests that other responses from different primed liver cells in 
vivo may occur (Steers et al., 2005). 
Recently, a number of studies using different epitopes from the Plasmodium CS protein as a way to 
pulse dendritic cells or access the induction of MHC class I-restricted antigen-specific T cells, have 
validated and confirmed the role of dendritic cells as skilled to process and present sporozoite 
antigens. Moreover, the priming events are clearly different between normal or irradiated parasites, 
where the latter induce higher levels of IFN-γ production (Plebanski et al., 2005). 
Furthermore, it was shown that the successful synthetic peptide vaccine trial that induced high 
antigen-specific T cell responses in volunteers is likely to be due to dendritic cell cross-presentation, 
which requires the proteosome and the MHC class I pathway for processing and the endosomal 
compartment for the presentation (Prato et al., 2005).   
Analyzing the extremely complex interaction between Plasmodium sporozoites and hepatocytes, it 
becomes clear that several other molecules must play significant roles during liver infection, either 
from the parasite or the host sides. New findings are elucidating the recognition and invasion 
process of the hepatocyte by the parasite. These processes appear to involve other sporozoite 
proteins besides CS and TRAP, such as microneme proteins essential for cell traversal, other 
proteins involved in sporozoite motility or even proteins essential for the recognition of surface 
receptors on host cells (Ishino et al., 2005 a, b; Ishino et al., 2004; Khater et al., 2004).  
In this thesis, we have also addressed the host’s input to this interplay. Cellular death can be either 
induced or inhibited (Vaux and Strasser, 1996). Both events constitute opposite mechanisms that 
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carry different benefits to each one of the parts involved. On the host side, apoptosis is seen as a 
defence mechanism because infection is eliminated. On the other hand, for the parasite, the 
inhibition of host cell apoptosis has huge advantages as it allows the pathogen to prolong its life 
within the host cell, thereby perpetuating infection. Examples of such inhibitors can be found 
among different intracellular parasites like Leishmania and Toxoplasma (Sinai et al., 2004; Luder et al., 
2001). Such evidence is also present within viral infections, where a few inhibitors have been 
characterized in detail (Hasnain et al., 2003). Moreover, parasites find ways of imitating the 
modulation of apoptotic pathways that occur in normal cells. All these data suggest that Plasmodium 
might engage in similar strategies during liver infection, but little is known regarding this issue. 
Thus, our study’s starting point was to examine how sporozoite infection related to these 
observations and in order to achieve that understanding, we analyzed the outcome of induced 
apoptosis on infected hepatocytes. Our results confirmed that Plasmodium infection protects host 
hepatocytes from apoptosis during liver stage malaria. Such behaviour was expected since similar 
observations were already made for other intracellular parasites like Toxoplasma and Leishmania (Nash 
et al., 1998; Moore and Matlashewski, 1994). 
Previous work has shown that, during Plasmodium infection, sporozoites migrate through several 
hepatocytes before establishing in a definitive one (Mota et al., 2001). By breaching their plasma 
membranes, the parasite leaves a trail of wounded cells which secrete a host molecule, HGF, to the 
surrounding environment. The secreted HGF and the activation of its receptor c-Met, makes host 
cells more susceptible to malaria infection. Furthermore, sporozoite infection is dependent on this 
activation and induced stimuli, which facilitates parasite development (Carrolo et al., 2003).  
HGF is responsible for activating a vast cascade of signaling pathways within cells, including 
inhibition of apoptosis (Birchmeier et al., 2003). Therefore, we hypothesized that, during liver 
infection, HGF/MET signaling could play a role in the previously observed anti-apoptotic effect. 
Data obtained confirmed our hypothesis and provided further evidence that infection-induced 
protection is mediated by the PI3K/AKT signalling pathway. Previously, numerous studies had 
already shown that this survival cascade is usually constitutively activated in several types of cancer 
cells and is currently being targeted as therapeutic approach (Kim et al., 2005).  
More recently, it was demonstrated that P. berghei inhibition of hepatocyte apoptosis also occurs 
during the late phase of liver infection. Resistance to induced apoptosis of infected cells was shown 
to be increased 2 days after infection, independent of the HGF/MET signalling pathway (van de 
Sand et al., 2005). Our results concerning apoptosis inhibition at the early phase of the parasite 
development are in agreement with the observation that HGF/MET signalling protracts for several 
hours only. Additionally, a new interest has arisen concerning a different but highly plausible 
occurrence is to know how the parasite inhibits pro-apoptotic signals instead (van de Sand et al., 
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2005). Our data implicate and reinforce the inhibition of apoptosis as a crucial strategy through 
which Plasmodium controls the survival outcome of the hepatocytes.  
The HGF/MET complex has been as well extensively studied in cancer research, and constitutes an 
attractive target for use in therapy since several approaches have been described that can be 
employed to interfere with this pathway. However, the practical results of an application of such 
strategies remain unclear, mainly due to the lack of appropriate delivery systems (Corso et al., 2005).  
An extrapolation of these procedures to malaria infection could lead to an interesting progress in 
terms of preventive strategies, since HGF/MET usage as a targeting candidate for drug 
development would hold an effect in liver infection. In addition, such a target could avoid the 
emergence of drug resistance since there is no direct interaction with the pathogen itself. 
At the end of our studies, we attempted to identify a Plasmodium gene responsible for infection-
induced hepatocyte survival. It is known that cell death is a highly conserved process throughout 
evolution (Vaux et al., 1994; Wyllie et al., 1980). Therefore, parasites themselves should encode 
proteins that may be responsible for interfering with the regular function of this cellular process. In 
fact, there are reports of viruses that carry genetic information for anti-apoptotic genes, namely 
homologues to cellular regulators (Clarke et al., 2005; Barry and McFadden, 1998). Finding 
Plasmodium homologues of a known apoptosis inhibitor would open future possibilities for 
functional studies using knock out parasites. Additionally, gene targeting knock out experiences 
could lead to the elimination of this putative apoptosis inhibitor gene. The availability of the 
Plasmodium genome sequence facilitates the identification of prospective candidates that might be 
involved in liver infection, which may hold a huge potential as novel targets in disease control 
(Duffy et al., 2005; Cooper and Carucci, 2004). 
Likewise, heat shock proteins (HSPs) belong to a group of molecular chaperones that are also highly 
conserved (Lindquist and Craig, 1988). These proteins are specialized in rescuing cells from damage 
when they are exposed to stress, and their mode of action includes ensuring cellular survival. 
Therefore, HSPs commonly act as anti-apoptotic chaperones being themselves checkpoints along 
the apoptosis pathways with the ability of shutting these pathways off (Beere, 2005).  
HSP70 is one of the most abundant protein families that is present in several organisms including 
parasites (Dobbin et al., 2002; Rico et al., 1999; Levy et al., 1992). Plasmodium HSP70 is expressed 
among different parasite species and has a high degree of immunogenicity which makes it a target of 
immune responses during infection (Zhang et al., 2001; Behr et al., 1992). 
All together and since P. yoelii HSP70 (PyHSP70) fitted in these profiles we decided to examine its 
function as an apoptosis inhibitor candidate. Our preliminary results suggest that the PyHSP70 
could influence the infection process, as this protein has the ability of inhibiting hepatocyte 
apoptosis and is, therefore, worth considering and exploring in a future project. This plausible 
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identification of a Plasmodium gene responsible for apoptosis inhibition of hepatocytes does not 
exclude the possibility of more and different genes being implicated in this process, which justifies 




The work presented in this thesis provides immediate contribution to the understanding of the 
cellular and molecular mechanisms involved in some aspects of Plasmodium-hepatocyte interactions. 
Crucial steps in malaria infection take place inside hepatocytes which are related not only to parasite 
development but also with the immune responses developed against the disease.  
One of the greatest challenges facing infectious diseases research at the present time is to learn how 
to arm the host immune system strong enough to defeat disease. At the moment vaccine 
development interests are focused in finding Plasmodium molecules that can confer a long-lasting 
protection against liver and subsequent blood stage infection. The use of a single protein in a 
vaccine has consistently led to failure, thus progress must also be applied to the development of 
whole attenuated parasite vaccine. Besides irradiation other options are now being exposed such as 
the use of genetically engineered inactivated parasites and combinations of various vaccination 
regimens (Good, 2005; Todryk and Walther, 2005). 
Due to the latest examples and the enlightening on different infection models, some authors do 
agree that dendritic cells should be targeted in order to obtain an effective malaria vaccine 
application (Bertholet et al., 2005; Blachere et al., 2005; Plebanski et al., 2005; Sher et al., 2003; 
Norbury et al., 2002). The selection of the right Plasmodium antigen as well as the adjuvant that would 
target an innate response involving dendritic cells could be much more protective. Therefore, in the 
future it should be considered the interaction maintained by Plasmodium with these antigen 
presenting cells, and also the direct relation that is observed between these and the CD8+ T cell 
interactions (Engwerda and Good, 2005). 
In addition, remaining questions address a few issues like the migration of parasite-specific T cell to 
the infected liver, their elimination and the development of memory against the parasite. It is still 
very important to engage a thorough characterization of the important antigens relevant to vaccine 
development and theirs respective induced-immunity (Krzych and Schwenk, 2005). 
Within technical support new tools are becoming available in particular in the imaging field, which 
will contribute to enhance the accuracy of our knowledge specially and if possible at a more 
physiological environment closer to what occurs in vivo. A new input is also being applied to the 
search for alternative methods concerning detection of immune responses (Amino et al., 2005; van 
Baalen et al., 2005). 
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Plasmodium antigens presented in the context of host cell apoptosis are an alternative mechanism 
involved in the induction of protective immunity by irradiated sporozoites. Our findings are being 
reinforced by out coming results. Clearly the consequences of apoptosis are being redefined specially 
at the immunological level. Certainly with all the evidence raising from different infection models it 
would be very misleading to view apoptotic death as single simplistic event. An opposite outlook is 
taking this common cellular process to a level of importance that for sure will worth to continuous 
studying (Restifo, 2000).     
In the future, and making use of both parasite and host transcriptome and proteome, an extensive 
study will help to reveal more parasite strategies used to influence host cell apoptosis during 
infection, either by activating anti-apoptotic mechanisms or by inhibiting pro-apoptotic ones 
(Cooper and Carucci, 2004). 
As previously mentioned, the targeting of malaria parasites both through vaccine or anti-malaria 
drugs is mostly performed using components of the parasite. Those are involved in the host-parasite 
interactions and are essential for survival and development or on the other hand involved in disease 
pathology. Another strategy that could be undertaken is to act on and exploit the host molecules 
that interact with the parasite components or molecules produced by it. In this context, HGF/MET 
signalling should be consider a drug target candidate against malaria since an intervention based on 
the tools available should lead to a successful prevention of infection. 
Presently, in the new post-genomic era is essential that a clear view of the elements that are involved 
either in basic understanding of Plasmodium species biology or in applied work aimed at control and 
prevention of the disease is achieved. Taking a step forward within research would leads us to the 
application of systems-biology to malaria, since an integration of several data sets would raised the 
chances of being successful both in vaccine and drug development against the disease (Young and 
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Apoptotic Plasmodium-Infected Hepatocytes Provide
Antigens to Liver Dendritic Cells
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Malaria starts with infection of the host liver by Plasmodium sporozoites. Inoculation with radiation-attenuated
Plasmodium sporozoites induces complete protection against malaria. Protection is mediated by dendritic cells
(DCs) and CD8+ T cells, but the source of parasite antigens mediating this response remains unclear. Here,
we show that hepatocytes infected with irradiated Plasmodium sporozoites undergo apoptosis shortly after
infection. Infection with irradiated sporozoites induces the recruitment of DCs to the liver, where they phago-
cytose apoptotic infected hepatocytes containing parasite antigens. We propose that apoptotic Plasmodium-
infected hepatocytes provide a source of parasite antigens for the initiation of the protective immune response.
Complete protection against malaria in humans and
mice can be obtained by inoculation with irradiated
Plasmodium sporozoites that induce specific CD8+ T
cells [1]. Irradiated sporozoites infect hepatocytes in
vivo, as normal sporozoites do; however, irradiated spo-
rozoites do not progress further to blood-stage infec-
tions and, therefore, do not induce malaria-associated
pathology [2]. During sporozoite infection, no “pro-
fessional” antigen-presenting cells (i.e., cells that may
stimulate not only memory T cells but also naive T
cells) are infected by Plasmodium sporozoites, since they
replicate only in hepatocytes. Nevertheless, specific
CD8+ T cells reactive to Plasmodium antigens are found
in irradiated sporozoite–immunized hosts [3, 4], sug-
gesting that parasite antigens are transferred to profes-
sional antigen-presenting cells [5]. Dendritic cells (DCs)
are able to present exogenous antigens associated with
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major histocompatibility complex (MHC) class I mol-
ecules and activate CD8+ T cells, a process called “cross-
presentation” [6]. Interestingly, DCs are required for
induction of specific antimalaria CD8+ T cells after vac-
cination with irradiated sporozoites [7].
Intrahepatocytic development of irradiated sporozo-
ites appears to be required for induction of protection,
since infected hepatocytes and their extracts have been
shown to induce significant protection [8], whereas in-
activated sporozoites and their extracts have consistently
failed to achieve the same goal [9, 10]. That hepatocyte
infection is required for induction of a cytotoxic response
in the host suggests that the source of Plasmodium an-
tigens for the initiation of an immune response is not
individual sporozoites but infected cells [11].
During pathogenic infections, apoptosis of infected
cells results in the formation of apoptotic bodies loaded
with pathogen antigens. Cross-presentation of antigens
in apoptotic bodies phagocytosed by DCs has been pro-
posed as a mechanism of antigen presentation in cy-
totoxic immune responses against intracellular patho-
gens [12, 13]. It has also been proposed that apoptosis
of host cells contributes to immunity induced by ir-
radiated-parasite vaccines [14]. Here, we show that ap-
optotic infected hepatocytes are phagocytosed by DCs
in the liver of the host, providing a source of Plas-
modium antigens for the initiation of antimalaria im-
mune responses.
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MATERIALS AND METHODS
Host cells, parasites, and mice. Hepa 1-6 (ATCC CRL-1830),
a hepatoma cell line derived from a C57L/J mouse that is ef-
ficiently infected by rodent malaria parasites, was used for in
vitro hepatocyte cultures. Plasmodium yoelii (cell line 17X NL)
and Plasmodium berghei (parasite line NK65) sporozoites were
isolated from salivary glands of infected Anopheles stephensi
mosquitoes. Sporozoites were irradiated with a g source (20
krad). BALB/c mice were purchased from Taconic.
In vitro infections. One day before infection, Hepa52  10
1-6 cells/mL were plated in 24-well plates (Costar) over glass
coverslips in Dulbecco’s MEM (Sigma) supplemented with 10%
heat-inactivated fetal bovine serum, 100 U/mL penicillin, 0.1
mg/mL streptomycin, and 2 mmol/L l-glutamine at 37C with
5% CO2. A total of sporozoites were added to Hepa 1-
51  10
6 cell coverslips on plates, centrifuged for 5 min at 1800 g, and
incubated for different durations. Cells were washed twice with
PBS and fixed in 4% paraformaldehyde.
In vivo infection, isolation, and staining of liver mononuclear
cells. Two mice per group were infected with P. yoelii g-irra-
diated, nonirradiated, or heat-killed (15 min; 56C) sporozoites
by intravenous (iv) injection (1106 sporozoites/mouse). Six
hours after injection, livers were removed and mechanically ho-
mogenized. The cell suspension was washed and resuspended in
a 35% Percoll (Pharmacia Biotech) gradient solution and cen-
trifuged at 500 g for 10 min. The mononuclear-cell pellet ob-
tained was resuspended in 1 mL of erythrocyte lysis buffer for
1 min and washed. Isolated cells were counted and placed for 1
h on poly-l-lysine coverslips (∼ cells/liver were ob-61.5  10
tained). After fixation, cells were incubated with phycoerythrin
(PE)–anti-CD11c and fluorescein isiothiocyanate (FITC)–anti-
Mac3 (Pharmigen) for staining of DCs and macrophages, re-
spectively. Parasites were stained with anti-Hsp70 monoclonal
antibody (2E6). Cells were also stained with anti-albumin (Cap-
pel/ICN Irvine) and anti–activated caspase-3 (Promega).
Detection of apoptosis. Apoptotic cells were detected and
quantified by staining with anti–NF-kB p65 (relA) (Santa Cruz
Biotechnology), for examination of the translocation of NF-kB
from the cytoplasm to the nucleus of the cell, or with anti–
activated caspase-3 (Promega). All cells were also incubated
with 4′6′-diamidino-2-phenylindole (DAPI) for nuclear stain-
ing, to allow morphological detection of apoptosis.
DC recruitment to the liver. Groups consisting of 3 mice
were infected by mosquito bite (each anesthetized mouse was
in contact with 50 P. yoelii–infected mosquitoes for 20 min)
or by iv injection with P. yoelii sporozoites (g-irradiated51  10
or nonirradiated) or with salivary glands of uninfected mos-
quitoes as a control. At different times after infection, livers
were removed and frozen, and 15 histological sections from
each mouse were examined with PE–anti-CD11c (Pharmigen)
for detection and quantification of DCs.
RESULTS
During in vitro infection of hepatocytes by Plasmodium spo-
rozoites, a decrease in the number of developing parasites is
observed 2–3 days after infection. This decrease is more pro-
nounced for irradiated sporozoites than for nonirradiated ones
[2, 15]. To study the survival of hepatocytes infected with ir-
radiated Plasmodium sporozoites at earlier times after infection,
we stained Plasmodium-infected hepatocyte cultures with an
anti-Hsp70 antibody, a molecule that is highly expressed in
developing parasites inside hepatocytes but not in sporozoites
[16]. We found that the number of Hepa 1-6 hepatoma cells
infected with P. yoelii and P. berghei (data not shown) irradiated
sporozoites was lower than the number infected with nonir-
radiated sporozoites and that the number of infected cells had
already decreased shortly after infection (figure 1A).
The decrease in the number of infected hepatocytes has been
attributed to degeneration of intracellular parasites [2]. We
wanted to determine whether the reduction in the number of
infected hepatocytes is due to hepatocyte apoptotic death trig-
gered by degenerated parasites. Apoptosis in infected hepato-
cyte cultures was first monitored by assessment of nuclear mor-
phology and activation of NF-kB p65 (relA), a transcription
factor that is translocated to the nucleus early after initiation
of certain apoptotic pathways [18] (figure 1B). We observed
that hepatocytes infected with irradiated sporozoites undergo
apoptosis 6 h after infection (figure 1C). Apoptosis in hepa-
tocytes infected with irradiated sporozoites was also confirmed
by detection of caspase-3 activation (figure 1D). Irradiation
probably inhibits the synthesis of parasite factors that are nec-
essary for the prevention of apoptosis of infected hepatocytes,
resulting in an abortive infection and cell death. However, a
lower but significant amount of apoptosis was also found in
hepatocytes infected with normal sporozoites, suggesting that,
in some cases, normal sporozoite infection cannot prevent the
apoptosis of host cells.
In response to inflammatory signals, immature DCs are re-
cruited from the blood into peripheral tissues, where they ef-
ficiently phagocytose foreign antigens. To determine whether
liver infection by P. yoelii sporozoites induces the recruitment
of DCs, livers of mice injected with irradiated or nonirradiated
sporozoites were obtained at different times after injection. His-
tological sections showed a recruitment of DCs early after in-
fection (figure 2A). When mice were subjected to bites from
infected mosquitoes, a similar effect was observed (figure 2B).
The recruitment of DCs induced by bites from infected mos-
quitoes is of a lower magnitude, probably because of the smaller
numbers of sporozoites injected by mosquito bite [19].
Increased numbers of DCs in the liver during malaria in-
fection would allow rapid capture of parasite antigens. How-
ever, to activate DCs for antigen presentation, these cells need
to receive a maturation signal, which can be provided by the
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Figure 1. Infected hepatocyte apoptosis. A, Infection of Hepa 1-6 cells by irradiated (white circles) or nonirradiated (black circles) Plasmodium
yoelii sporozoites, quantified at different times after infection. Infection was quantified by counting the no. of infected cells with developing parasites
in duplicated samples. Variation between duplicates was !8%. Shown are the results of 1 experiment that was representative of 3. B, Hepa 1-6
cells were incubated with P. yoelii irradiated (upper panels) or control (lower panels) sporozoites for 6 h. Intracellular parasites were stained with
anti-Hsp70 antibody (green). The size of the parasite vesicle is smaller in irradiated parasites [17]. Apoptosis was monitored by assessment of nuclear
morphology (4′6′-diamidino-2-phenylindole [DAPI] staining, blue) and nuclear translocation of NF-kB p65 (red) [18]. C, Quantification of apoptotic infected
cells by nuclear morphology (black bars) and NF-kB translocation (white bars). Error bars represent the SD of triplicate samples. Asterisks (*) indicate
a significant difference between control and irradiated sporozoites ( ). D, Apoptosis was also detected by anti–activated caspase-3 stainingP ! .05
(red) in infected cells containing intracellular parasites (green, marked by an arrowhead).
pathogen itself or by inflammatory lymphokines [20]. Before
infection, Plasmodium sporozoites migrate through several he-
patocytes in the liver, disrupting their plasma membranes and
causing cell wounding and necrotic death [21, 22]. Wounded
and dying cells induce local inflammatory responses that me-
diate the recruitment of DCs to tissues [23]. In fact, Plasmodium
liver infection induces an inflammatory response and the re-
cruitment of mononuclear cells [24]. Release of uric acid from
dying cells would provide an additional maturation signal for
DCs [25].
Apoptotic cells are rapidly phagocytosed in the body by mac-
rophages and DCs [26]. To determine whether apoptotic he-
patocytes containing P. yoelii antigens are phagocytosed by an-
tigen-presenting cells in the liver, we isolated nonparenchymal
mononuclear cells from the livers of mice immunized with
irradiated sporozoites, at different times after injection. We
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Figure 2. Phagocytosis of apoptotic hepatocytes containing Plasmodium antigens by dendritic cells (DCs) and macrophages in the liver. A and B,
Quantification of DCs in histological sections of mouse livers. A, DCs in uninfected mice (black bars) and in mice after different times of infection
with P. yoelii nonirradiated (white bars) or irradiated (striped bars) sporozoites. B, DCs in mice bitten by 50 uninfected (black bars) or infected (white
bars) mosquitoes. Error bars represent the SD of triplicate histological samples, each composed of 5 liver sections to cover 10 mm2. Asterisks (*)
indicate a significant difference between the sample and the control at time 0 h ( ). C–M, Liver nonparenchymal mononuclear cells, obtainedP ! .02
6 h after injection of mice with P. yoelii irradiated sporozoites and stained with different markers: DC marker (CD11c, red), macrophage marker (mac-
3, green), and Plasmodium Hsp70 (blue). DCs (C and D) and macrophages (E) were found to contain vesicles positive for Hsp70. F–I, Albumin/Hsp70
staining, in the same microscope field showing a cell in transmitted light (F), staining for albumin (red, G), Plasmodium Hsp70 (blue, H), and an overlay
of albumin and Hsp70 staining (I). J–M, Apoptosis/Plasmodium staining, in the same microscope field showing cells in transmitted light (J), staining
for activated caspase-3 (red, K), Plasmodium Hsp70 (green, L), and an overlay of caspase-3 and Hsp70 (M).
found that, 6 h after injection, macrophages and DCs in the
liver carry vesicles that contain P. yoelii Hsp70 (figure 2C–2E).
In 3 separate experiments, we found an average of 3 macro-
phages and 2 DCs in each liver containing Hsp70-positive ves-
icles. The number of DCs containing these vesicles is probably
higher in the mouse, but DCs rapidly leave peripheral organs
and migrate to the lymph nodes after receiving activation sig-
nals. The Hsp70-positive vesicles found inside macrophages and
DCs must be derived from infected hepatocytes, since this pro-
tein is not expressed in sporozoites and appears only in infected
hepatocytes ∼6 h after infection [16]. In addition, we found
that P. yoelii Hsp70-containing vesicles also contain mouse al-
bumin, a protein present in the cytosol of hepatocytes (figure
2F–2I), confirming that these vesicles are derived from infected
hepatocytes. No P. yoelii Hsp70 or albumin staining was present
in nonparenchymal liver mononuclear cells isolated from non-
infected control mice. To confirm that these Hsp70-positive
vesicles were derived from apoptotic cells, we stained cells with
anti–activated caspase-3. We found that vesicles positive for
Plasmodium Hsp70 were also positive for activated caspase-3
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(figure 2J–2M), confirming that DCs phagocytose apoptotic
infected hepatocytes during malaria infections in vivo.
When liver nonparenchymal mononuclear cells were ana-
lyzed 12 h after infection, no cells were found containing P.
yoelii Hsp70, which suggests that infected hepatocyte death and
clearance occurs early during in vivo infections with irradiated
sporozoites. This is consistent with the observation that Plas-
modium sporozoite infection and initiation of the immune re-
sponse occurs rapidly, since activation of specific anti–P. yoelii
CD8+ T cells is detected as soon as 8 h after inoculation of
sporozoites [27].
DISCUSSION
Protection against malaria can be achieved by immunization with
irradiated sporozoites [28]. This discovery raised expectations for
the development of a malaria vaccine; however, because of the
lack of an in vitro system for the generation of large numbers
of sporozoites, broad use of an irradiated sporozoite vaccine
against malaria is not considered feasible. It is important to un-
derstand the mechanisms underlying protection induced by ir-
radiated sporozoites, since this efficient protection has not yet
been replicated by other forms of human antimalaria vaccines.
CD8+ T cells and DCs mediate immunity induced by irradiated
sporozoites [4, 7], but the mechanisms involved in antigen pre-
sentation to T cells remain unclear, since the low number of
Plasmodium-infected hepatocytes in the liver has prevented the
development of direct antigen-presentation studies.
We found that both macrophages and DCs phagocytose in-
fected hepatocyte apoptotic bodies but that, in Plasmodium liver
infection, only DCs are required for activation of CD8+ T cells
in vivo [7]. DC phagocytosis triggers cross-presentation of an-
tigens within the phagosome and results in efficient CD8+ T
cell activation [29, 30]. Apoptotic hepatocytes containing Plas-
modium antigens provide an optimal source of antigens for DC
cross-presentation, since they are of the appropriate size (1–10
mm) to be internalized by phagocytosis. This mechanism would
also explain the requirement for liver infection to achieve pro-
tection against this stage of the parasite, as well as the activation
of CD8+ T cells by an obligate intracellular parasite that can
develop only inside hepatocytes, which are nonprofessional an-
tigen-presenting cells. The inflammatory environment induced
during sporozoite infection in the liver [24] will also favor this
process, by inducing the recruitment of large numbers of DCs
and providing maturation signals for these cells.
DCs can acquire virus-infected dead or dying cells as exoge-
nous sources of antigens for presentation on MHC class I and
II molecules to initiate T cell responses [12]. This pathway is
thought to be critical for the development of effective antiviral
immunity in vivo [13]. Recently, DC presentation of Mycobac-
terium tuberculosis antigens derived from apoptotic infected mac-
rophages has been described as an alternative pathway of T cell
activation [31]. Like Plasmodium sporozoites in hepatocytes, My-
cobacterium is secluded in an intracellular compartment during
infection, which suggests that presentation of antigens from ap-
optotic infected cells may represent a common mechanism of
immune activation for vesicle-contained pathogens.
Experimental live vaccines based on irradiated parasites have
been used as a model for protection in malaria [1] and schis-
tosomiasis [32]. It is possible that irradiation of these parasites
blocks their ability to neutralize the apoptotic machinery of
host cells, allowing them to resume their natural tendency to
undergo apoptosis upon being infected. Further work is re-
quired to demonstrate that phagocytosis of apoptotic infected
host cells results in efficient presentation of parasite antigens
to T cells.
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, the causative agent of malaria, migrates
through several hepatocytes before initiating a
malaria infection. We have previously shown that this
process induces the secretion of hepatocyte growth
factor (HGF) by traversed cells, which renders neigh-
bour hepatocytes susceptible to infection. The signal-
ling initiated by HGF through its receptor MET has
multifunctional effects on various cell types. Our
results reveal a major role for apoptosis protection of
host cells by HGF/MET signalling on the host suscep-
tibility to infection. Inhibition of HGF/MET signalling
induces a specific increase in apoptosis of infected
cells leading to a great reduction on infection. Since
HGF/MET signalling is capable of protecting cells
from apoptosis by using both PI3-kinase/Akt and, to
a lesser extent, MAPK pathways, we determined the





infection. Although inhibition of either of these path-
ways leads to a reduction in infection, inhibition of
PI3-kinase/Akt pathway caused a stronger effect,
which correlated with a higher level of apoptosis in
infected host cells. Altogether, the results show that
the HGF/MET signalling requirement for infection is
mediated by its anti-apoptotic signal effects. These
results demonstrate for the first time that active inhi-




 is required for a successful infection.
Introduction
 









 interactions are neces-




 sporozoites are injected into the mammalian
host by infected mosquitoes, they migrate to the liver.
There, sporozoites traverse the cytosol of several hepato-
cytes before invading a final one by forming a parasito-




., 2001). We have shown that










also induce traversed cells to secrete hepatocyte growth
factor (HGF), which signals through its receptor MET on






Exploitation of host cell resources is a well known sur-
vival strategy of intracellular pathogens (Muller and Rudel,
2001). Apoptosis can be used by the host cell as a
defence mechanism against intracellular pathogens, as it
is beneficial for the organism to eliminate infected cells
rather than to preserve them and risk spreading of the
pathogen. Conversely, inhibition of host cell apoptosis is
advantageous for the pathogen to prolong life in the
infected cell in order to complete its development. Studies
have focused primarily on viral infections, where several
inhibitors of host cell apoptosis have been characterized
in detail (Blaho, 2003). Generally, inhibitors are homo-
logues of cellular proteins used in normal cells for the
modulation of apoptotic pathways. Inhibition of apoptosis









 has also been documented





ever, the genes involved in this process have not been





Hepatocyte growth factor (HGF) stimulation elicits
through MET a wide spectrum of biological responses
such as motogenesis, mitogenesis and protection from
apoptosis. HGF has strong anti-apoptotic effects in a













., 2001). In this study, we sought to




P. Leirião et al.
 















results show a crucial role for the anti-apoptotic signal





Infected cells are protected from apoptosis
 
To determine whether infected cells were protected from





 sporozoites (live or heat-killed, as control) and
treated 18 h later with TNF and Cycloheximide to induce
apoptosis. Six hours later apoptosis was quantified using
different methods: (i) nuclear morphology detected by




















































Similar results were obtained using a different cell type
(Hepa1-6  cells)  and  a  different  inductor  of  apoptosis





















infection protects host cells from apoptosis.
 




 sporozoite infection 
and protects infected cells from apoptosis
 
We have previously reported that HGF-induced increase





., 2003). Since HGF-induced MET activation













., 2001), we hypoth-
esized that HGF/MET signalling increases infection by
protecting host cells from apoptosis. Pretreatment of
HepG2 cells with HGF leads to an increment in infection





-infected cells (Fig. 2A and B). Similar


















Previous work has described two monoclonal antibod-
ies (DO-24 and DN-30) directed against the extracellular




., 1998). These are agonist
mAbs but while DO-24 is a full agonist and can induce a
strong receptor activation and trigger the complete inva-
sive growth programme, DN-30 is a partial agonist that





mAbs enhanced the level of infection, although at distinct
levels (Fig. 2C). The increment caused by the full agonist
DO-24 mAb was higher than that induced by the partial
agonist DN-30 (Fig. 2C). Apoptosis of infected cells was
reduced proportionally to increased infection level, as
measured by nuclear morphology detected by DAPI

























 0.4). Similar results
were also observed in Hepa1-6 cells (data not shown).
Taken together, these results show that the increase on
hepatic infection induced by the HGF/MET signalling cor-
relates with the apoptosis protection conferred by this
ligand–receptor system to the infected cells.
 
MET inactivation leads to early apoptosis of infected cells
 
Hepatocyte growth factor activation of its receptor MET is









., 2003). The above-




sporozoite infection caused by MET activation correlates
with an increased level of host cell protection from apop-
tosis. Thus, we hypothesized that MET requirement for
infection could be dependent on its anti-apoptotic role in
infected host cells. HepG2 cells were transduced with a
lentivirus expressing a chimeric construct containing the

































Infected cells are more resistant to apo-




 sporozoites and treated 18 h later 
with TNF and Cycloheximide to induce 
apoptosis.




 (green) not showing apoptotic signs 
and surrounded by apoptotic non-infected cells, 
as detected by DAPI in blue and anti-active 
caspase-3 in red.
B. Apoptosis quantification by nuclear morphol-





 sporozoites (live or heat-killed, 
as control) 6 h after apoptosis induction with 
TNF and Cycloheximide.
 














at the plasma membrane and binds HGF but it is unable
to transduce signals into the cell since it lacks the kinase
domain and the tyrosines acting as docking sites for intra-
cellular substrates. This chimeric receptor thus behaves
as a dominant interfering protein since it dimerizes with




., 2002). As control, HepG2 cells were transduced
with a lentivirus expressing GFP only. Since cells trans-
duced with these lentivirus (control or MET-GFP) become
fluorescent, we were able to determine the infection level
of single-transduced cells 24 h after infection (Fig. 3B). As




., 2003), no individual cells





 24 h later (Fig. 3B). The results show that MET
inactivation correlates with a significant increase of apo-
ptosis in infected cells (21% in control and 68% in infected
MET-GFP transduced cells), as observed by nuclear mor-
phology 6 h post infection detected by DAPI (Fig. 3A and
C). Presumably, all infected cells undergo apoptosis in the
absence of a functional MET receptor within 24 h, as no
infected cells are found at this time (Fig. 3B). No increase
in apoptosis of non-infected transduced cells was found.
To definitively assess the role of MET anti-apoptotic
activity we abrogated MET expression by interference
RNA. Lentivirus engineered to express MET-specific
siRNA oligos were used to transduce HepG2 cells.
Expression of MET siRNA, but not of a control sequence,
caused a reduction of MET expression, as detected by





zoite infection rate of these cells was severely decreased
as compared with cells infected with lentivirus expressing
the control siRNA (Fig. 3E). Moreover, sporozoite infec-
tion in MET siRNA expressing cells was inversely propor-
tional to the level of apoptosis, as measured by nuclear
morphology detected by DAPI 6 h after infection (Fig. 3F).




 sporozoite infection is highly dependent on
its anti-apoptotic activity.
 
HGF/MET signalling protects infected host cells via 
activation of PI3-kinase pathway
 
In several cellular models, HGF has a strong anti-apop-
totic activity mediated by PI3-kinase/Akt signal transduc-





2001), since it is almost completely inhibited by the spe-
cific PI3-kinase inhibitor LY294002. An additional anti-
apoptotic role is played by MAPK, although the protective
effect mediated by this pathway is less marked than that




., 2001). Thus, we sought to
determine the role of each of these pathways on hepato-




 sporozoites. The results show
that inhibition of either PI3-kinase/Akt or MAPK pathways
(by LY294002 and PD98059 respectively) induced a
decrease in infection. However, the decrease was more
marked with LY294002 (Fig. 4A). When we quantified
apoptosis on the same infection experiment (6 h post
infection), we detected a significant increase in the level
of apoptosis only in cells treated with the PI3-kinase/Akt
inhibitor LY294002, as detected by DAPI (Fig. 4B) or
























 10.0). These results show that, although
both PI3-kinase and MAPK pathways play a role in infec-
tion, only the PI3-kinase/Akt pathway seems to play a













































































Increased infection correlates with MET 
activation and protection of infected cells from 
apoptosis.
A, B. HepG2 cells were incubated or not 




 sporozoites. (A) Infection was quan-
tified 24 h post infection by counting the number 
of infected cells (EEFs). (B) Apoptosis was 
quantified 6 h post infection by nuclear mor-
phology by DAPI staining.
C, D. HepG2 cells were incubated with the ago-
nist anti-MET monoclonal antibodies DN-30 or 





zoites. The same procedure (as in A, B) was 
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MET inactivation leads to early apoptosis of infected cells.
A, B, C. HepG2 cells were transduced with lentivirus expressing MET-GFP or GFP alone (control). Cells were then seeded on glass coverslips 




 sporozoites. (A) Right panel represents an infected cell expressing MET-GFP (green) 6 h after infection with 
a parasite starting to develop (red) and showing signs of apoptosis as indicated by the nuclear morphology stained by DAPI (blue). Left panel 
represents an infected cell not expressing MET-GFP and not showing apoptotic features. (B) Infection was quantified 24 h post infection by 
counting the number of infected cells (EEFs). (C) Apoptosis was quantified 6 h post infection by nuclear morphology by DAPI staining.
D, E, F. HepG2 cells were transduced with lentivirus expressing MET siRNA oligos or an unrelated oligo (control) (D) Western blot analysis of 
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Fig. 4. Inhibition of PI3-kinase pathway leads 
to a decrease in infection both in vitro and in 
vivo.
A, B. HepG2 cells were pretreated with 
LY294002 or PD98059 for 1 h followed by 
washes and infection with P. berghei sporozoi-
tes. Control cells were not incubated with either 
LY294002 or PD98059. (A) Infection was quan-
tified 24 h post infection by counting the number 
of infected cells (EEFs) (*PLY £ 0.001; 
PPD = 0.003). (B) Apoptosis was quantified 6 h 
post infection by nuclear morphology by DAPI 
staining (*PLY = 0.002; PPD = 0.09).
C. Mice were injected or not (control) with 
LY294002 30 min prior to infection with 
P. berghei sporozoites. Livers from both groups 
were removed 40 h post infection and real-time 
RT-PCR performed with parasite-specific prim-
ers to quantify liver infection (*P < 0.005).
D. Mice were injected or not (control) with 
LY294002 or DMSO, 30 min prior to infection 
with P. berghei sporozoites. Livers were 
extracted 3 h post infection and phospho-
Ser473-Akt and total Akt were quantified. ni, not 
infected.
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Inhibition of PI3-kinase pathway decreases Plasmodium 
infection in vivo
To determine whether the above-described finding
observed in vitro could be extrapolated to a natural infec-
tion in vivo, we treated mice with the PI3-kinase inhibitor
LY294002, that is also active in in vivo models (Hu et al.,
2002; Semba et al., 2002). The results show that in vivo
inhibition of the PI3-kinase pathway led to a reduced liver
infection by Plasmodium sporozoites (Fig. 4C). Western
blot analysis was also performed to confirm that the inhib-
itory treatment was targeting the PI3-kinase pathway. As
shown in Fig. 4D, the phosphorylation of AKT was
reduced in LY294002-treated animals. Taken together, our
in vitro and in vivo results reveal that the anti-apoptotic
effect exerted by HGF/MET signalling through activation
of the PI3-Kinase/Akt pathway is crucial for the success
of a malaria infection.
Discussion
On entering their host, Plasmodium sporozoites migrate
directly to the liver. Once there, they migrate through sev-
eral hepatocytes by breaching their plasma membranes
before infecting a final one surrounded by a parasito-
phorous vacuole where the intrahepatic form of the para-
site grows and multiplies (Mota et al., 2001). Although
during this period there is an extensive parasite multipli-
cation (each parasite gives rise to 10–30 thousand new
parasites in 2–10 days, depending on the parasite spe-
cies), not much is known about its requirements and the
strategies used to survive and to accomplish a successful
development. It is known that intracellular pathogens have
developed powerful abilities to manipulate host cell func-
tions that benefit the pathogen (Sibley, 2004). In particular,
it seems that many pathogens have evolved to exploit host
cell machinery involved in normal cell proliferation, devel-
opment and cell death (apoptosis) to their own advantage
(Blaho, 2003). The results presented in this report show
that P. berghei sporozoites are not an exception and
require an active process of inhibition of host cell apopto-
sis in order to reach the next infective stage. However,
Plasmodium sporozoites seem to use a unique feature
since they take advantage of a host molecule not secreted
by the infected cell but by neighbouring ones, previously
traversed by the parasite. Whether this is the solely mech-
anism used by the parasite to avoid host cell apoptosis
remains unknown.
Our results also show that PI3-kinase activation is
important for the survival of the infected cell. The anti-
apoptotic effect mediated by HGF uses this signal trans-
duction pathway. However, we cannot exclude that the
infection inhibition observed both in vitro and in vivo by
the specific PI3-kinase inhibitor could be due to PI3-
kinase mediated survival signals other than those gener-
ated through HGF/MET signalling.
We have previously shown that HGF and its receptor
are required for a malaria hepatic infection and that host
cell actin cytoskeleton remodelling is one of the causes
of such requirement (Carrolo et al., 2003). In fact, we have
observed that pretreatment of host cells with HGF abro-
gates the negative effect that cytochalasin-D has on infec-
tion. This strongly suggests that HGF/MET signalling
effect on infection involves the host cell actin cytoskeleton
reorganization (Carrolo et al., 2003). We now report that
part of HGF/MET activity on infection is also due to pre-
vention of infected host cell apoptosis, a crucial require-
ment to elicit the full development of the parasite. Upon
HGF stimulation, MET mediates the coordinated execu-
tion of multiple cellular processes. Thus, it is likely that
many of these processes might play a role during the
development of Plasmodium sporozoites inside cells. It is
also likely that apoptosis protection and actin reorganiza-
tion are linked. In fact, studies in bacteria have demon-
strated that several bacteria interfere with the fate of host
cells through their activity on Rho GTPases, also favour-
ing survival or death depending on their needs (Fiorentini
et al., 2003).
Recently, a protein called SPECT (sporozoite micron-
eme protein essential for cell traversal) was characterized
in one of the secretory organs of sporozoites, the micron-
emes (Ishino et al., 2004). Transgenic parasites lacking
this protein do not migrate through cells in vitro and show
a strong reduction of infectivity in vivo, indicating that
migration through host cells is required to establish a
successful infection in the host. However, these results
appear to contradict our hypothesis that migration through
cells leads to HGF secretion required for infection, as they
are able to infect host cells in vitro without previous migra-
tion through cells. Therefore, they would not induce host
cells to produce HGF and infection would be inhibited. The
reason for this apparent discrepancy may be found in the
particular characteristics of the in vitro cell system used
for infection. The hepatoma cell line (HepG2 cells) pro-
duces constitutively HGF and other factors that induce a
basal level of activation of MET receptor (Conrotto et al.,
2004). This is different from the conditions that sporozoites
encounter in vivo, as in resting conditions primary hepa-
tocytes do not express HGF and MET is not activated
(Matsumoto and Nakamura, 1991). These constitutive lev-
els of HGF are probably enough to support sporozoite
infection at a basal level and therefore the additional HGF
induced by migration would not be required.
Hepatocyte infection by Plasmodium sporozoites
begins by traversing several hepatocytes disrupting their
plasma membranes. This process induces the activation
of sporozoite exocytosis (Mota et al., 2002) and the secre-
tion of HGF from hepatocytes (Carrolo et al., 2003). HGF
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binds to its receptor (MET) in neighbour hepatocytes, and
activates signal transduction pathways that make them
susceptible for infection (Carrolo et al., 2003). Inhibition of
HGF/MET signalling leads to an increase of infected host
cell apoptosis during early stages of intrahepatic parasite
development, thus decreasing the success of infection.
Development of Plasmodium sporozoites inside hepa-
tocytes is the first obligatory step in a mammalian host
and it is decisive for the success of a malaria infection.
Thus, the study of parasite requirements to achieve the




HepG2 or Hepa1-6 cells were maintained in DMEM 10% FCS,
1% penicillin/streptomycin and 1 mM glutamine. P. berghei ANKA
sporozoites were obtained from dissection of infected Anopheles
stephensi mosquito salivary glands.
Sporozoite infection
Plasmodium berghei sporozoites (3 ¥ 104) were added to mono-
layers of 2 ¥ 105 HepG2 or Hepa1-6 cells for 6 or 24 h before
fixation and staining with anti-EEF mAb (2E6) (Tsuji et al., 1994),
followed by anti-mouse secondary antibodies. Infection was
quantified by counting the number of infected cells (EEFs, exo-
erythrocytic forms) per coverslip. The study of the effect of differ-
ent reagents on infection were performed in distinct ways: (i) HGF
(500 ng ml-1) was added to cells 1 h prior to infection; (ii) The
agonist antibodies DN-30 and DO-24 (1 mg ml-1) were added to
cells 90 min post infection; and (iii) LY294002 (25 mM) and
PD98059 (30 mM) were added to cells 1 h prior to infection and
followed by washes before addition of P. berghei sporozoites.
Apoptosis induction and detection assays
For the apoptosis induction assays, HepG2 or Hepa1-6 cells
were treated with TNF (10 ng ml-1, R&D Systems) and Cyclohex-
imide (10 mg ml-1, Sigma) or with UV stimuli, in order to induce
apoptosis, 18 h post infection with P. berghei sporozoites. Heat-
killed parasites (30 min at 56∞C) were used as control. Six hours
later cells were fixed and stained for parasite detection and
apoptosis quantification. Three distinct fluorescent methods for
apoptosis detection were used, based on different features of
apoptosis: (i) TUNEL (Roche), which detects DNA breaks; (ii)
nuclear morphology by DAPI staining; (iii) active caspase-3
detection (Promega). During infections with P. berghei sporozoi-
tes, apoptosis was detected 6 h post infection. The effect of
different reagents on infected cell apoptosis was performed as
described above.
Hepatocyte cell lines transfection and MET modulation
Vectors collected from 24 h supernatants of transfected Phoenix
cells were used to infect HepG2 cells. Infected cells were
selected with G418 (1 mg ml-1) and the resistant cells were
pooled and examined by Western blot.
MET expression was down-modulated in HepG2 cells by trans-
duction with the lentiviral vector PCCLsin.PPT.hPGK.GFP.Wpre,
used to express siRNA for MET or control siRNA (under the
transcriptional control of the H1 promoter). The oligonucleotides
used were as follow: for MET, 5¢- GATCCCCGTCATAGGAAGA
GGGCATTTTCAAGAGAAATGCCCTCTTCCTATGACTTTTTGG
AAA-3¢ and 5¢-AGCTTTTCCAAAAAGTCATAGGAAGAGGGCAT




TCTTCCTATGAGGGG-3¢. Lentivirus production and infection of
HepG2 cells were performed as previously described (Vigna and
Naldini, 2000).
Quantification of in vivo infection by real-time PCR and 
Akt Western blot
Mice were injected intraperitonealy with 2.5 mg of LY294002
(Calbiochem) in DMSO. The control group was injected with the
same volume of DMSO. Thirty minutes later, mice were infected
by intravenous injection with P. berghei (5 ¥ 104) sporozoites.
Real-time PCR using primers specific for P. berghei 18S rRNA
(5¢-AAGCATTAAATAAAGCGAATACATCCTTAC-3¢ and 5¢-GGAG
ATTGGTTTTGACGTTTATGTG-3¢) was used for quantification of
parasite load in the livers of mice 40 h after challenge, according
to the method developed to P. yoelii infections (Bruna-Romero
et al., 2001).
Mice were injected or not (control) with LY294002 or DMSO
30 min prior to infection with P. berghei sporozoites. 3 h post
infection, livers were extracted and SDS-PAGE gels of cell lysates
were probed with polyclonal antiphospho-Akt (phospho-Ser-473)
and total Akt antibodies (Cell Signalling). Detection was per-
formed by using enhanced chemiluminescence (Amersham
International).
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